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ABSTRACT
Flavonols are polyphenols, secondary plant metabolites commonly found in 
plants and foods of plant origin. They have widespread biological properties in the 
human body. The recent discovery of their potential antioxidant activities has prompted 
extensive research. Flavonols particularly quercetin are potent antioxidants with higher 
antioxidant properties than the well known antioxidant vitamins C and E. Several 
epidemiology studies have demonstrated a strong inverse association between flavonoid 
intake and risk of coronary heart disease. The association with cancer is less defined 
with only some studies showing an inverse association and others not. In view of their 
potential to act as antioxidants and prevent oxidative damage-related diseases, it is 
important to have an understanding of their bioavailability. Indeed, information of the 
absorption and metabolism of individual flavonols in man is limited. Previous 
investigations of their absorption have shown conflicting results. It was previously 
speculated that flavonol glycosides were not absorbed due to their conjugation to sugar 
molecules and that only the agi y cones were transported into the blood stream. However, 
recent research has detected the presence of quercetin glycosides in plasma. These 
findings disagree with the earlier postulation that flavonol glycosides were not absorbed. 
In addition to absorption, the metabolism of flavonoids is another important area of 
research. As yet, little flnn information is available on the fate of flavonols following 
absorption. The aim of the present study was to conduct further research on the 
absorption and metabolism of flavonols and to establish the influence of flavonol 
structure on the extent of their absorption and metabolism.
In the first study, the accumulation of flavonols in plasma and their excretion in 
urine was investigated after a meal of lightly fried onions. Five healthy volunteers 
followed a low flavonol diet for 4 days. On day 3, after an overnight fast, subjects 
consumed 300 g of lightly fried yellow onions containing quercetin-3,4'-diO-p- 
glucoside, isorhamnetin-4'-0-p-glucoside and quercetin-4'-0-P-glucoside. Blood was 
sampled at 0 min, 0.5, 1.0, 1.5, 2, 3, 4, 5 and 24 h after the supplement. In addition, 
subjects collected all their urine for 24 h following the onion supplements. Isorhamnetin- 
4'-0-p-glucoside, a minor flavonol in onions accumulated in plasma at higher levels than 
quercetin-4'-0-p-glucoside which was a major onion flavonol. The peak concentration
in plasma, expressed as percentage of intake of isoihamnetin-4'-(9-P-glucoside and 
quercetin-4'“0-p-glucoside was 10.7 ± 2.6% and 0.13 ± 0.03 %, respectively. The time 
taken to reach peak plasma concentration after ingesting the onions was 1.8 ± 0.7 h for 
isorhamnetin-4'-0-p~glucoside and 1.3 ± 0.2 h for quercetin-4'-O-p-glucoside. 
Excretion in urine, as a proportion of intake, was 17.4 ± 8.3% for isorhamnetin-4 -O-P- 
glucoside and 0.2 ± 0.1% for quercetin-4'-0-P-glucoside. It was concluded that 
flavonols are absorbed into the bloodstream as glucosides. Structural differences in the 
flavonol molecule appeared to affect the level of accumulation and the extent to which 
they are excreted.
Further studies investigated the influence of structural modifications on flavonol 
absorption from the intestine. An in vitro everted rat gut model was employed to assess 
the uptake of several flavonol glycosides as well as free quercetin. Everted rat jejunal 
segments (6-10 cm) were incubated at 37°C in 20 ml of Krebs buffer containing 10 pM 
of the test flavonols. The incubation media was continuously gassed with 95% O2 and 
5% CO2 . Incubation was performed for 30 min with samples taken every 5 min from the 
serosal side. The rate of uptake of flavonols were in the order of quercetin-3,4'-di(9-p- 
glucoside > quercetin-3-O-p-rutinoside > quercetin-3-O-p-glucoside > quercetin-3-O-p- 
rhamnoside > quercetin-4'-0-p-glucoside > isorhamnetin-4'-O-P-glucoside > quercetin 
demonstrating the structural dependence of flavonols on their uptake across the intestinal 
mucosa. Quercetin glycosides and diglucosides as well as isorhamnetin-4'-O-p- 
glucoside were better absorbed than quercetin aglycone. Flavonol glycosides with 
glucose substitution at C3 or at both C3 and C4' were better absorbed across the small 
intestine than those with a glucose substitution only at C4'.
In the light of the differential uptake of flavonols across the intestine, the 
mechanism of their absorption was explored using the everted rat gut model described 
above. The uptake of quercetin-3-O-p-glucoside appeared to be concentration dependent 
with evidence of saturation observed in the concentration range of 10 pM to 500 pM. 
Several experiments were performed to assess the role of the sodium-glucose transport 
pathway (SGLTl) in flavonol transport. There was no significant difference in the rate 
of uptake of 10 pM quercetin-3-O-P-glucoside in the presence of 0, 1, 10, 50 and 100 
mM glucose (P>0.05). Phloridzin, an inhibitor of SGLTl did not reduce the rate of
i i
transport of 10 pM quercetin-3-<9-p-glucoside at concentration of 1 mM and 5 mM 
(P>0.05) although the same concentration inhibited glucose transport by ca. 33%. A 
slight inhibition was observed in the uptake of 10 pM quercetin-3,4'-diO-p-glucoside in 
the presence of 1 mM phloridzin, but this was not statistically significant (P>0.05). The 
possibility of quercetin-3-O-P-glucoside acting as an inhibitor of SGLTl was also 
investigated. This glucoside did not inhibit uptake of 10 mM glucose at concentrations 
of 10 pM, 50 pM and 500 pM. This study showed that the intestinal uptake of 
quercetin-3-(9-P-glucoside and possibly other quercetin glucosides was carrier-mediated. 
We conclude from this study that SGLTl did not play a role in the uptake of flavonol 
glucosides.
The liver metabolism of flavonol glucosides, quercetin-3,4'-di0-p-glucoside, 
quercetin-4"-0-p-glucoside, quercetin-3-O-p-glucoside , and isorhamnetin-4'-0-P- 
glucoside was investigated in an in vitro experiment. A 24 nM solution of flavonol was 
incubated in 10 ml of phosphate buffer (50 mM, pH 7.4, containing 10 mM MgCL) 
together with 1 g of rat liver homogenates with or without 24 nM .S-adenosyl methionine, 
incubation was performed for 2 h at 37°C with samples withdrawn every 10 min for the 
first half an hour followed by every 30 min thereafter. Metabolism of the four flavonol 
glucosides was seen. The extent of the reaction was highest for quercetin-4'-O-P- 
glucoside (89.1 ± 1.7 %), followed by quercetin-3-O-p-glucoside (67.6 ± 2.7 %), 
isorhamnetin-4'-0-p-glucoside (63.6 ± 0.4 %) and quercetin-3,4'-diO-P-glucoside (31.9 
± 4.1 %). Extensive méthylation of quercetin-3-O-p-glucoside occurred with less than 
10 % remaining after 2 h. Deglycosylation of the flavonol glycosides occurred, evident 
from the appearance of deglycosylation products. As the percentage accumulation of 
metabolites was much lower than the percentage of the substrate metabolised, other 
metabolic reactions, in addition to deglycosylation and méthylation, would appear to 
have been taking place.
Results obtained from this thesis can partially explain the seemingly low 
absorption of flavonol glycosides from the small intestine and their accumulation in 
plasma. The structure of flavonols, particularly the nature and position of the sugar 
moiety, has a major influence on their absorption and potential bioavailability.
Ill
Furthennore, the substantial metabolism of flavonol glucosides by the liver may 
contribute to the low levels of the parent compounds detected in plasma and urine.
Findings from this present study raised interesting health promotion possibilities 
as identification of the flavonol conjugates which will be highly absorbed into the 
bloodstream can be used to encourage the public to increase their intakes of flavonol-rich 
fruit and vegetables. Identification of the metabolites of flavonol metabolism with 
potential anti oxidant activities can further contribute towards promoting the beneficial 
effects of increasing intakes of flavonol-rich foods.
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CHAPTER 1: LITERATURE REVIEW
1.1 Introduction
The feîatïonshfp between human diet and disease has been studied for many 
years. Diet is tecognised as one of the main factors influencing disease and life- 
threatening conditions particularly in the middle aged and elderly. Each year, a 
significant percentage of the groups suffer from diet-related diseases such as 
hypertension, cancer and diabetes. Thus, the potential contribution of diet towards 
prevention of disease is widely studied as one of the means of improving or maintaining 
quality of life. Furthermore, as prevention is better than treatment, various ways are 
being investigated to prevent development of diseases.
1.2 Diet and d isease
Coronary heart disease results in more deaths than any other single cause in 
countries around the world, particularly in western populations. The UK has one of the 
highest deaths from coronary heart disease in the world. Recent Scottish Health 
Statistics Report (1998) indicated a general fall in the incidence and mortality rates of 
ischaemic heart disease in Scotland over the period 1987-1996. However, Scotland 
holds the top position for coronary heart disease in the UK. Smoking, high blood 
pressure and raised serum cholesterol levels are the major risk factors for heart disease, 
the last two largely affected by diet.
In addition to coronary heart disease, diet may also be related to the development 
of cancer at several sites. After heart disease, cancer is the second cause of death in 
western countries. Scotland for instance, has the world’s highest incidence of lung 
cancer in females (Scottish Health Statistics Report, 1998). Cancer of the breast, 
stomach and bowel are attributable primarily to diet (Doll and Peto, 1981).
Diet can either promote or prevent heart disease and cancer. Fat, cholesterol, salt 
and alcohol are possible initiators of heart disease and cancer whereas dietary fibre and
I
the antioxidant nutrients may be protective. In view of the potential protective effects of 
diet, extensive research, has been carried out to identify these beneficial nutrients, as well 
as foods in which they are present in high levels. The ability of fruit and vegetables to 
provide high quantities of the antioxidant nutrients is well established (Williamson, 
1996).
1.3 The importance o f fruit and vegetables.
Fruit and vegetables have long been known to be beneficial to health. They are a 
rich source of vitamins and minerals that the body cannot synthesize but which are 
essential to maintain normal development and function as well as provide protection 
against a variety of diseases. People with diets rich in fruit and vegetables enjoy better 
health than those with a low intake. In view of the beneficial health properties of fruit 
and vegetables, it has been recommended that people should consume at least 5 portions 
of fruit and vegetables each day (Foerster et a i, 1995).
There is emerging epidemiological evidence that low intakes of fruit and 
vegetables can contribute to several disease conditions including coronary heart disease, 
cancers, obesity and diabetes (Knekt et al,, 1994, Ness and Powles, 1997, Williams et 
al., 1999). In addition to vitamins and minerals, fruit and vegetables are also low in fat 
and calories and a good source of dietary fibre. Extensive studies have been performed 
to identify the compounds in fruit and vegetables thought to provide protection to the 
body. Among the compounds identified are the antioxidant nutrients, the main ones 
being vitamins C, E and carotenoids and also the minerals selenium and manganese. 
Antioxidants are able to scavenge highly reactive free radicals which cause oxidative 
damage to body tissues (Flalliwell, 1996). This helps delay or prevent development of 
diseases related to free radical damage (see section 1.8). Although the human body has 
its own defense against oxidative damage, this is inadequate. Thus, diet-derived 
antioxidants are important in maintaining health.
Attempts have been made to further identify other bioactive compounds in fruit 
and vegetables with potential health properties. This has led to the discovery of various 
other non-nutrients with potential antioxidant activities. The most important are
2
phenolic compounds that are secondary plant metabolites made irp of various classes of 
compounds inclnding bydtoxybenzoales, hydioxycinnamates and a range of 
polyphenols. Flavonoids are the main class of polyphenols. They are potent 
antioxidants and some are more active than the well-known vitamin antioxidants (Vinson 
et a l, 1995, 1999). This thesis describes the nature and importance of flavonoids and 
discusses these bioactive compounds and their possible role in providing protection 
against diseases. Their absorption and metabolism, which is of particular importance 
will be discussed in detail later in this chapter.
1.4 History of flavonoids
Flavonoids have been reported from as early as 1925, with the description of the 
anthocyanin pigments in plants (Onslow, 1925). Even before their antioxidant properties 
were identified, flavonoids had been used for many years in traditional medicine for the 
purpose of maintaining good health and general well being. Approximately 40 species 
of plants have been reported to be used as phytomedicines due to their flavonoid content. 
One of the more popular is Ginkgo biloba.
Initially, certain citrus-flavonoids were claimed to have vitamin properties, and 
were referred to as ‘Vitamin P’ (Rusznyak and Szent-Gyorgyi, 1936). However, this 
term was later dropped due to insufficient evidence to support their role as indispensable 
food components equivalent to vitamins. In recent years, research has been focussed on 
the identification and quantification of flavonoids from plants. In this way, the 
physiological and biological properties of individual flavonoids can be evaluated. More 
importantly, flavonoids that are especially beneficial to health can be identified.
1.5 Chemistry of Flavonolds
Flavonoids are a class o f polyphenols that occur ubiquitously in plants and plant 
products. They are not synthesised in animals, but are found in plant-derived foods. The 
biological activities o f flavonoids at pharmacological doses are well established (Ferry et 
a i,  1996, Herrera et al., 1996) but an important issue is whether they can provide any 
potential health benefits at normal dietary intakes.
Flavonoids are found in every family and nearly every species o f higher plant 
(gymnosperms and angiosperms). Flavonoids typically occur as conjugates linked to 
sugars such as glucose, rhamnose or galactose (Cook and Samman, 1996). Relatively 
small amounts are found in the free form as aglycones.
A basic flavonoid molecule consists o f two 6C aromatic rings (A and B rings) 
linked by a 3C unit (C ring) (Figure 1.1). Ring A is formed by the acetate pathway 
whereas ring B is formed by the shikimate pathway. Condensation o f  ring A with the 
carboxyl group o f ring B formed the chalcones which then undergo cyclization to flavane 
derivatives.
Figure 1.1: Basic flavonoid structure
The structure o f the flavonoid molecule allows a multitude o f substitution 
patterns to occur, giving 13 different sub-classes, the main ones being flavones, 
flavonols, flavan-3-ols, isoflavones, anthocyanidins and flavanones. The substitutions in 
the flavonoid molecule include hydrogenation, hydroxylation, méthylation, sulphation 
and glycosylation (Cook and Samman, 1996).
To date, over 8000 different flavonoids have been identified and the list still 
increasing. Not all plant-derived foods have been examined to determine their exact 
flavonoid content, therefore the information regarding actual flavonoid intake o f humans 
is incomplete. However, this situation is changing as more studies are perfonned on the 
identification and quantification o f flavonoids in foods commonly consumed in the 
human diet. Hertog et al. (1992) recently reported the tlavone/flavonol content of 28 
vegetables and 9 fruits consumed in the Netherlands. An extension o f such studies will 
be useful in the estimation o f flavonoid intake o f the human diet and at the same time, 
the findings can be used in epidemiological studies to determine the association between 
flavonoid intake and disease occurrence. Before going into further detail on the 
beneficial role o f this polyphenol, a brief explanation on the different sub-classes and 
their biosynthesis is discussed.
1.5.1 Sub-classes of flavonoids
Flavones
o
Figure 1.2: Structure of  flavone
Flavones consist o f a group o f pale yellow pigments o f flower petals, leaves, 
seeds and fruits. They are less prominent in fruits compared to other classes of 
flavonoids, with the exception o f citrus fruits. Common flavones include apigenin, 
luteolin and diosmetin. Their roles in plants are to provide colour and taste to plant 
tissue (Peterson and Dwyer, 1998). Herbs such as parsley, rosemary and thyme and 
cereal grains contain flavones (Peterson and Dwyer, 1998).
1.5.1.2 Flavonols
OH
Figure 1.3: Structure o f  flavonol
The structure o f Havonol is very similar to llavones except for the addition o f a 
hydroxyl group at C3 o f ring C in the former. Flavonols are pale yellow and sparingly 
soluble in water. They are abundant in flowers and leaves making the flavonols one o f 
the most widely studied flavonoid groups. Some o f their roles include acting as 
regulators o f  germination, flowering and pollen tube growth (Furuya el uL, 1962). 
Quercetin, kaempferol and isorhamnetin are some o f the more common flavonols and are 
found in leafy vegetables, berries, herbs and legumes.
1.5.1.3 Flavan-3-ols
Figure 1.4: Structure of  (+)-catechin
Flavan-3-ols such as (+)-catechin (Figure. 1.4) and (-)-epicatechin are colourless, 
water-soluble and oxygen-sensitive substances. Their structure consists o f one OH 
group in position C3 o f ring C as well as saturation o f ring C. Catechins represent the 
group o f flavonoids that occur in highest concentrations in green plants especially in teas 
and fruits such as grapes, black currants and strawberries (Peterson and Dwyer, 1998, 
van het H of et a!., 1999). Catechin derivatives including epicatechin, epicatechin gal late 
and epigallocatechin gallate are present in high concentrations in grape seed and black 
and green tea. The astringent taste o f fruits, teas and wine are provided by catechins.
Condensation o f catechins leads to the formation o f a range o f oligomeric 
proanthocyanidins.
isoflavones
Figure 1.5: Structure o f  isoflavone
Isotlavones differ from the other sub-classes o f flavonoids with attachment o f the 
B ring at the C3 position of ring C. Daidzein and genistein are the most common 
isoflavones. Isoflavones are water-soluble compounds. This sub-class is found almost 
exclusively in legumes such as black bean, chickpeas and green split peas. Soybean is 
the most abundant source o f isoflavones and research has been performed on the possible 
health properties o f soybean. Isoflavones are widely known for their estrogenic 
properties (Setchell and Cassidy, 1999). This has prompted investigation on their role as 
potential alternative therapies for a range o f hormone dependent conditions including 
cancer, menopause symptoms and osteoporosis.
1.5.1.5 Anthocyanidins
OH
Figure 1.6: Structure o f  anthocyanidin
Anthocyanidins are water-soluble plant pigments and contain a flavylium 
structure with a cation group on ring C. Anthocyanidins such as cyanidin, delphinidin 
and pelargonidin are responsible for most o f  the red, blue and intermediate colours o f
(lowers and fruits, their role being associated with pollination or seed distribution. They 
occur in leafy vegetables, cereals, tubers and bulbs and are also present in fruits such as 
berries, apples and plums. The most common naturally occurring anthocyanins in the 
plant kingdom are the 3-glycosides or 3,5-diglycosides o f anthocyanidins (Harbome, 
1967). Conjugated anthocyanidins are called anthocyanins. The colour o f anthocyanins 
is pH-dependent with anthocyanidins being relatively insoluble whereas their glycosides 
are easily soluble and stable at pH 3-7.
Flavanones
Figure 1.7: structure of flavanone
Flavanone is the precursor for the synthesis o f other sub-classes o f tlavonoids. 
Flavanones are found mainly in citrus fruits and contribute to the flavour o f these fruits. 
In addition, liquorice roots, cumin and peppermint also contain flavanones. Naringin, 
which is found in grapefruit, provides the bitter taste whereas hesperidin in oranges is 
tasteless.
1.6 The brosynthesîs of flavonoids
1.6.x Introduction
The biosynthesis of all flavonoids involves three main pathways consisting of the 
shikimate pathway for the synthesis of aromatic amino acids, the general 
phenylpropanoid pathway for the synthesis of the intermediates for various flavonoids 
and the pathway for the modification of the flavonoid aglycones.
1.6.2 The shikimate pathway
The shikimate pathway, found only in microorganisms and plants is an essential 
route to the biosynthesis of aromatic amino acids including phenylalanine, tyrosine and 
tryptophan. It is responsible for the formation of the phenylpropanoid units, the 
precursors for flavonoid biosynthesis. Intermediates derived from this pathway act as 
protein building blocks and more important, in the synthesis of various secondary 
metabolites such as plant pigments and UV light protectants, although in this case, only 
the biosynthesis of flavonoids will be discussed (Figure 1.8). As only a brief explanation 
is given, the enzyme involved in each step is not discussed.
The carbon skeleton of the flavonoid molecule is derived from acetate and 
phenylalanine. Phenylalanine undergoes a series of reactions to form 4-coumaroyl CoA 
which forms the B ring and parts of the heterocyclic C ring of the flavonoid skeleton. 
Ring A is formed by condensation of three acetate units via malonyl CoA. Malonyl-CoA 
and 4-coumaroyl CoA are the precursors for the synthesis of all flavonoids. 
Condensation of ring A with 4-coumaroyl CoA produces tetrahydroxychalcone which 
subsequently undergoes isomerization to flavanone (naringenin). Flavanone acts as the 
precursor for the synthesis of the other sub-classes of flavonoids including flavones, 
flavonols, anthocyanidins and isoflavonoids.
Flavones (e.g apigenin) are synthesised from flavanones by introduction of a 
double bond between C2 and C3. On the other hand, oxidative rearrangement of the 
flavanone with a shift of ring B from position 2 to 3 give rise to isoflavone such as
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genistein. Hydroxylation of flavanone in position 3 fonns dihydroflavonol, acting as 
intermediates in the synthesis of flavonols, catechins, proanthocyanidins and 
anthocyanidins. Introduction of a double bond between C2 and C3 of dihydroflavonols 
leads to the synthesis of the subclass flavonol.
Reduction of dihydroflavonols in position 4 leads to the formation of 
leucopelargonidin which act as an intermediate in the synthesis of catechin, 
proanthocyanidin and anthocyanidin. The synthesis of anthocyanidin involves a series of 
reactions including reduction of the carbonyl group of dihydroflavonol (Harbome and 
Grayer, 1986). Further reduction in position 4 of leucoanthocyanidins gives rise to 
catechins (e.g. Afzelechin). Leucoanthocyanidins are also the precursors for anthocyanin 
biosynthesis.
1.6.3 Steps to flavonoid modification
Simple flavonoids can be modified to give various aglycones or conjugates 
within each flavonoid class. This is achieved by further hydroxylation of rings A and B, 
followed by méthylation, glycosylation or sulphation of the various hydroxyl groups. 
The most common structural modifications of flavonoid aglycones are hydroxylation and 
subsequent méthylation in the 3' and 5' positions of ring B (Ebel and Hahlbrock, 1982). 
Extensive studies have been performed on the biosynthesis of flavone and flavonol 
glycoside particularly in parsley (Ebel and Hahlbrock, 1982). The sequence of reactions 
includes substitutions of ring B of the aglycones by hydroxylation and O-methylation 
followed by glycosylation and acylation of the resulting glycosides.
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Figure 1.8: A schematic diagram of the pathway of  the biosynthesis o f  flavonoids
1.7 Role of flavonoids
1.7.1 Role of flavonoids in plants
Table 1.1: Summary of the role of flavonoids in plants
Function Example of flavonoids Reference
UV protectants Anthocyanins, flavones, 
isoflavonoids
Dixon and Paiva, 1995
Regulate auxin levels Flavones Moore, 1989
Provide colour to plants Anthocyanins Harbome and Grayer, 1986
Attract pollinators Anthocyanins Harbome and Grayer, 1986
Aid in seed dispersal Anthocyanins Harbome and Grayer, 1986
Feeding deterrents Anthocyanins Harbome and Grayer, 1986
Protection against stress;
i) Pathogen attack 
11) Cold temperature 
lii)Nutritional stress
(e.g. low nitrogen or low 
phosphate)
Flavonols, isoflavonoids 
Anthocyanins
Isoflavonoids, anthocyanins
Bailey and Mansfield, 1982 
Christie et ai, 1994 
Graham, 1991
The main role of flavonoids in plants is to act as UV protectants and they are 
synthesised in response to light. They also control the levels of auxins, the regulators of 
plant growth and differentiation (Moore, 1989) in addition to providing colour, texture 
and taste to food plants (Harbome, 1986). At the same time, flavonoids can affect 
pollination by inhibiting or stimulating insect feeding (Hedin and Wangea, 1986).
Flavonoids are synthesised in response to UV-B light. Hence, they accumulated
in the upper epidermal cells of leaves (Day et al., 1993) and absorbed UV-B, preventing
further penetration into the leaf cells. Mutant plants lacking the ability to synthesise
flavonoids are more sensitive to UV-B (Landry et ai, 1995). Flavonoids are also
produced in plants in response to stress and this includes pathogen attack, high UV light,
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cold temperature and nutritional stress (Dixon and Paiva, 1995). Isoflavonoids and 
flavonols (e.g quercetin and kaempferol) are synthesised in response to pathogen attack 
(Bailey and Mansfield, 1982) and low levels of nitrogen in nitrogen-fixing plants 
(Graham, 1991) whereas anthocyanins increase following cold stress (Christie et al., 
1994).
Flavonoids can exist in both coloured and colourless forms in plants, and 
influence the feeding habits of animals, especially insects, birds and herbivores and 
thereby can indirectly affect pollination. Anthocyanins are the most important flavonoid 
plant pigments. The flower colours provided by flavonoid pigments provide attraction to 
pollinating insects with each class of pollinator having its own colour preferences. In 
addition, flower colour may also signal the availability of the flower for pollination to 
attract pollinators and may then change colour, lose their attractiveness and hence be 
avoided by the pollinators (Harbome and Grayer, 1986). This will assist in increasing 
the efficiency of the pollination process.
Certain flavonoids can act as attractants to stimulate insect feeding and in most 
cases, the 0-glycosides are the active compounds rather than the aglycones (Harbome 
and Grayer, 1986). At the same time, flavonoids that act as attractants for some insects 
may be a deterrent to others. The structure of the flavonoid molecule together with their 
substitution pattern helps determine their role either as attractants or deterrents in insect 
feeding. Flavonoids acting as insect deterrents have the potential to be used as 
insecticides and confer protection to crops against insect attack.
1.7.2 Role of flavonoids in human health
1,7.2.1 Introduction
Of greater interest is the role of flavonoids in human health and their ability to 
influence various functions in the human body. Clinically relevant functions have been 
ascribed to flavonoids including anti-inflammatory, anti-microbial, anti-cancer and 
hypocholesteroiaemic properties (Formica and Regelson, 1995; Table 1.2).
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Table 1.2: Summary of the role of flavonoids in human health
Function Example of flavonoids ; Reference
Anti-inflammatory agents Quercetin, myricetin, fisetin Koshihara etal., 1983
Vascular responses
i) inhibits platelet aggregation
ii) inhibits LDL oxidation
Quercetin, myricetin 
Catechins
Lanza etal., 1987 
Rice-Evans etal., 1996
Anti-microbial
1) anti-viral 
ii)'anti-bacterial
Quercetin, morin, catechin Selway, 1986
Schramm and German, 1998
Anti-cancer
i) inhibits protein kinase
ii) inhibits calmodulin
iii) prevents oxidative DNA damage
Quercetin, genistein, daidzein 
Quercetin
Quercetin, myricetin
Srivastava, 1985 
Nishino etal., 1984 
Duthie et al., 1997
Inhibitors of enzymes
i) catechol-O-methyl transferase
ii) membrane NaVK^ ATPase
Quercetin 
Flavonol aglycones
Borchardt and Huber, 1975 
Umarova etal., 1998
Antioxidant
See section 1.9
Quercetin, catechin Rice-Evans etal., 1996
1.7.2.2 Flavonoids as anti-inflammatory agents
The role of flavonoids as anti-inflainmatory agents is well established. 
Flavonoids such as quercetin and catechin can reduce inflammation by suppressing 
various functions of neutrophils including release of oxidants during phagocytosis 
(Busse et al., 1984). The mechanism of their action appears to involve the enzyme 
systems of signal transduction and cell activation processes of the immune system 
(Formica and Regelson, 1995). This includes the widely reported ability of quercetin to 
inhibit lipooxygenase and monooxygenase, enzymes of arachidonate metabolism 
responsible for maintaining integrity of the inflammatory systems (Koshihara et al., 
1983, Da Silva e ta l ,  1998).
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1.7.2.3 Flavonoids and anti-microbial activity
The antimicrobial activity of flavonoids against a variety of bacteria {E. coli and 
Salmonella), viruses (Influenza A, rhino viruses) and fungi are well documented (Selway, 
1986, Schramm and German, 1998). Compounds such as quercetin, morin and catechin 
possess antiviral activity and the mechanism of action is related to their ability to bind to 
viral coat protein and interfere with nucleic acid synthesis, therefore damaging DNA 
(Formica and Regelson, 1995). Damage of bacterial DNA by flavonoids is also 
postulated as the mechanism for the anti-bacterial activity of flavonoids. The aglycones 
appear to be the active forms particularly the methylated or lipophilic flavones 
(Ramaswamy et aL, 1972).
1.7.2.4 Flavonoids and vascular responses
Various mechanisms have been ascribed to the role of flavonoids in vascular 
responses. The ability of flavonoids to act as antioxidants and prevent LDL oxidation is 
well established (See section 1.9.1). The other important role is their capacity to block 
platelet aggregation. Flavonoids such as quercetin can inhibit the enzyme 
phosphodiesterase involved in cAMP breakdown (Lanza et al., 1987) as well as lipid 
peroxidation in the platelets (Gryglewski et aL, 1987), subsequently leading to inhibition 
of platelet aggregation. In addition, flavonoids are able to promote vascular relaxation, 
thereby regulating normal blood flow to the heart and this has been postulated as one of 
the mechanisms of protection against heart disease (Formica and Regelson, 1995).
1.7.2.5 Flavonoids and cancer
The role of flavonoids in the prevention of cancer is associated with their
ability to influence cancer-inducing processes in the body. These include the ability of 
certain flavonoids to inhibit enzymes for instance protein kinase (Srivastava, 1985) as 
well as the protein calmodulin (Nishino et aL, 1984) responsible for regulating many 
physiological activities such as tumour promotion and regulation of cell transformation 
and cell growth. In addition, flavonoids particularly quercetin and myricetin can 
suppress hydrogen peroxide-induced DNA damage in isolated human lymphocytes
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(Duthie et al., 1997). Neither a-tocopherol nor p-carotene showed protective effects 
implying the importance of flavonoids as an alternative source of antioxidants.
1.7.2.6 Flavonoids as inhibitors of enzymes
Other biological effects of flavonoids observed may be largely contributed by 
their ability to inhibit or promote several enzyme systems involved in major pathways 
that regulate various processes in the body. Some of the common enzymes inhibited by 
flavonoids are catechol-O-methyl transferase (Borchardt and Huber, 1975), protein 
kinase C (Srivastava, 1985) and NaVK^-ATPase (Umarova et al., 1998). These enzymes 
play a role in the function of various mammalian cellular systems including tumour 
promotion and the regulation of cell transformation and cell growth. In most cases, the 
aglycones are the active forms whereas the glycosides are less active (Harbome and 
Grayer, 1986).
Catechol-O-methyl transferase is involved in the metabolism and inactivation of 
the catecholamines epinephrine and norepinephrine which regulate various metabolic 
processes in the body. Flavonoids such as quercetin, are inhibitors of catechol-O-methyl 
transferase, resulting in prolonging physiological actions of catecholamines. This could 
subsequently promote anti-histaminic and anti-inflammatory effects as well as reducing 
capillary permeability (Kuhnau, 1976).
Flavonoids can inhibit membrane-located Na^/K^-ATPase responsible for 
maintenance of transport processes across membranes (Umarova et al., 1998). The 
Na^/K^-ATPase plays an essential part in the mechanism of the inotropic effect of 
cardiotonic compounds. Several flavonoids particularly quercetin are able to inhibit this 
enzyme and showed positive inotropic effect. This inhibitory action would restrict 
membrane permeability.
1.7.2.7 Flavonoids and pro-oxidant activity
Polyhydroxylated flavonoids are susceptible to oxidation reactions, which can 
lead to formation of oxygen radicals (Canada et al., 1990). This process has been 
suggested as the basis for the proposed mutagenic properties of flavonoids (Brown,
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1980). However, the superoxide anions formed during autooxidation of flavonoids could 
still be scavenged by the body’s defense system including superoxide dismutase, other 
antioxidants or by flavonoids themselves. Furthermore, at dietary levels (26 mg/day), 
flavonoids have not been shown to be carcinogenic or mutagenic, in fact several 
flavonoids possess anti-tumour activities (Kamei et ah, 1996).
1.7.2.8 Medicinal properties of flavonoids
Many species of plants with medicinal properties contain flavonoids. 
Approximately 40 species have been used as phytomedicines due to their flavonoid 
content. Ginkgo biloba, for instance, has various health properties and has been used for 
generations as a herbal medicine for treating peripheral vascular disease such as 
intermittent claudication^ and cerebral insufficiency" in the elderly (Kleijnen et al., 
1992). This plant contains'a number of compounds including flavonols, flavones and 
proanthocyanidins. Although there is strong evidence that Ginkgo can relieve cerebral 
insufficiency, its role in treating intermittent claudication is inconclusive (Kleijnen and 
Knipschild, 1992). It is thought that the alleged affects are linked to the anti oxidant 
properties of flavonoids and their interaction with various enzymes in the body (See 
section 1.7.2.6 and 1.9). Indeed, flavonoids have been shovm to exhibit potent action on 
the nitric oxide system which is involved in various aspects of physiological regulation 
particularly in the regulation of vascular tone (van Acker et a i, 1995).
1.7.3 Summary
Flavonoids are not only important to plants but also play a major role in humans 
too. However, of particular current interest is their potential to act as antioxidants. As 
most of the observed beneficial roles of flavonoids are possibly linked to their 
antioxidative ability, extensive research has been carried out on this topic. Knowledge of 
the mechanisms of action involved is crucial towards understanding the potential role of
 ^ Pain and cramp in the calf muscles, aggravated by walking and caused by insufficient blood supply.
 ^ A collection of symptoms associated with impaired cerebral circulation: include difficulties of 
concentration and of memory, absent mindedness, confusion, lack of energy, tiredness, decreased physical 
performance, depressive mood, anxiety, dizziness, tinitus, headache.
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flavonoids in preventing oxidative damage and protecting against diseases such as 
coronary heart disease and cancer. The next section describes the relationship between 
oxidative damage and these two diseases and the role flavonoids play in providing 
protection.
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1.8 Oxidative dam age in the body
In order to assess the antioxidant potential of flavonoids, an understanding of the 
mechanism of free radical reactions is needed. The human body is constantly under 
attack from free radicals, causing oxidative stress in tissues and organs. As mentioned 
previously, free radicals and oxidative stress play a role in the development of several 
diseases including cancer and coronary heart disease. Free radicals are highly reactive 
atoms or molecules, capable of existing independently. Electrons in atoms or molecules 
are usually paired and are thus able to function normally. However, the presence of one 
or more unpaired electrons create free radicals that are very unstable and have the 
potential to cause extensive damage to the human body. Examples of free radicals 
produced in the body include hydroxyl (OH"), superoxide (O2" ’) and nitric oxide (NO*) 
radicals.
Free radical reactions involve either donation or acquisition of a single electron 
from another atom. This process leads to the generation of a new radical. If this process 
is repeated, more radicals will be generated, creating a series of reactions known as the 
chain reaction of oxidation. Chain reactions can cause a lot of damage to cells and 
tissues in the body, subsequently affecting their normal structure and function. Free 
radicals can react with either another free radical or a nonradical. When a free radical 
reacts with another free radical, their unpaired electrons are joined to produce a 
nonradical. A typical example is the reaction of nitric oxide (NO*) with superoxide 
radical (O2 * ') (Figure 1.9a). This type of reaction is desirable as the free radical reaction 
can be terminated. However, the reaction between a free radical and a nonradical will 
result in the generation of a new radical. An example is the reaction between superoxide 
radical (O2* ') and a fatty acid (Figure 1.9b). This type of reaction is more common in 
the body as most biological molecules are nonradicals.
NO* + O2 "  --------- ► ONOO' (a)
O2 " + LOOH ---------► LOO’ + H2 O (b)
Figure 1.9: Examples of free radical reactions
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Sources of free radical production are varied; there are endogenous as well as 
exogenous sources. Endogenous sources include normal metabolic processes occurring 
in the body such as aerobic metabolism and the immune system. Approximately 1-3% of 
the oxygen we breathe into our lungs is turned into free radicals. Some free radicals 
however are made deliberately. The immune system, for instance, generates free radicals 
(superoxide and nitric oxide) as part of the body’s defence system against foreign 
materials. However, at the same time, too high a concentration of these radicals can 
damage nearby cells or tissues.
There are various exogenous sources of free radical production with cigarette 
smoke, pollution and radiation being the more important. Cigarette smoke is a major 
hazard in promoting oxidative damage in the body and its role in the development of 
cancer and heart disease is well established (Kalra et aL, 1991). Radiation, especially 
from sunlight can also contribute significantly to free radical production.
Oxidative stress caused by these free radicals can damage important cells in the 
body, affecting DNA, proteins and lipids and leading to impairment of their normal 
function. The human body normally has its own defence system to counteract free 
radical attack. This defence system is in the form of enzymes and antioxidants. The 
enzyme systems are synthesised naturally in our body whereas antioxidants are obtained 
from the diet. Thus, dietary antioxidants are important as intakes of food containing high 
levels of antioxidants can boost the body’s defence system and protect against free 
radical damage. Ideally, there should be a balance between free radicals and antioxidants 
in the body to limit damage but when there are more free radicals and insufficient 
antioxidants to protect against their effects, this will lead to oxidative damage.
Various diseases are associated with free radical damage. Cancer and coronary 
heart disease are the major diseases associated with free radicals, followed by cataracts 
and brain dysfunction such as Parkinson’s disease and Alzheimer’s disease.
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1.9 Antioxidant properties o f flavonoids
The structure of the flavonoid molecule together with the presence of hydroxyl 
groups makes them very strong anti oxidants. Various experimental studies have been 
performed to demonstrate the mechanisms of flavonoid action as antioxidants, using both 
aqueous and lipophilic systems (Cotelle et al., 1992, Salah et al., 1995). Attempts were 
also made to determine the hierarchy of the antioxidant activity of different flavonoids 
and to establish their structure-antioxidant activity relationships.
The effectiveness of flavonoids as antioxidants is dependent on their solubility in 
either the aqueous or lipophilic phase to achieve maximum interaction with the free 
radicals. Most of the initial research was carried out using in vitro systems (Rice-Evans 
et al., 1996, Frankel et al., 1993) and it was not until recently that more in vivo 
experiments were performed with the development of better and more sensitive 
analytical procedures (Day et al., 1997, Nigdikar et al., 1998, Serafmi et a l, 1998). 
Most of the in vitro studies determined the relationship between the structure of the 
different flavonoids and their effectiveness as antioxidants (Rice-Evans et al., 1996, van 
Acker et al., 1996). Based on the antioxidant activity of flavonoids in aqueous phase, it 
has been proposed that the requirements for maximum radical scavenging activities are i) 
a 3-OFI group on ring C and 5-OH group with 4-keto function in the A and C rings, ii) a 
2,3-double bond adjacent to the 4-carbonyl in ring C and iii) a catechol moiety on ring B 
(van Acker et aL, 1996). Quercetin, for example, satisfies all the criteria above and is a 
potent antioxidant (Vinson et al., 1995, van Acker et aL, 1996) (Figure 1.10a). 
Unsaturation in ring C allows electron delocalization across the molecule for stabilisation 
of the radical form. Catechin on the other hand did not satisfy one of the criteria above 
and showed a lower antioxidant activity than quercetin (Figure 1.10b). Unsaturation in 
ring C of catechin resulted in the loss of electron delocalization from the radical on the B 
ring to the A ring. Most studies have demonstrated strong antioxidant activities of the 
flavonoid aglycones compared to the glycosides (da Silva et al., 1998, Vinson, 1998). 
Glycosylation of flavonoids, for example in rutin (quercetin-3-rutinoside), reduces their 
activity due to blockage of the 3-OH group on ring C, while still retaining the catechol 
moiety (Rice-Evans et aL, 1996) (Figure 1.10c).
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Figure 1.10; Structural modification of  flavonoids and their antioxidant activities
The structural features for optimum antioxidant activity o f flavonoids in a 
lipophilic phase requires only the presence of a 3',4'-orthodihydroxy structure in the B 
ring and a 4-keto group in the C ring. The O-dihydroxy substitution in the B ring is 
needed for stabilising the resulting free radical form. In general, flavonoids especially 
the aglycones are not particularly water-soluble and have a more lipophilic characteristic. 
Thus, they are more likely to act as potent antioxidants in the lipophilic phase depending 
on their partition coefficient into the lipophilic region and their ability to react with the 
autooxidising lipids, it has been hypothesised that flavonoids such as catechins might be 
localised near the membrane surface, scavenging aqueous radicals and preventing 
consumption of a-tocopherol, whereas a-tocopherol mainly acts as a chain-breaking 
lipid peroxidation process within the LDL (Salah et al., 1995).
Although extensive research on the in vitro antioxidant activity o f flavonoids has 
been performed, very little information is available on the mechanisms through which 
these compounds act in vivo. Ultimately, in vivo studies are crucial to assess the 
bioactive role o f flavonoids in the body. Many o f the in vivo studies have investigated 
the antioxidant potential o f red wine and teas which are known to contain high levels of 
flavonoids (Princen et al., 1998, Serafini et al., 1998).
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Consumption of tea, particularly green tea, protects the plasma against 
peroxidation (Serafini et aL, 1996, Ishikawa et aL, 1997). High levels of the tea 
flavonoid catechins and theaflavins were postulated to prevent LDL oxidation by 
incorporation into the LDL molecule. In the first study, plasma of human volunteers 
collected after consumption of 300 ml of green tea significantly increased the lag-phase 
of 2,2’-diazobis(2-amidinopropane)dihydrochloride (ABAP)-induced peroxidation 
(Serafini et aL, 1996). The second study investigated the antioxidant effect of drinking 
five cups of tea per day for four weeks (Isliikawa et al., 1997). Plasma of volunteers 
collected at the end of the study prolonged the lag time of copper-catalysed LDL 
oxidation. In contrast to this, consumption of six cups per day of green and black tea 
over four weeks had no effect on copper-induced LDL oxidation in a group of smokers 
(Princen et aL, 1998). However, the large amounts of free radicals in cigarette smoker, 
which.can deplete antioxidant levels as well as cause lipid peroxidation in plasma, may 
explain the negative results. This may suggest that maximum protection is afforded to 
healthy humans where flavonoids can act in the prevention of free radical oxidative 
damage but may not be potent enough to act on damaged cells/tissues. Details on the 
mechanisms of antioxidant action of flavonoids are discussed in section 1.9.1.
Red wines have long been thought to provide beneficial health properties. They 
are rich in flavonoids particularly flavonols, anthocyanins and catechins (Bums et aL, 
2000) and it is thought that these components contribute to the protective effects of red 
wine against cardiovascular disease, a phenomenon popularised as the ‘French Paradox’. 
As people in France particularly the Southern of France consumed high amounts of red 
wine, this may explain the low incidence of cancer and coronary heart disease in France 
compared to the rest of the world (Renaud and De Lorgerii, 1992, Frankel et aL, 1993).
Data on the in vivo antioxidant activities of red wine are controversial with one 
study showing no effects (de Rijke et aL, 1996) whereas another showed protection 
against LDL oxidation (Nigdikar et aL, 1998). The possibility of alcohol in red wine 
influencing the in vivo antioxidant activities are excluded as similar studies with alcohol- 
free red wine (Serafini et aL, 1998) and concentrated red grape juice (Day et aL, 1997) 
showed enhanced plasma antioxidant capacity following their consumption.
1.9.1 Flavonoids and coronary heart disease
Oxidative damage caused by free radicals has been associated with the 
development of coronary heart disease (Strain et al., 1991). The three pathological 
conditions for coronary heart disease are angina pectoris, myocardial infarction and 
atherosclerosis. Atherosclerosis occurs as a result of narrowing of the blood vessels 
responsible for carrying blood to the heart. This can lead to heart attack due to 
impairment in blood flow.
Oxidative damage to low density lipoprotein (LDL) is implicated in the aetiology 
of atherosclerosis (Regnstrom et al., 1992). Figure 1.11 illustrates a schematic diagram 
of LDL oxidation. LDL is responsible for transporting cholesterol from the blood to the 
body’s tissues for storage and is susceptible to free radical attack especially in the blood 
vessel wall. Free radical attack on LDL leads to oxidation of the LDL molecule (Figure 
1.11). This is not recognised by the normal LDL receptors and is taken up instead by 
‘scavenger’ receptors on macrophages, a part of the white blood cell. A variety of 
products are formed as a result of LDL oxidation. Some of these products, for example 
lysolecithin are capable of inducing adhesion molecules for monocytes on the surface of 
endothelial cells (Kume et al., 1992). Other compounds such as cytokines can affect the 
growth of monocytes and their differentiation into macrophages and can also contribute 
to the disruption of endothelial cell integrity (Galis et aL, 1994). At the same time, 
smooth muscle proliferation occurs leading to injury of the endothelial cells. As more 
LDL is being oxidised, macrophages will be overladen with oxidised LDL, leading to the 
formation of foam cells. Foam cells together with smooth muscle cells will subsequently 
transform to fatty streaks, which over time slowly deposit on the endothelial cells 
causing narrowing of the blood vessels. A series of reactions occur which ultimately 
lead to platelet aggregation and subsequently to occlusive thrombosis. Myocardial 
infarction is caused by coronary thrombotic occlusions whereby the thrombotic clot 
breaks away and flows to a branch of the coronary arterial tree, thus blocking the artery.
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Figure 1.11: A schematic diagram of LDL oxidation
25
Polyphenols including flavonoids have been shown to inhibit copper-induced or 
macrophage-induced LDL oxidation in vitro (Frankel et al., 1993, de Whalley et al., 
1990, Vinson et al., 1995). The proposed mechanism of inhibition of LDL oxidation is 
via reducing the formation or release of free radicals in macrophages or possibly by 
protecting a-tocopherols in LDL from oxidation by becoming oxidised themselves (de 
Whalley et al., 1990). In addition, flavonoids can terminate the chain reaction of lipid 
peroxidation by hydrogen donation, thus becoming a flavonoid radical and in turn react 
with free radicals to stop the chain reaction from propagating (Robak and Gryglewski, 
1988).
In addition to preventing LDL oxidation, flavonoids can also act as anti­
thrombotic agents in vitro. Activated platelets lead to the generation of lipid peroxides 
and superoxide anions. These radicals can destroy the endothelium dependent relaxing 
factor (EDRF) which are responsible for vasodilatory activity as well as inhibiting 
platelet aggregation. Flavonoids particularly from the sub-class flavonols are able to 
bind to platelet membranes, and together with their free-radical scavenging action can act 
as anti-thrombotic and vasoprotective agents and preventing the generation of lipid 
peroxides (Gryglewski et al., 1987). At the same time, they can also prolong the half-life 
ofEDRF.
Flavonoids are also scavengers of superoxide anions and have the ability to break 
the chain of formation of free radicals. They act as hydrogen-donating radical 
scavengers, for example by scavenging lipid alkoxyl and peroxyl radicals (Robak and 
Gryglewski, 1988, Salah et al., 1995). This will stop or limit the initiation of free radical 
chain reaction that can ultimately lead to lipid peroxidation.
Flavonoids also possess metal-chelating properties e.g. towards iron and copper. 
Iron and copper are known to catalyse many processes leading to the generation of free 
radicals. Thus, their removal from the cells may inhibit the formation of oxygen 
radicals. Catechin, quercetin and diosmetin are capable of removing iron from iron- 
loaded hepatocyte cultures (Morel et aL, 1993) possibly by forming an inert complex 
with iron. Afanas’ev et al. (1995) demonstrated the formation of an iron-rutin complex 
which is inactive and unable to produce oxygen radicals and this may play an important 
role in the antioxidant action of flavonoids.
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1.9.2 Flavonoids and cancer
Oxidative stress by free radicals has also been implicated in the development of 
cancer at many sites. Sunlight exposure and radiation, some of the sources of free 
radical production are risk factors for skin and lung cancer.
Cancer occurs as a result of abnormal cell division during growth and renewal of 
cells. Carcinogens, including free radicals, can initiate cancer by causing changes in
DNA, leading to mutation of the DNA. When a mutated DNA is fixed in replication, the 
damage will be transferred into the new DNA. Accumulation of damaged DNAs 
ultimately leads to cancer. Various mechanisms have been postulated for the role of 
antioxidants in preventing cancer. This includes their ability to repair damaged DNA 
and react with free radicals to limit or stop their action on DNA (Ames et aL, 1993). A 
recent study has demonstrated that diet supplemented with vitamin C, E and (3-carotene 
to a group of smokers and non-smokers resulted in a significant decrease in endogenous 
oxidative base damage in the lymphocyte DNA (Duthie et aL, 1996). Moreover, the 
lymphocytes from these subjects showed an increase resistance to HiOz-induced 
oxidative damage in vitro.
Flavonoids have the potential to provide protection against cancer. Two methods 
are commonly used to investigate the anti-cancer properties of flavonoids. One involved 
animal studies whereby the ability of flavonoids to inhibit or reduce chemically-induced 
cancer was assessed. The second approach involved studying the effect of flavonoids on 
cultured cancer cells in vitro. The anti-carcinogenic properties of quercetin have been 
extensively studied. Quercetin has been shown to inhibit skin tumours in mice induced 
by chemicals such as 7,12-dimethylbenz(a)anthracene, 3-methylcholanthrene and 
benzo(a)pyrene (Mukhtar et aL, 1988). In addition, dietary quercetin (2%) and rutin 
(4%) suppressed hyperproliferation of colonic epithelial cells and ultimately colon 
tumour incidence induced by azoxymethanol (Deschner et aL, 1991). In a recent study, 
quercetin has been shown to inhibit growth and induce apoptosis in cultured colon 
carcinoma cells (Richter et aL, 1999). Low dosage of quercetin (4-6 pM) was able to 
reduce cell numbers by 50%.
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The anti-carcinogenic properties of flavonoids described above were based on 
animal studies and their relevance to humans is not known. Obviously, human studies 
would provide more beneficial information. Recently, a clinical trial was performed on 
51 patients with terminal cancer. Following intravenous administration of quercetin at 
varying doses (60-1700 mg/m^), the levels achieved in plasma inhibited lymphocyte 
tyrosine kinase activity, the enzyme capable of overriding growth regulatory control, 
subsequently leading to cancer (Ferry et aL, 1996). This is one of the initial studies 
describing the possible role of flavonoids as anti-cancer agents in humans.
On the other hand, a few studies have shown that flavonoids, when used at higher 
doses may promote the development of cancer. Quercetin was employed in many of 
these studies whereby high concentrations of this compound can increase the incidence 
of cancer including intestinal bladder tumours (Pamukcu et aL, 1980), kidney tubule 
lesions in male rats (Dunick and Hailey, 1992) and colon cancer (Pereira et aL, 1996). 
However, at the level of dietary intake, mutagenic properties of flavonoids have not been 
observed.
Several mechanisms have been suggested for the role of flavonoids in cancer 
prevention. They include the ability of flavonoids to act as modulators of cell 
differentiation and apoptosis, as antioxidants, as modulators of protein function and as 
hormones, the last mechanism possibly by the estrogenic properties of flavonoids. 
Quercetin for example, has antiviral activities, being able to bind viral coat protein and 
inflict damage to DNA, therefore destroying the proliferative capacity of certain viruses 
(Castrillo and Carrasco, 1987). Quercetin also possesses anti-tumour activities as 
demonstrated by its ability to suppress the growth of cultured human tumour cells 
(Kamei et al., 1996). One of the reported mechanisms of action was by inhibiting 
protein kinase C (Srivastava, 1985). Quercetin has been shown to inhibit epidermal 
growth factor (EGF) receptor in cultures of colonic tumour cells, thereby inducing 
apoptosis (Richter et aL, 1999). Flavonoids may also act as antioxidants in protecting 
cells or tissues against oxidative damage. Quercetin for instance has been shown to 
protect CaCo-2 cells against oxidative attack (Duthie et al., 1999).
Although the above studies show promising anti-cancer properties of quercetin, 
the relevance of such studies to the anticarcinogenic properties in humans is
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questionable. For one, the high dose and type of carcinogens used in the animals is 
possibly different from cancer initiators in humans. Thus, the effect of quercetin may 
vary in human cells. In most cases, high doses of flavonoids were employed to induce 
an anti-cancer effect and their ability to show the same effect at dietaiy levels is not 
known.
1.9.3 Conclusion
Strong evidence exists particularly from animal studies on the ability of 
flavonoids to modulate various biochemical processes relating to protection against 
coronary heart disease and cancer. Their potent antioxidant action appears to play a 
major role in providing the beneficial effects. However, their ability to provide the same 
effect at the levels of dietary intake has yet to be addressed. Information on their 
absorption is crucial for this purpose. To address this issue, epidemiology studies 
investigating intake of dietary flavonoids and risk of coronary heart disease and cancer 
were performed.
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1.10 Ëpîdemidldgy evidence on fîavonoîd intake
and d isease occurrence
1.10.1 Introduction
Earlier studies have suggested that high dietary intake of fruit and vegetables, 
strongly correlated with the intake of antioxidant vitamins, may protect against 
cardiovascular diseases (Gaziano et al., 1994). Fruit and vegetables contain amongst 
others, high levels of flavonoids which may contribute to protection against diet-related 
diseases. Assessment of the health protective effects of dietary flavonoids requires 
nutritional epidemiology studies investigating the habitual intake of a certain population 
and the development of diet-related diseases. Such studies are not easy to evaluate due 
to the presence of other .nutrients including non-nutrients in the diet, as well as 
flavonoids. Therefore, a detailed protocol is required when conducting epidemiology 
studies, taking into account these confounding factors, as well as subject bias.
These factors not withstanding, epidemiology studies are useful for investigating 
the association between the dietary intake of flavonoids and risk of disease. This type of 
study monitors large populations and can provide important information regarding the 
flavonoid intake of a population group and occurrence of disease. However, the data 
should be interpreted with caution taking into account factors such as study design, 
effects of chance, subject bias, for instance smoking habit and lifestyle which may 
influence development of diseases studied. Data collection has to be carefully done to 
ensure maximum information is obtained. Also, reliance on existing food tables which 
do not have accurate flavonoid content of foods may result in under- or over-estimation 
of flavonoid intake. In addition, data on the bioavailability of flavonoids is still lacking 
and such information is important for assessing the relevance of the results obtained. 
Furthermore, the methods used to assess dietary intake have to be considered. The use of 
poor or inappropriate methods for assessing dietary intake is a major problem in this type 
of study.
30
1.10.2 Epidemrology evrderrce orr Oavonard Intake and 
caronary heart d isease
To date, six epidemiological studies have been cairied out investigating the 
association between flavonoid intake and the occurrence of coronary heart disease. Four 
of the studies established an association between flavonoid intake and coronary heart 
disease whereby higher intakes of flavonoids were associated with lower incidence of 
coronary heart disease.
Table 1.3r Summary of epidemiological studies investigating the association 
between flavonoid intakes and incidence of coronary heart disease
study Population Follow up
(y)
Flavonoid
intake
(mg/dy
Disease risk 
(relative risk)
Hertog et ali  ^t993
The Zutphen Elderly Study
Netherlands
805 men 
(65-84 y)
5
(1985-1990)
25.9 0.32
Hertog etal., 1995
The Seven Countries Study
16 cohorts from 7 countries 
12 768 men 
(40-59 y)
25
(1960-1985)
2 .6 -6 8 .2 r = -0.50
(p=0.01>
Keli etal., 1996
The Zutphen Study 
Netherlands
552 men 
(50-69 y)
15
(1970-1985)
18 .3 -28 .6 0.27
Knekt etal., 1996
Finland
5133 men and women 
(30-69 y)
20
(1967-1992)
0-4 1.4 Women = 0.73 
Men = 0.67
Rimnref s7., 1996
Male health professionals
USA
34 789 male 
(40-75 y)
6
(1986-1992) 20.1 1.08
Hertog et al., 1997 
The Caerphilly Study 
UK
1900 men 
(45-59 y)
14
(1979-1993)
26.3 1.1 ■
The first study was a five-year observation study in the Netherlands, otherwise
known as the Zutphen Elderly Study (Hertog et al.^ 1993). Some of the subjects were
recruited from a previous study in 1960, while others were recruited at the beginning of
this study in 1985. The age group ranged from 65-84 years and was therefore not
representative of the general population. Following a 5-year follow up, a strong inverse
association was found between mortality from coronary heart disease and intakes of
flavonoids in the highest against the lowest tertile of flavonoid intake with a relative risk
of 0.32. The study also suggested that flavonoid intake and tea consumption was
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inversely associated with mortality from coronary heart disease (rr=0.45) suggesting tea 
as a possible major source of dietary flavonoids in protection against coronary heart 
disease.
In a prospective cross-cultural study, the same investigators looked at 16 different 
cohorts in seven countries; Finland, Italy, Greece, the former Yugoslavia, Japan, the 
Netherlands and the United States (Hertog et al., 1995). After 25 years of follow up, 
average flavonoid intake was inversely associated with mortality from coronary heart 
disease and this explained about 25% variance in coronary heart disease in the 16 
cohorts. The cohort in Japan had the highest flavonoid intake (68.2 mg/d) and the lowest 
age-adjusted 25-year mortality (4.5-6.3%) compared to the other cohorts. Japanese 
people are known to drink a lot of tea, particularly green tea, which is rich in flavonoids 
(Hertog et a i, 1995) and this may explain the above results. On the other hand, green tea 
consumption has been shown to reduce serum concentrations of lipids and lipoproteins, 
suggesting a different mechanism for their protection against cardiovascular disease 
(Imai and Nakachi, 1995). The 16 cohorts recruited in this study showed vaiying 
background and may not be representative of the general population. In addition, the 
subjects may also have different lifestyles and dietary habits depending on their 
countries, which may influence the outcomes measured. The results, therefore, should 
be interpreted cautiously due to the influence of other dietary or non-dietary factors. 
Furthermore, although a 7-day dietary record was employed to assess nutrient intake in 
most of the cohort, in some cases, only a 1-day dietary record was used. The accuracy of 
the latter method is questionable, as it may not represent the habitual dietary intake of the 
subjects.
In another study, a cohort in Zutphen, Netherlands, consisting of 552 men aged 
50-69 years were monitored for 15 years (Keli et al., 1996). The subjects were followed 
from 1970 onwards although information on their dietary intake was available from 
1960, 1965 and 1970 owing to a previous study. The study demonstrated a strong 
inverse association between flavonoid intake and risk of stroke (rr=0.27) with 
participants in the highest quartile of flavonoid intake showing 73% lower risk of stroke. 
Based on the food data from 1960 to 1970, a strong inverse association was observed 
between tea consumption and stroke risk. Men who drank 4.7 cups of tea daily had a 
relative risk of 0.31 compared to those who drank less than 2.6 cups daily.
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In Finland, 5133 men and women were observed for 20 years (Knekt et al., 
1996). To date, this is the only study which provided information on the association 
between flavonoid intake and coronary heart disease in women. A weak association was 
found between the intake of flavonoids and risk of coronary heart disease with a relative 
risk of 0.54 and 0.78 for women and men, respectively. However, after adjusting for 
intakes of antioxidant vitamins, the relative risk was higher in women (0.73) but lower 
for men (0.67). Intake of fruits, which are rich in antioxidant vitamins, was strongly 
correlated with flavonoids intake. Therefore, the possibility that the inverse association 
observed in this study was also contributed by intakes of antioxidant vitamins cannot be 
excluded.
More recently, 34,789 male health professionals in the United States were 
observed for 6 years (Rimm et al., 1996). The data obtained did not support an inverse 
association between flavonoid intake and coronary heart disease and a relative risk of
1.08 was attained. In this study, men with a higher flavonoid intake tended to have a 
healthier lifestyle, drank less alcohol and smoked less. On the other hand, an inverse 
association was found between total flavonoid intake and coronary mortality in men with 
previous history of coronary heart disease (rr=0.63), although this was not statistically 
significant. This could be attributed to changes in lifestyle or dietary habits once 
diagnosed with cardiovascular disease. Another possible explanation is that flavonoids 
can be protective in men with prevalent coronary heart disease, probably due to their 
antioxidative action on thrombosis (Gryglewski, 1987).
The latest prospective cohort study was published three years ago involving 1900 
Welsh men (Hertog et al., 1997). After 14 years of follow up, no association was found 
between the intake of flavonoids and incidence of ischemic heart disease. The relative 
risk was 1.1 in the highest versus the lowest quartile of flavonoid intake. Instead, men in 
the group with high tea consumption appeared to have a higher incidence of ischemic 
heart disease which contrasted with previous results. This study argued that there was no 
association probably due to the effects of adding milk to tea. This might have caused the 
protein in milk to bind to flavonoids, thus inhibiting their absorption (Serafini et al., 
1996). As this style of drinking tea is common among the British, it may explain the 
above observation. However, not much information is available on the absorption of 
flavonoids from tea without milk and available data appear to suggest low bioavailability
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of flavonoids in tea (Hollman, 1997). This could be another alternative explanation to 
the results obtained. Also, in this study, men with high flavonoid intake tend to smoke 
more, which may have affected the outcomes due to production o f free radicals, leading 
to oxidative damage and subsequently heart disease.
In most of the studies, the average flavonoid intake of the participants was 
estimated from the study by Hertog et a l, (1992) who determined the flavonoid content 
of several common fruit, vegetables and beverages. Although flavonoid intake was 
inversely associated with coronary heart disease, the bioavailability of flavonoids from 
different foods should be taken into account. Furthermore, not much information is 
available regarding the absorption of dietary flavonoids from different foods and 
available data appear to indicate either low bioavailability of flavonoids from foods or 
their extensive metabolism following absorption (Hollman et a i, 1995, 1997). Further 
studies are therefore required to elucidate the absorption of flavonoids from various 
foods.
Most of the studies mentioned above employed either the dietary history method 
or a food frequency questionnaire, although in some instances, a 7-day dietary record 
method was used (Hertog et al., 1995, Rimm et al., 1996). Although ideally the 7-day 
dietary record is the best method to assess dietary intake, it is often not suitable for large 
population studies because of its high cost and low compliance from subjects. However, 
this method allows determination of nutrient intake based on the weight of all the food 
consumed and recorded by the subjects. The dietary history method or food 
frequency questionnaire, although less reliable than the 7-day dietary record are more 
applicable to population studies. Food frequency questionnaires are normally designed 
to assess intakes of specific foods or nutrients and may not be accurate enough for 
assessing flavonoid intake whereby certain high-flavonoid foods may have been 
excluded. On the other hand, the dietaiy history method requires subjects to recall their 
food intake, for example what they eat the year prior to the study. Subjects may not be 
able to recall what they ate last year or may have changed their dietary habits, which may 
influence the outcomes measured.
At the same time, flavonoid content can also vary significantly between cultivars 
of the same fruit and vegetables. Yellow and red onions for instance contain much
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higher levels of flavonols than white onions (Tsushida and Suzuki, 1996). Lollo Rosso 
lettuce contains 100 times more flavonols than Round lettuce (Crozier et al., 1997). 
Therefore, if  the specific type of fmit and vegetables or beverages is not recorded, this 
could result in either under-estimation or over-estimation o f flavonoid intake o f the 
participants. Several of the studies found an inverse association between tea 
consumption and mortality from coronary heart disease (Hertog et al., 1993b, Keli et al.,
1996). However, in addition to the flavonols in tea, the above effects could have also 
been contributed by the presence of other tea polyphenols particularly epicatechin gallate 
and epigallocatechin gallate. This type of study cannot prove causal relationships 
between flavonol intake and mortality from heart disease. More epidemiology as well as 
experimental studies on the mechanisms involved is still needed before definite 
conclusions can be made.
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1 . 1 0 . 3
cancer
E p i d e m i o l o g y  e v i d e n c e  o n  f l a v o n o i d  i n t a k e  a n d
A vast number of epidemiological studies have consistently shown an association 
between high consumption of fruit and vegetables with a reduced risk of cancer at most 
site (Block et a i, 1992). Although the compounds responsible for this have not been 
identified, it is postulated that several antioxidants present in fruit and vegetables may 
play a role. These include the well known antioxidants carotenoids and vitamins E and 
C. Other non-nutrient compounds have also been identified as possible anti-cancer 
agents including dietary fibre and polyphenols, among which flavonoids are extensively 
studied. Several large epidemiological cohort studies as well as case-control studies on 
the cancer protective effects of flavonols and ftavones have been conducted, as 
summarised in Table 1.4.
Table 1.4: Summary of epidemiological studies investigating the association 
between flavonoid intakes and incidence of cancer.
Study Population Follow up
(y)
Flavonoid
intake
(mg/d)
Disease risk 
(relative risk)
Hertog etaL, 1994
The Zutphen Elderiy Study
Netherlands
738 men 
(65-84 y)
5
(1985-1990)
25.9 1.21
Goldbohm etal., 1996 
Netherlands Cohort Study
120,852 men & 
women 
(55-69 y)
4.3 n.a 1
Hertog etal., 1995
The Seven Countries Study
16 cohorts from 7 
countries 
12,763 men 
(40-59 y)
25
(1960-1985)
2.6-68.2 r=0.39
(p=0.86)
Knekt ef aL, 1997
Finland
9,959 men & women 
(15-99 y)
24
(1967-1991)
4
(0-41.4)
0.54
Case-control studies
Garcia-Closas etal., 1998
Lung cancer risk in women 
Barcelona, Spain
103 cases 
206 controls 
(mean age=63 y)
3
(1989-1992)
5.1-5.6 Odds ratio=0.51
(p=0.1)
Garcia-Closas etal, 1999
Risk of gastric cancer 
Spain
354 cases 
354 controls
2
(1987-1989)
9.5 Odds ratio=0.44 
(p=0.003)
n.a = not analysed
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The Zutphen Elderly Study, which began in 1960, was a longitudinal study 
investigating risk factors for chronic diseases (Hertog et aL, 1994). In addition to new 
randomly selected subjects, some subjects from this study were recruited in 1985. This 
was also a part of the same study which investigated the association between flavonoid 
intake and coronary heart disease risk reported in the previous section. During the 5 
years of follow-up, total flavonoid intake was not related to all-cause cancer incidence or 
cancer mortality (rr=1.21). Although flavonoids from tea were not associated with all­
cause cancer risk, flavonoids from fruit and vegetables were inversely associated with 
cancer incidence (rr=0.57). This may suggest the contribution of other beneficial 
compounds in fruit and vegetables including the antioxidant vitamins which are not 
present in tea. At the same time, men with cancers tended to be older and smoked more 
than men without cancer. This implies that long-term cigarette smoking may have 
already caused irreversible damage and flavonoid or other bioactive compounds in foods 
could not protect against cancer.
In another study, a relationship between flavonoid intake, tea consumption and 
cancer incidence in 120,852 Dutch men and women aged 55-69 y was observed 
(Goldbohm et aL, 1996). Initially, an inverse association between flavonoid intake and 
risk of lung and stomach cancer was detected; however, the association disappeared 
following adjustment for confounding factors including other dietary antioxidants.
The Seven Countries Study which investigated the association between flavonoid 
intake and coronary heart disease (see section 1.10.2) also looked at the incidence of 
cancer (Hertog et aL, 1995). However, the study did not find any association between 
flavonoid intake and all-cause cancer mortality, even after adjusting for fat intake and 
percentage of smokers. The use of dietary records taken at baseline (1960) to estimate 
flavonoid intake is questionable. This may not reflect long-term intakes of flavonoids 
and because no new dietary data were taken, any changes in the dietary habits of the 
subjects will not be recorded.
Another study in Finland followed 9,959 men and women and after 24 years 
found an inverse association between the intake of flavonoids and incidence of all-cause 
cancers (Knekt et aL, 1997). The relative risk was 0.80 between the highest and lowest 
quartile of flavonoid intake. The association was particularly strong for lung cancer
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(0.54). Participants who had lung cancer tended to be older males who smoked and 
consumed fewer fruit and vegetables. To date, this is the only epidemiology study in 
which a protective effect of flavonoids against cancer was obtained and the association 
still remained significant after adjustment for confounding factors including the intake of 
other antioxidant vitamins. However, further prospective studies are required, taking 
into account dietary as well as environmental factors which can influence the aetiology 
of cancer.
In a recent case-control study in Spain, the association between flavonoid intake 
and the risk of lung cancer was investigated in 103 cases and 206 controls (Garcia- 
Closas et aL, 1998). The study found a nonsignificant negative association between the 
intake of kaempferol and the risk of lung cancer (or=0.51). No protective effect was 
observed for quercetin, luteolin or total flavonoid intake. It should be noted that the food 
frequency questionnaire used in this study was designed to estimate intakes of 
carotenoids rather than flavonoids. Only 33 food items were included, most of them 
high-carotenoid foods and many high-flavonoid foods were excluded, for example 
onions and teas. Therefore, intake of flavonoids was probably underestimated and may 
not represent the actual intake of the groups studied. This was evident from the average 
amount of flavonoids consumed in this study (5.1 mg/d), which was lower than the other 
previously reported studies.
The same group performed a case-control study investigating the intake of 
flavonoid and risk of gastric cancer in Spain (Garcia-Closas et aL, 1999). A protective 
effect of flavonoid intake against the risk of gastric cancer was reported between the 
highest and the lowest quartile of intake with an odds ratio value of 0.44. At the same 
time, an inverse association was also found between the risk of gastric cancer and the 
consumption of fruit and vegetables. In addition to flavonoids, fruit and vegetables are 
also rich in antioxidant vitamins as well as other bioactive compounds which may 
contribute to the results obtained.
Apart from cohort study, the case-control study is another way to assess the 
association between diet and disease. In this type of study, people with the disease 
(known as cases) are compared with individuals without the disease (controls) and 
ideally, they have to be as closely matched as possible to avoid any confounding factors
or bias. However, one of the disadvantages of this study is the possible misclassification 
between cases and controls for example, a case may reflect on their past diet differently 
from a control who has no reason to look back over what they ate.
Therefore, with one exception, the results of epidemiological studies so far do not 
show any protective effects of flavonoid intake and the risk of cancer at various sites. At 
the same time, a case-control study also showed a protective effect of flavonoids against 
gastric cancer. It is more difficult to assess the effects of diet, in particular flavonoids 
and their association with cancer as various other factors, dietary as well as 
environmental, can influence the development of cancer. Also, cancer at different sites 
has different aetiologies. Furthermore, the follow up period of 4-5 years in several of the 
studies may have been too short to see an effect of flavonoids on carcinogenesis, a 
process which can take approximately 15-20 y.
1.10.4 Conclusion
The epidemiology studies described in this section showed promising results on 
the potential of flavonoids to protect against diseases particularly coronary heart disease 
and to a lesser extent, cancer. However, experimental data are required to support this. 
Although the in vitro antioxidative capability of flavonoids is well established, 
knowledge on their absorption and metabolism is not well understood. This area of 
research is important in trying to evaluate the biological properties of flavonoids.
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1.11 Absorption and metabotfsm o f  fIavon^oids
1.11.1 The importance of absorption studies
Various beneficial health properties have been attributed to flavonoids. This is 
largely contributed by their potent antioxidant activities. The ability of flavonoids to 
limit free radical reaction, which are determinants of diseases, implies their possible role 
in maintaining health and protect against diseases. Furthermore, epidemiology studies 
also suggest an inverse association between flavonoid intake and risk of coronary heart 
disease and to a lesser extent with cancer. To provide maximum protection, flavonoids 
have to maintain their active form in the body as well as being deposited in the target 
tissues where they can exert their antioxidative effects. With various complex chemical 
reactions taking place in the human body, flavonoids need to avoid the metabolic 
pathways that could transform them into inactive molecules, thus destroying their 
antioxidanf properties.
The increasing interest on the potential role of flavonoids in human health has 
thus created new prospects for flavonoid research particularly on their absorption and 
metabolism. Information on the bioavailability of these compounds is essential as the 
fate of these compounds once absorbed from the intestine can be determined and their 
health protective effects can then be evaluated.
1.11.2 Historical background on the absorption of 
flavonoids
Studies investigating flavonoid absorption began as early as the 1950s, 
concentrating mainly on animals. In most cases, pure flavonoids in high doses were used 
due to the lack of sensitivity of methods for flavonoid analysis. Over the years, 
absorption studies have gradually advanced to humans, and the information obtained is 
more relevant and directly related. Furthermore, the development of better and more 
sensitive analytical methods for flavonoid identification and quantification has facilitated 
the advancement of absorption studies.
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Attempts to investigate the absorption and metabolism of flavonoids have shown 
conflicting results. It was previously postulated that only free flavonoids were absorbed 
and not the glycosides due to their conjugation to sugar moieties (Kuhnau, 1976). 
However, this perception is slowly changing as more detailed studies are performed. 
There is emerging evidence that flavonoids appeared to be absorbed as their glycosides 
(Hollman et al., 1995, 1997). Clearly, additional studies are needed to further establish 
this, in parallel with the use of improved analytical methodology.
1.11.3 Absorption and metabolism of non-dietary flavonols
Most of the studies have been performed on animals with pure compounds 
instead of dietary flavonols (Table 1.5). Four separate studies administered quercetin 
aglycone to rats. In all instances, similar metabolites of quercetin metabolism were 
detected in plasma, urine and bile. The metabolites consisted of conjugated derivatives 
of quercetin, isorhamnetin and tamarixetin (Table 1.5), One of the studies which 
employed radiolabelled quercetin identified the conjugates as glucuronides and/or 
sulphates (Ueno et al., 1983; Table 1.5). Unchanged quercetin was also detected, mainly 
in faeces (Ueno et al., 1983, Manach et a i, 1995).
In contrast to the animal studies, human studies did not detect conjugates of 
isorhamnetin or tamarixetin following administration of quercetin aglycone (Table 1.6). 
Four years ago, a study was performed whereby pure quercetin aglycone was orally 
administered to nine ileostomy volunteers (Hollman et aL, 1995). A small percentage of 
quercetin (0.12%) was excreted in urine (Table 1.6). Quercetin in urine was analysed 
after acid hydrolysis. Thus, the presence of specific metabolites was not described. 
However, when absorption was estimated by subtracting quercetin content of the 
ileostomy effluent from the oral intake, percentage absorption of 24% was obtained 
(Table 1.6). This implies absorption of the aglycone and as only 0.12% was excreted, 
extensive metabolism/sequestration of quercetin has probably occurred. This contrasted 
with the findings of Gugler et al (1975) who did not detect anything in the urine even 
after a high oral dose of quercetin aglycone (4 g; Table 1.6). However, approximately 
50% of unchanged quercetin were excreted in faeces, suggesting low absorption. This
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group detected excretion of quercetin conjugates in urine only following i.v. 
administration. However, the validity of the method employed to analyse flavonols was 
equivocal and probably not sensitive enough to detect low levels of quercetin.
In addition to the aglycone, studies with flavonol conjugates are also needed to 
establish the differences, if any, between the absorption of flavonol conjugates and the 
aglycones. Rutin (quercetin-3-rutinoside), orally administered to rats was absorbable 
and metabolites were present as conjugates in plasma (Manach et aL, 1995, 1997; Table 
1.5). The rutin supplement produced similar metabolites as the quercetin supplements. 
However, the plasma concentration of metabolites from the rutin supplement was lower 
than the quercetin supplement. This raises the possibility that quercetin is absorbed and 
metabolised at a different rate than rutin. On the other hand, following oral 
administration of pure rutin compounds to human ileostomy volunteers, none of the 
metabolites mentioned above were detected (Hollman et aL, 1995; Table 1.6). Although 
the estimated percentage absorption of rutin was 17%, no metabolites were excreted in 
urine which contained only traces of rutin (<0.1% of dose; Table 1.6).
1.11.4 Absorption and metabolism of dietary flavonols
Although data are available on the absorption of flavonols following 
administration of the pure compounds, the main issue which needed to be addressed 
concerns the bioavailability of flavonols from common foods. Such studies are more 
complex as various factors can influence bioavailability of the dietary flavonols. This 
includes, for example, the ease in which flavonoids can free themselves from the food 
matrix and their solubility in the small intestine for the purpose of absorption. In 
addition, their interaction with other substances in foods may also affect their 
bioavailability.
Flavonoids in foods are normally present as glycosides. Although data are 
available on the absorption of pure flavonoid glycosides (e.g. rutin), their absorption 
from dietary sources needs to be established, particularly in humans. This type of study 
began only a few years ago and results are summarised in Table 1.7. The pioneer 
research was performed by a group in the Netherlands who demonstrated the absorption
44
%
3
3e
333
%
’ o
3
O:ts
t
I
§•iS
eu9n,
O
«A
A
3
3
e
3©
. 2î3
s
%
o
3
Ss
3
( /)
<U
A
H
c
0
1
il
O lA X3 JQjS ”
%
"O
1
t
C
I
g
oc
01
e
%
Q
S
I
Q.
{/i
ë .
C lo
a
S•o
OJ T-
•s s !?
ra ra 
&8
S ”
O)
E
§
Æ 'a
II
I f f
\ë (?
i ra o
! i “
! o
ra
3
O
! < <
z
I cr
leiCN
iS
2
S
Q.i
iS
O)
E
to
CNJ
(fl : </l i toc 1 C i c
o '.2 1.2c ■ c i £=o i o 1 °Xf I'D i*CÏra .g ira
5 : 4- ’ 4:
en ! O) ! O)
lO io Im!tn iCVJCvj SCM
! ® ira ! ra
ira ira ira
i ra
Üto i c  to ; c  07 r^en :5  07 i<  07 1 ü 07 0707 ô  en : ra 07
X  c . i S  C . : iz
! ra i ra ! ra
il
II
II
1(0ioi
Icôi'u-
i s ?  . 2
! ra o.î ra Q.
1 5  ro
1
e 1 1X j-p c  i c  m07 j _  i_i t™
O IO 3o Ito oto
i l
: ra
II!>-
I lII
X3
II
II
Cw oO ro
ilo vî 
' 3
3Ie ;
ë 'S
l i
I III
ü O X3tn ra T3rO <y7 ra3 Z ' ra(D cj ra
f g
• s o OQ 3 p
ra
CL < T3
z c
45
of quercetin glycosides following a meal of lightly fried onions (Hollman et aL, 1995; 
Table 1.7). However, they only measured quercetin after acid hydrolysis (which 
included estimates of free quercetin as well as the aglycone liberated from the glycosides 
following acid hydrolysis). Therefore, it was not entirely certain that all the quercetin 
was present as conjugates and not the aglycone. Ileostomy subjects with minimal 
resection were employed to overcome the problem of colonic degradation of flavonoids 
by microorganisms. In this way, absorption could be estimated by subtracting the 
amount of flavonols recovered in the ileostomy effluent from total intake. They reported 
that quercetin gluco sides from the onion meal were highly absorbable at 52% of the total 
intake. However, only 0.31% was recovered in urine. Thus, more than 50% of quercetin 
glucosides was unaccounted for. This study determined quercetin content following acid 
hydrolysis, therefore the presence of any quercetin metabolites such as glucuronides or 
sulphates will not be detected as these conjugates are also broken down to the aglycone 
form by the acid hydrolysis procedure.
A more recent study performed by the same group reported 1% absorption of 
quercetin glucosides in plasma of human volunteers when measured at peak plasma 
concentrations (Hollman et aL, 1996; Table 1.7). This was detected following 
consumption of high-flavonol fried onions. This was the first study that demonstrated 
absorption of quercetin glucosides into plasma. However, as only 2 subjects were used 
in the study, the validity o f the results have to be evaluated using a bigger sample size. 
The most recent feeding experiment with onions was published this year using similar 
protocol to the ones used by Hollman (McAnlis et aL, 1999). The percentage absorption 
of 1.5% in plasma for quercetin conjugates was similar to Hollman's (1996; Table 1.7). 
This supports the findings of Hollman et al (1996) as bigger number of subjects were 
used this time. It should be noted that the above studies reported the presence of 
quercetin conjugates based on the liberation of the aglycone compound after acidic or 
enzymic hydrolyses and did not analyse the non-hydrolysed samples for presence of free 
quercetin. Thus, it is not clear if the quercetin detected were actual conjugates liberated 
by the hydrolysis procedure or mfact free quercetin already present in the samples.
In addition to onions, feeding studies with other high-flavonol foods or beverages 
were also performed. Consumption of broccoli, rich in kaempferol and quercetin, 
resulted in excretion of the conjugates of kaempferol as well as lower levels of its
46
aglycone (Nielsen et al., 1997; Table 1.7). No quercetin or its metabolites were detected 
in urine suggesting either their extensive metabolism or their presence at minute levels, 
below the limits of detection.
In another study, human volunteers consumed black currant and apple juice for 1 
week, after which 0.3-0.5% of the dose was excreted in urine as quercetin conjugates 
(Young et al., 1999). The excretion in urine was similar to the ones obtained in the 
ileostomy study where subjects consumed fried onions (Hollman et al., 1995; Table 1.7). 
The only difference is that in the ileostomy study, only a single dose was used whereas in 
the study by Young et al., the juice was consumed daily over a period of one week. 
However, the total intake of quercetin was similar in both studies.
Flavonols are also able to undergo ring fission in the large intestine (Booth et al., 
1956, Griffiths and Smith, 1972). This process is performed by the intestinal 
microorganisms, leading to production of phenolic acids. Phenolic acids can still be 
absorbed from the large intestine and this process is discussed further in Section 1.12.4.
The study performed by Hollman et al (1995) appeared to indicate the ability of 
flavonols to be absorbed as glycosides from foods, thus contradicting the theory by 
Kuhnau (1976) that flavonoid glycosides are not absorbed. However, based on levels 
detected in plasma and urine, the bioavailability of flavonols appears to be low. If the 
ileostomy study showed 52% absorption of quercetin glucosides (Hollman et aL, 1995) 
whereas only 1% was detected in plasma (Hollman et aL, 1996), thus a large percentage 
of the compounds were unaccounted for. This would suggest possibly extensive 
metabolism of the absorbed flavonols, the most likely reaction being glucuronidation, 
sulphation or méthylation and/or rapid removal from the blood stream via organs such as 
the liver.
1.11.5 Absorption and metabolism of catechins
Extensive information is available on the absorption and metabolism of catechin 
although most of the studies were carried out using pure compounds rather than dietary 
sources (Table 1.8). Catechins appeared to be more readily absorbed compared with
47
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quercetin. This was evident from several studies that reported approximately 41-50% 
excretion of the total radioactivity in urine following administration of radioactive 
catechin (Das and Sothy, 1971, Shaw and Griffiths, 1980, Hackett and Griffiths, 1981; 
Table 1.8). Roughly 34-51% of the administered radioactivity were excreted into the 
faeces of rats (Hackett and Griffiths, 1981).
Following administration of the catechin supplements, the metabolites detected 
were mostly conjugated derivatives of the original supplement (Table 1.8). In most 
cases, the conjugates were glucuronides and to a lesser extent, sulphate conjugates. 
Shaw and Griffiths (1980) detected the glucuronide of 3 '-0-methyl-(+)-catechm 
following oral administration of (+)-catechin to rats. Following the oral administration 
of (+)“Catechin to human volunteers, the major urinary metabolites were the glucuronides 
and sulphates of the administered compound (Hacket et a l, 1983). Humans also 
excreted glucuronides and sulphates of 3-(9-methyl-(+)-catechin in addition to the 
glucuronides of 3,3'-dimethyl -(+)-catechin following an oral dose of 3-G-methyl-(+)- 
catechin (Hackett et al., 1985). This suggests méthylation as another important pathway 
in the metabolism of catechins whereby the formation of methyl and dimethyl catechin 
metabolites was common. The most common position for méthylation to occur was 
either at C3 of ring C or C3 ' of ring B; or in the case of dimethylation, both C3 and C3 ' 
(see Table 1.8). In addition to méthylation, glucuronidation and sulphation, ring fission 
of catechins also occurred by bacteria in the large intestine. This reaction generated 
phenolic acids which are readily absorbed. This is discussed in more detail in Section 
1.12.4.
A recent study investigated the absorption of epicatechin from dark chocolate. 
This study demonstrated the absorption of epicatechin in plasma of human volunteers 
following ingestion of the chocolate (Richelle et aL, 1999; Table 1.8). Absorbed 
epicatechin was estimated after enzymic hydrolysis and did not describe the metabolites 
formed. Therefore, any glucuronides or sulphates of epicatechin cleaved by the enzymes 
as well as free epicatechin will be included. Méthylation products were not reported.
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1 .1 1 .6  Absorption and m etabolism  o f o th er  flavon oid s
Table 1.9 summarises the studies on the metabolites formed following 
administration of flavone, flavanone or anthocyanin. The pathway for the metabolism of 
diosmetin (5,7,3'-trihidroxy-4'-methoxy flavone) was followed in rats following oral 
treatment. Diosmetin was observed to circulate as glucuronides as well as 
diglucuronides in plasma. No free diosmetin was present in blood or urine (Boutin et aL, 
1993). This indicated a rapid glucuronidation process. In another study, no unchanged 
compound was detected in plasma after oral treatments of diosmin (diosmetin-7- 
rutinoside) to human volunteers although its aglycone diosmetin was present (Cova et 
aL, 1992). Both diosmin and diosmetin were not detected unchanged in urine, however 
their minor metabolites were excreted in urine, mainly as glucuronic acid conjugates. 
Degradation products such as alkyl-phenolic acids were present suggesting ring fission 
had occurred (See section L 12.4).
Following administration of luteolin (5,7,3 ',4 '-tetrahydroxyfiavone) to rats, 
methylated metabolites of luteolin (9-14% of dose) as well as the unchanged compound 
(6-15% of dose) were excreted in urine and bile (Liu et aL, 1995; Table 1.9). The 
presence of catechol group on ring B of luteolin probably promotes its méthylation.
The metabolic fate of anthocyanin is not as widely researched as the other 
flavonoids despite their wide presence in the plant kingdom. Recently published data 
reported absorption of intact cyanidin-3-glucoside and cyanidin-3,5 -diglucoside 
following oral administration of these compounds to rats and humans (Miyazawa et aL, 
1999; Table 1.9). No metabolites of the parent compounds were detected. Unchanged 
cyanidin-3 -glucoside was also present in plasma of rats following oral administration 
(Tsuda et aL, 1999). The authors also reported the presence of protocatechuic acid, a 
metabolite formed from the degradation of cyanidin-3-glucoside. Levels of 
protocatechuic acid exceeded that of cyanidin-3-glucoside suggesting the high absorption 
or extensive degradation of cyanidin-3-glucoside. It was postulated that the structure of 
anthocyanins with the flavylium cation group confers resistance against conjugation or 
hydrolysis reaction. At the same time, this group also detected 0-methylation products 
of cyanidin-3-glucoside in the liver and kidneys (Tsuda et al., 1999). However, these
51
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methylated metabolites were not present in plasma, suggesting they were probably 
retained in the tissues. Oral and i.v. administration of either mono- or tri-hydroxyethyl 
mtoside led to the urinary and biliary excretion of glucuronides of the parent compounds 
(Hackett and Griffiths, 1977, 1979). The unchanged compound was also absorbed and 
excreted in urine without modification (Table 1.9). In most instances, more than 50% of 
the radioactivity was excreted in faeces.
1.11.7 Biliary excretion of flavonoids
In addition to urine, another pathway for the excretion of flavonoids is through 
bile. Absorbed flavonoids and their conjugates can be reexcreted into the bile where 
they will flow into the duodenum. Flavonoids from biliary excretion may be subjected to 
further metabolism by the intestinal microorganisms. Alternatively, they may be 
reabsorbed from the intestine, transferred via the hepatic portal vein to the liver, 
metabolised and re-excreted in bile, creating an enterohepatic recirculation. 
Enterohepatic circulation may be important for bioactive substances including flavonoids 
as they can maintain fiavonoid concentration in target tissues
Biliary excretion has been demonstrated in several animal experiments. 
Conjugates of quercetin, isorhamnetin and tamarixetin were excreted in bile following 
administration of quercetin to rats (Ueno et al., 1983, Manach et al., 1996). Biliary 
excretion was also observed in rats after administration of catechins, methyl catechins 
and epicatechin (Das and Sothy, 1971, Hackett and Griffiths, 1981, Okushio et a i, 
1999). In most instances, the conjugated forms of the parent compounds (including 
glucuronides and sulphates) or their metabolites were excreted in bile (see Table 1.5 and 
1.8). Administration of labelled mono- and tri-hydroxyethyl rutoside to mice led to 
extensive biliary excretion of the unchanged rutosides as well as their glucuronides (71% 
of dose; Hackett and Griffiths, 1977). The extent of biliary excretion of flavonoids is 
comparable or maybe even higher than their excretion in urine. This implies the 
importance of this pathway in fiavonoid metabolism as these beneficial compounds can 
be subjected to enterohepatic circulation, thus maintaining a constant level in the general 
circulation.
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1 .1 1 .8  T h e  kinetics o f fiavonoid absorption  in hum ans
Investigations of the kinetics of fiavonoid absorption are useful to address their 
bioavailability. Bioavailability is defined as percentage of the ingested flavonoids that 
enters the blood circulation and becomes available for utilisation. The plasma profile of 
fiavonoid accumulation can be used to establish various kinetic parameters including the 
absorption, distribution and elimination phases of flavonoids. Such information can give 
an insight into the pattern of fiavonoid absorption, for instance whether flavonoids 
persist in the circulation following absorption or whether they are rapidly removed from 
the blood for excretion.
Absorbed flavonoids have to be transported by the blood to the corresponding 
tissues or organ to provide a biological response. Thus, it is possible that the 
concentration and persistence of flavonoids in the blood is a direct measure of their 
intensity and duration in the target tissues. One way of estimating this is by quantifying 
the area under the curve (AUC) of plasma fiavonoid concentration versus time. The size 
and duration of the biological response should be related to the AUC. AUC is also 
useful for evaluating the bioavailability of flavonoids and their clearance. When a single 
oral dose of flavonoids is administered, absorption as well as elimination can occur 
simultaneously in blood. The peak fiavonoid levels in plasma only represents the time 
where the rate of absorption equals the rate of elimination and does not necessarily 
indicate the end of the absorption phase. In theory, AUCs of flavonoids administered 
intravenously as well as orally are required to determine their absolute bioavailability. 
However, this is hot always possible and only relative bioavailability can be estimated 
from AUC of plasma flavonoids from oral doses.
1.11.8.1 Quercetin
So far, only three studies have followed the kinetics of quercetin absorption in 
humans. The first study used pure quercetin aglycone and failed to detect the unchanged 
compound in plasma following oral administration (Gugler et al., 1975). It is possible 
that a large fraction of the absorbed quercetin was conjugated with glucuronic acid or 
sulphate. As the authors only analysed plasma without prior deconjugation of quercetin 
conjugates, this could explain why they did not detect quercetin aglycone in plasma.
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Two studies reported the kinetics of quercetin glycosides absorption following a 
fried onion meal (Hollman et al., 1996, McAnlis et al., 1999). Both studies consumed 
similar amounts of quercetin from the onions. When absorption was expressed as 
proportion of intake, approximately 1-1.5% of quercetin glycosides was present in 
plasma at peak concentration. The time taken to reach peak concentration varied from 2 
to 2.9 h between the two studies. The plasma profile of quercetin indicates a rapid 
absorption phase followed by a slower elimination period. Low levels of quercetin could 
still be detected 24-48 h after the onion meal. As these studies only measured quercetin 
after hydrolysis, information on the absorption of quercetin aglycone was excluded.
Studies with ileostomy subjects found 52% absorption of quercetin glycosides 
from onions (estimated after acid hydrolysis; Hollman et al., 1995). However, the 
figures obtained in plasma (1-1.5%) were nowhere near this (Hollman et al., 1996, 
McAnlis et al., 1999). The low values obtained in plasma implied possibly extensive 
metabolism of this compound to its metabolites or their effective removal from the 
general circulation.
The profile for absorption of pure rutin indicated a slower absorption phase than 
quercetin with peak concentration achieved 9 h after taking the supplement (Hollman,
1997). This suggests slower absorption from the intestine or possibly absorption taking 
place further down the gastrointestinal tract. The author also compared the profiles of 
the absorption of quercetin from apples and from onions. Similar profiles were noted, 
although at peak plasma concentration, levels in the former was half that of the latter. 
Apples contained different types of quercetin glycosides compared to onions which 
maybe absorbed at different rates.
In most cases, flavonols were still detectable in plasma up to 24 h after the 
supplements. Thus, repeated intake of high-flavonol foods may lead to their build-up in 
plasma. Such studies are needed to confirm this.
Absorption studies reported above only determined absorption of flavonols from 
foods and did not specify or identify the absorption kinetics of the specific flavonols 
present in the dietary sources. Onions for example contain a wide variety of quercetin 
glucosides particularly quercetin-3,4 -diglucoside, quercetin-3-glucoside and quercetin-
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4'-glucaside. Investigation of the kinetics and bioavailability of these compounds as 
well as other ubiquitous flavonol glycosides can provide better information on the 
structure-absorption relationship of flavonols. At the same time, knowledge on the 
flavonols that are highly absorbable can be used to encourage the general population to 
consume foods containing high levels of these compounds.
1.11.8.2 Catechins
Catechins were readily absorbed and in most instances, peak plasma 
concentration was reached within 1 to 3 h, implying rapid absorption. Plasma analysis 
showed the compound was still present 12 h after the start of the supplement (Hackett et 
al., 1983, 1985), indicating a slow elimination phase. Longer periods of blood collection 
could provide further information on the existence of catechins in the general circulation. 
When areas under the plasma were estimated, the values obtained for 3-(9-methyl-(+)- 
catechin (Hackett et al., 1985) was 5 fold more than (+)-catechin (Hackett et al., 1983; 
Table 1.10). Thus, introduction of a methyl group substantially increased their 
absorption, possibly altering their stereospeciflcity, favouring their uptake from the 
intestine. Alternatively, methylated catechin may be less extensively metabolised in the 
body. However, as areas under the curve of plasma levels were determined only up to 12 
h, it may not be truly representative of the complete elimination phase.
In another study, a proportionate increase between AUC of plasma of epicatechin 
and the administered dose was observed (Richelle et al., 1999; Table 1.10). This implies 
a non-saturable effect on the absorption of epicatechin up to a dose of 164 mg. 
Maximum concentration in plasma was reached between 2 to 3 h, followed by rapid 
elimination.
Comparing the AUC for epicatechin from chocolate and quercetin from onions, 
the latter appear to be more bioavailable than the former (Table 1.10). The structural 
variation of quercetin and epicatechin may have an impact on their absorption. At the 
same time, influence of the nature and/or position of the sugar moiety on quercetin 
absorption should not be dismissed.
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Table 1.10: Areas under the plasma of flavonoids following consumption of the 
supplements
Fiavonoid supplements
. ■ —... .... ■ .. .
Dosage- Peak plasma 
concentration
AUC
(ng/ml/h)
Reference
Quercetin glucosides 
(from onions)
68 mg 224 ng/ml 
(1.5%)
2330 Hollman’s thesis 
1997
Rutin 100 mg 90 ng/ml 
(0.27%)
983 Hollman’s thesis 
1995
3-0-methyl-(+)-catechi n 2g 18000 ng/ml 
(3%)
41600 Hackett et al 
1985
(+)-catechin 2g 1507 ng/ml 
(0.2%)
8970 Hackett et al 
1983
Epicatechin 
(from chocolate-40 g)
82 mg 103 ng/ml 
(0.4%)
445 Richelle et al 
1999
Epicatechin 
(from chocolate-80 g)
164 mg 196 ng/ml 
(0.4%)
1069 Richelle et al 
1999
Diosmin 10 mg/kg body wt. 400 ng/ml 
(0.24%)
5617 Cova ef al 
1992
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1.11.8.3 Flavones
Interestingly, following the administration of diosmin, (diosmetin-7- rutinoside), 
no unchanged compound could be detected in plasma (Cova et a l, 1992). Instead the 
aglycone, diosmetin, was present. Absorption was rapid with peak plasma concentration 
reached 1 h after dosage. This was followed by a slower elimination period with 
diosmetin still present above baseline levels at 48 h. Although similar dosage were 
consumed, a higher peak plasma concentration was obtained for diosmetin (400 ng/ml) 
compared to quercetin (248 ng/ml; Table 1.10) suggesting a higher rate of absorption of 
the former compound. The presence of the aglycone instead of the parent compound 
implies deglycosylation had taken place. At similar dosage, flavones appear to be more 
bioavailable than quercetin glucosides from onions, rutin and epicatechin (Table 1.10).
1.11.8.4 Aiithocyanins
Following oral ingestion of cyanidin glucoside and cyanidin diglucoside, high 
levels of the former was detected in plasma of human volunteers with a peak 
concentration of 13 ng/ml (Miyazawa et a l, 1999). In contrast, only trace levels of the 
latter were observed. Absorption of cyanidin glucoside was rapid with peak 
concentration reached 60 min after the supplement. However, when compared to 
quercetin, the percentage of anthocyanin absorbed from total intake was relatively low 
(0.02%) compared to 1.5% for quercetin.
1.11.8.5 Conclusion
Excluding 3-0-methyl-(+)-catechin and (+)-catechin, diosmin from the sub-class 
flavones appeared to be more bioavailable than the other flavonoids. Comparison of the 
relative bioavailability of 3-0-methyl-(+)-catechin and (+)-catechin with the other 
flavonoids could not be made due to the higher dosage of the two compounds (2 g; Table 
1.10). The AUC of plasma for epicatechin may have been underestimated as blood was 
collected only up to 8 h when levels of epicatechin was still above baseline.
It is evident that various factors play a role in determining the 
absorption/bioavailability of flavonoids from the small intestine. Modification in the
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structure of the fiavonoid molecule appears to have a big impact on their absorption. 
This could be as a consequence of changes in stereospeciflcity of the molecule or their 
solubility in either the lipid or aqueous phase. The mechanism of fiavonoid uptake from 
the small intestine needs to be established. Hollman et al., (1995) postulated 
involvement of the Sodium-Glucose Co-transport system (SGLTl) in the absorption of 
quercetin glucosides. This area of research merits further investigation as determination 
of the mechanism of fiavonoid absorption can provide information on the mode and 
extent of their absorption from the intestine.
Information obtained so far are still limited and there are still many missing 
pieces to be put together to get a clearer picture. However, with the development of 
better procedure for fiavonoid identification, rapid progress can be made. At the same 
time, identification of individual flavonoids following consumption of high-flavonoid 
foods can provide valuable infonnation on the bioavailability of the different flavonoids 
present in the foods. Eventually, this can be used to encourage high consumption of 
foods containing highly bioavailable flavonoids.
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1.12 S ites for fiavonoid metabolism
1.12 1 Introduction
Little infonnation is available on the metabolic pathway of dietary flavonols in 
humans following their absorption from the intestine. Knowledge on the fate of 
flavonoids following their absorption is relevant to assess their potential biological 
effects in the human body. Absorption studies indicated rapid absorption o f the 
unchanged flavonoids followed by a slower elimination phase (see section 1.11.8). 
When absorption or excretion was expressed as percentage of the amount ingested, it 
appears that very little flavonoids are absorbed from the intestine. It is not known if this 
is a result o f low bioavailability of flavonoids or their extensive modification before 
appearing in the general circulation. Another alternative explanation is their effective 
removal from the bloodstream for the purpose of sequestration in tissues or excretion. 
The extent of fiavonoid metabolism determines their ability to maintain their bioactive 
form in order to provide protection to human health. Furthermore, the metabolites 
formed need to have the capability to be stored in a significant amount in the body to 
exert their beneficial effects. The nature of the fiavonoid molecule with multiple 
hydroxyl groups and substitution patterns makes them susceptible to various enzymes 
and modification reactions.
Animal studies indicated that several sites are responsible for the metabolism of 
flavonoids and this may be true in humans too. The liver and the large intestine are the 
most common sites for fiavonoid metabolism (Hackett, 1986). At the same time, the 
small intestine and kidney may to a certain extent contribute to the biotransformation of 
flavonoids. The metabolic reactions which occur on the fiavonoid molecule include 
conjugation (e.g. with glucuronic acid or sulphate), méthylation, oxidation, reduction and 
ring fission. Animal studies particularly with radioactively labeled flavonoids are ideal 
for metabolic studies. Such methods allow monitoring of the radioactive flavonoids 
following their absorption as well as estimation of the radioactivity in various cells and 
tissues.
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1 .1 2 .2  Liver m etabolism  of flavonoids
The liver is probably the main organ responsible for the metabolism of flavonoids 
and contains various enzymes for these reactions. Some of the more important enzymes 
include UDP-glucuronyl transferases and catechol-O-methyl transferases. Furthermore, 
animal studies with radioactively labeled quercetin have reported a rapid decrease of 
radioactivity in the blood following absorption, accompanied by short-term increase in 
the levels in the liver and kidneys (Ueno et ah, 1983).
1.12.2.1 Méthylation
Phenolic compounds, including flavonoids with adjacent hydroxyl groups, can 
undergo O-methylation. An in vitro experiment with rat liver microsomes demonstrated 
the metabolism of fiavonoid aglycones by enzymes of the microsomes, the main 
reactions being hydroxylation, déméthylation and méthylation (Nielsen et al., 1998). 
Modification in the structure of the fiavonoid molecule particularly in the B ring appears 
to influence their metabolism by the microsomes. The extent of fiavonoid metabolism is 
highly dependent on the number and position of the hydroxy and methoxy groups in the 
B-ring. Flavonoids without hydroxyl groups or with a 4 -OH group in the B-ring were 
hydroxylated to give the catechol structure (3',4'-dihydroxylation). On the other hand, 
flavonoids with 0-methylation at the 4 '-position (but not the 3'-position) were 
demethylated to the corresponding hydroxylated compound. The catechol moiety on the 
fiavonoid molecule then becomes the substrate for catechol-O-methyl transferase, 
causing 0-methylation at the 3 '-position. This structure may be more biologically 
stable.
Piskula and Terao (1998) detected activities of catechol-O-methyl transferase in 
the liver. This enzyme catalyses the transfer of methyl groups from S-adenosyl 
methionine to a variety of substrates containing a catechol group. Méthylation has only 
been observed at the 3' position and not the 4' implying specific affinity of catechol-O- 
methyl transferase for its substrate.
Several flavonoids have been reported to inhibit catechol-O-methyl transferase in 
rat liver and also in human liver (Kuhnau, 1976). This inhibitory action is largely
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dependent on the structure of the fiavonoid molecule with fiavonoid glycosides less 
active than the corresponding aglycones. However, the 3',4'-0-dihydroxylation of ring 
B of fiavonoids appears to increase the affinity of fiavonoids for this enzyme.
1.12.2.2 Conjugation
In addition to méthylation, a conjugation reaction also occurs in the liver. The 
conjugation of fiavonoids mainly involved the introduction of glucuronic acids and 
sulphates. These reactions feature prominently in fiavonoid metabolism particularly of 
catechin and quercetin (See Table 1.5 and 1.8). This perhaps is the most common final 
step in the metabolic pathway of fiavonoids.
Certainly, glucuronidation and sulphation of quercetin and catechin has been 
demonstrated using isolated perfused rat liver system (Shali et al, 1991). In addition, 
activities of glucuronosyltransferases and phenolsufotransferases, the enzymes 
responsible for glucuronidation and sulphation respectively, has also been detected in the 
liver of rats (Piskula and Terao, 1998).
Conjugation of fiavonoids increases their molecular weight and at the same time 
creates more polar molecules which subsequently favours elimination in urine or via the 
biliary route where they can be further metabolised by the colonic microorganisms. In 
rats orally fed [^ "^ C] quercetin, 20% of the absorbed quercetin was excreted in bile and 
urine as glucuronide and sulphate conjugates of [^'^Cjquercetin, [^ '^ C] 3'-0-monomethyl 
quercetin and [^"^C]4'-0-monomethyl quercetin (Ueno et al, 1983).
1.12.2.3 Deglycosylation
A recent study reported deglycosylation of fiavonoid glycosides in cell free 
extracts of human liver (Day et al, 1998). This demonstrated the presence of 
glycosidases in liver which has never been detected before. The rate and extent of 
fiavonoid deglycosylation appears to be dependent on the structure and type or position 
of the sugar moiety. Quercetin with sugars at either the 3' position or the 3,4'-positions 
(e.g. quercetin-3,4'-diglucoside) were resistant to hydrolysis. On the other hand, 
quercetin-4'-glucoside and several 7-glucosides of isofiavonoids were deglycosylated by
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the liver enzymes (Day et al., 1998). Perhaps binding of sugars at the 3 -position or 
3,4'-position reduces the affinity of the glycosidases towards these flavonoids.
1,12.2.4 Hydroxylation
The liver has also been suggested as the site for hydroxylation of flavonoids and 
monooxygenases are widely reported to catalyse this reaction (Hackett, 1986). Indeed, 
several flavonoids did undergo hydroxylation following incubation with rat liver 
microsomes (Nielsen et al, 1998). The structure of the fiavonoid molecule appears to 
affect their hydroxylation. Flavonoids lacking hydroxyl groups in the B ring are more 
prone to this reaction. The end product appeared to be formation of the catechol 
structure.
1.12.3 Small intestinal metabolism of flavonoids
1.12.3.1 Deglycosylation
It was previously postulated that only fiavonoid aglycones were absorbed, and 
not the glycosides, due to the lack of glycosidases in the small intestine capable of 
breaking the sugar bonds. Lately, however, in vitro incubations of fiavonoid glycosides 
with small intestinal contents have led to the formation of aglycones of the parent 
compounds (Day et al, 1998) suggesting the presence of glycosidases. The structure of 
flavonoids as well as the nature/position of the sugar residues determines the extent of 
their deglycosylation. Similar to liver, isofiavonoids with glucose at the C-7 position and 
quercetin-4'-glucoside were extensively deglycosylated (>60%). This was also observed 
by loku et al (1998). Quercetin-3-glucoside, which was resistant to deglycosylation by 
the liver enzymes, was deglycosylated, albeit at a lower proportion (16%), by enzymes 
of the small intestine. Previous incubations of flavonoids with small intestinal contents 
as well as digestive enzymes demonstrated their stability in this environment (Hollman et 
al, 1995). This implies that the glycosidases are possibly located at the brush border 
membrane and that deglycosylation takes place during passage of the flavonoids through 
the intestinal membrane. This is supported by recent publications which detected 
absorption o f quercetin aglycone in the serosal side following perfusion of isolated rat
intestines with quercetin-3-glucoside (Spencer et a l, 1999, Notebom et al., 1997).
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1.12.3.2 Glucuronidation
In addition to deglycosylation, glucuronidation of flavonoids has also been 
described in the small intestine. Until recently, liver was assumed to be the only site for 
glucuronidation of flavonoids. However, the recent detection of glucuronosyl transferase 
activities in the intestinal mucosa meant that the first step o f fiavonoid metabolism might 
already occur at the level of intestinal mucosa (Piskula and Terao, 1998). Indeed, the 
ability of the intestinal mucosa to glucuronidate other compounds such as naphthyl 
glucosides during their absorption have been reported (Mizuma et a i,  1994). Thus, the 
possibility of fiavonoid glucuronidation is also highly likely. It was only recently that 
the ability of the intestinal mucosa to glucuronidate flavonoids was demonstrated in in 
vitro experiments with rat intestines (Shimoi et ai, 1998, Spencer et a i, 1999, Walle et 
a l, 1999). In all cases, glucuronidation appeared to take place during the passage of 
flavonoids through the intestinal membrane. Glucuronidation includes the aglycone as 
well as the glycosides of flavonoids.
However, the extent of intestinal glucuronidation of fiavonoids in vivo is not 
known. Such findings question the role of the liver in glucuronidation of flavonoids. 
Intestinal glucuronidation has only been described for a small number of flavonoids 
(mainly flavonols and isofiavonoids). This area merits further research particularly the 
effect on catechins which are extensively glucuronidated upon their absorption.
1.12.4 Colonic bacterial metabolism
The colon is probably the main site for the metabolism of flavonoids that remain 
unabsorbed after passing through the small intestine. In addition, absorbed fiavonoids 
can be reexcreted into the duodenum in bile and thus be subjected to further metabolism. 
The colon contains a large population of anaerobic microorganisms, widely responsible 
for the biotransformations of unabsorbed substances including flavonoids. The colonic 
microfiora such as Bacteroides, Bifidobacterium and Eubacterium contain several 
enzymes capable of deconjugating the glycosidic as well as the glucuronide bonds of 
fiavonoid conjugates to liberate the free form. The resulting aglycones of fiavonoids are 
either absorbed or subjected to further metabolism by the intestinal microorganisms. The
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enzymes glycosidase and glucuronidase have been detected in colonic microorganisms 
(Kim et ai, 1998).
1.12.4.1 Ring fission of flavonoids
Ring fission is perhaps the most important step in the colonic bacterial 
metabolism of flavonoids. This reaction ultimately results in the split of the heterocyclic 
oxygen-containing ring of flavonoids to yield metabolites known as phenolic acids. 
Table 1.11 summarizes the animal and human studies on ring fission products following 
administration of flavonoids while the chemical structure of the resulting phenolic acids 
are illustrated in Figure 1.12. Evidence that ring fission of flavonoids required the 
presence of colonic microorganisms was obtained using rats treated with the antibiotic 
neomycin. The generation of ring fission products of flavonoids was not observed in 
these rats supporting the importance of colonic microorganisms (Nakagawa et ai, 1965, 
Griffiths and Smith, 1972).
In most cases, fiavonoid glycosides as well as their aglycone generated the same 
type of phenolic acids. Kaempferol and robinin (kaempferol-7-rhamnosyl-3- 
galactorhamnoside) for instance, underwent a cleavage reaction to generate a similar 
phenolic acid, hydroxyphenylacetic acid (Griffiths and Smiths, 1972; Table 1.11). The 
same was reported for quercetin and rutin (quercetin-3-rutinoside) (Booth et a i, 1956) as 
well as apigenin and naringin (apigenin-7-rhamnoglucoside) (Griffiths and Smiths, 1972; 
see Table 1.11). This implies that fiavonoid glycosides are initially hydrolysed by the 
intestinal microorganisms to the respective aglycones prior to the ring fission reaction.
Ring fission products are largely dependent on the structure of the fiavonoid 
molecule, therefore the phenolic acids formed varied depending on sub-classes of 
flavonoids. Investigations of the bacterial metabolism of flavonols, in particular 
quercetin, rutin and kaempferol showed that the compounds were degraded mainly into 
hydroxyphenylacetic acids (Booth et a i,  1956, Nakagawa et ai, 1965, Griffiths and 
Smith, 1972a, Baba et ai, 1981; Table 1.11). Oral administration to rats of certain 
flavone and flavanone, for instance apigenin and naringin resulted in the excretion of
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Figure 1.12: Structure o f ring fission products o f colonic bacterial m etabolism  of  
flavonoids
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hydroxyphenyl propionic acids (Griffiths and Smith, 1972a). Ring fission reaction on 
(+)-catechin generated hydroxyphenylpropionic acids, hydroxybenzoic acids and 
valerolactones (Das and Sothy, 1971, Hackett et al, 1983). In contrast to (+)-catechin, 
3-0-methyl-(+)-catechin was resistant to ring fission (Hackett and Griffiths, 1981). The 
presence of a methyl group at C-3 possibly confers resistance towards ring fission. 
Clearly, structural features of the fiavonoid molecule determine the type of ring fission 
products. The presence of hydroxyl groups appears to be necessary for ring fission and 
their numbers as well as position determine their susceptibility to degradation by the 
intestinal microorganisms.
Depending on their structure, some of these phenolic acids show considerable 
antioxidant activities and thus may contribute towards the biological properties of 
flavonoids. Phenolic acids such as 3,4-dihydroxyphenylacetic acid and 4- 
hydroxyphenylacetic acid showed higher anti-platelet aggregation activities than rutin 
and quercetin (Kim et al, 1998). Studies have shown that phenolic acids were capable 
of absorption in the colon as they could be detected in urine of animals and humans 
following administration of the parent compounds (Griffiths and Smith, 1972, Hackett et 
ai, 1983, Cova et a i,  1992). Thus, further information on the extent of phenolic acid 
absorption as well as their metabolism is useful to evaluate their potential contribution as 
anti oxidants in the human body.
1.12.5 Renal metabolism of flavonoids
The major purpose of the kidneys is to produce urine. They therefore act as a 
vehicle for the excretion of metabolic products which need to be disposed of by the body 
and at the same time maintain osmolarity of the body fluids. The role of the kidney in 
the metabolism of flavonoids is probably the least studied.
Animal studies with radiolabelled flavonoids have detected radioactivity in 
kidney following fiavonoid absorption (Ueno et al, 1983). The kidney may contain 
enzymes capable of biotransformation of flavonoids. Indeed, méthylation of flavonoids 
was observed in the kidney of rats (Piskula and Terao, 1998). The investigators also 
detected low levels of the enzyme catechol-O-methyl transferase responsible for this 
reaction.
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Fiavonoid metabolism in kidney is not widely studied. As their main purpose is 
in the excretion of substances, it is possible that they play only a minor role in fiavonoid 
metabolism.
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1.13 The mechanism of fiavonoid absorption
1.13.1 Introduction
Information regarding the uptake of flavonoids across the small intestine is 
limited. Such information is useful to provide an insight into the bioavailability of 
various flavonoids from the diet, their ability to be absorbed and subsequently provide 
beneficial health properties. Previously, fiavonoids were regarded as unabsorbable 
although recent evidence reported the selective absorption of quercetin glucosides from 
onions as well as lower levels of quercetin aglycone (Hollman et al., 1995).
Recent interest in the mechanism of fiavonoid uptake from the small intestine has 
sparked widespread research in this area. Evaluation of the mechanisms of fiavonoid 
uptake are important because:
i) it can provide a better understanding of the role of flavonoids in human health
ii) the bioavailability of various flavonoids from dietary sources can be determined
iii) the relationship between fiavonoid structure, their cellular location and biological 
function in the human body can be addressed.
1.13.2 Background on intestinal absorption
In order to study the mechanism of fiavonoid absorption, an understanding of the 
process that occurs in the small intestine during absorption of substances is important. 
The small intestine can be divided into 3 segments consisting of the duodenum, jejunum 
and ileum. Jejunum is the main segment where most of the absorption of compounds 
occurs. Its mucosal surface is enriched with villus as well as transport molecules to 
enhance the efficiency of the absorption process.
Intestinal absorption of substances can occur either by passive or active transport. 
Passive transport involves the flow of specific substances from high concentration to low 
concentration so as to equilibrate their concentration gradients. There are 2 mechanisms 
of passive transport, by simple diffusion or by facilitated diffusion. Simple diffusion 
involves direct diffusion of specific molecules across the membrane, for example fatty
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acids. Facilitated diffusion requires a specific carrier protein to transport specific 
molecules. GLUT5 for instance is a protein carrier for fructose as the cell membrane is 
not permeable to hexoses. At the same time, GLUTS may also be able to transport 
glucose, albeit at a lesser extent than fructose (Gould and Holman, 1993, Mueckler, 
1994). A simplified diagram of the various transport mechanisms in the small intestine 
is illustrated in Figure 1.13.
Compounds that are hydrophilic are mainly transported via carrier proteins as 
they are not soluble in the lipid phase of the membrane. On the other hand, lipophilic 
compounds can diffuse across the membrane depending on the partition coefficient 
between water and the non-polar phase or the compound’s tendency to transfer from the 
aqueous phase to the membrane’s non-polar core. It was postulated that quercetin 
glucosides maybe transported via a carrier-mediated system as they are more polar and 
have low solubility in lipids.
In active transport, specific molecules are transported against their concentration 
gradients, from low concentration to high concentration. An example is the Sodium- 
Glucose Co-transport protein (SGLTl) responsible for the active transport of glucose and 
galactose. These hexoses are transported across the bmsh border membrane mediated by 
the simultaneous movement of sodium ions into the basolateral membrane (Figure 1.13). 
Energy for this active transport is provided by a concentration gradient of sodium ions 
across the membrane, maintained by the enzyme Na^/K^-ATPase.
Once in the enterocytes, absorbed compounds are transported essentially by the 
same mechanism across the basolateral membrane into the blood stream. Fatty acids can 
diffuse directly across the membrane (Figure 1.13). Another carrier, GLUT2, which is 
not Na-dependent, is present in the basolateral membrane for the transport of glucose. 
GLUT2 is also able to handle fructose and galactose.
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Fatty acids
Fructose
GLUTS
GLUT2
SGLT1
Glucose
Na
Intestinal lumen Brush border 
membrane
Capillaries
Figure 1.13; A schematic diagram illustrating the various transport mechanisms 
involved in the uptake of specific substances across the intestinal membrane
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1 .1 3 .3  Approach in the stud y  of fiavonoid  transport
Transport studies are somewhat intricate as various factors have to be taken into 
account when conducting such studies. Movement of substances across the small 
intestine is defined as their passage through the epithelial barrier between the intestinal 
lumen and the blood vessels. The small intestine can transfer substances in 2 directions, 
(i) from the lumen to the bloodstream (absorption), and (ii) from the bloodstream to the 
lumen (secretion). Substances have to pass through 2 membranes during transport, the 
luminal (or mucosal) and the basolateral (or serosal) membranes. These 2 membranes 
have different characteristics and the mechanism of transport for one substance may 
differ between the 2 membranes.
Although many techniques are available to study intestinal absorption, there is 
not one perfect technique. In vivo methods are ideal due to the presence of blood 
circulation and maintenance of the physiological parameters. However, this is not 
always practical as several aspects of absorption cannot be studied, such as collection of 
the absorbed products. Although not without its disadvantages, in vitro methods are 
more popular as the experimental conditions can be easily controlled and at the same 
time allows better sampling from the mucosal as well as the serosal side. Perhaps a 
combination of different methods is best to provide better information on absorption and 
mechanism of transport, taking into account variations in physiological as well as 
intestinal function in the methods.
1.13.4 Fiavonoid uptake from the small intestine
Various studies have investigated the uptake of several flavonoids from the small 
intestine, using different in vitro techniques. This is summarised in Table 1.12. It is 
hoped that such studies could provide better understanding of the relationship between 
the structure of flavonoids and the extent of their absorption from the intestine.
A study used CaCo-2 cells as a model of human intestinal absorption and 
measured the permeability of various flavonoids in both luminal to basal and basal to 
luminal directions (Walgren et a/., 1998). Quercetin was the most permeable compound
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in the luminal to basal directions followed by much lower permeability of quercetin-3,4'- 
diglucoside and no absorption of quercetin-4'-glucoside (Table 1.12). It is possible that 
the glucose moiety in the 3-position promotes absorption whereas inhibits it in the 4'- 
position. The same method was used to study the uptake of chrysin (5,7- 
dihydroxy flavone; Walle et al., 1999). Movement from basolateral to luminal was two 
fold higher than from luminal to basolateral. This suggest bidirectional movement of 
certain flavonoids implying that not all the flavonoids absorbed will be available as a 
proportion of it might be excreted back into the intestinal lumen. However, the 
correlation between the cell culture technique and in vivo absorption is questionable. 
CaCo-2 cells are cancerous cells and any modification in the transport system as a result 
of cancer in not known. The relevance to uptake in normal subjects is open to argument. 
As the cell culture conditions may not be physiologically identical to the in vivo system, 
the observed basolateral to luminal movement of flavonoids may not occur in the actual 
human body as they might be taken up straight into the general circulation. Furthermore, 
in the in vivo system, the luminal concentration of ingested flavonoids would be 
expected to be much higher than the basolateral concentration, thus promoting passive 
diffusion. This gradient is expected to be maintained by removal of the flavonoids from 
the basolateral side by blood flow and plasma protein binding.
One other study indicated intestinal absorption o f quercetin aglycone (Notebom 
et ah, 1997) with another detecting low absorption, only 60 min after the start of 
incubation (Spencer et al., 1999; Table 1.12). However, Spencer et al found much 
higher presence of quercetin glucuronides following incubation with quercetin aglycone. 
This may explain the low absorption of the unchanged compound.
Recently published studies claimed the ability of the small intestine to both 
absorb and glucuronidate several flavonoids (Spencer et al., 1999, Shimoi et al., 1998; 
Table 1.12). This was observed in the glycosides as well as the aglycone of flavonoids 
although the structure of the molecule may affect the extent of their absorption and 
glucuronidation. The other previous studies only looked at absorption of the parent 
compoimd following their incubation. Therefore, the presence of glucuronides, if any 
were not included.
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In contrast to the above findings, following perfusion of isolated rat intestine with 
quercetin-3-glucoside, Spencer et al (1999) detected higher absorption of the aglycone 
compound compared to the parent compound and the glucuronides. This implies 
possibly deglycosylation of quercetin-3-glucoside while being transported through the 
intestinal tissue. Mizuma et al (1994) reported similar deglycosylation of naphthyl 
glucosides during intestinal absorption.
Most of the studies reported intestinal absorption of quercetin glycosides 
although one detected no absorption of quercetin-4'-glucoside (Walgren et al., 1998; 
Table 1.12). The aglycone fonn of several flavonol and flavone were also absorbed 
(Noteborn et al., 1997, Walgren et al., 1998, Spencer et al., 1999). However, one study 
reported glucuronidation of the aglycone of quercetin and kaempferol during their 
passage through the intestinal wall (Spencer et a l, 1999). Quercetin-3-glucoside was 
both deglycosylated and glucuronidated during intestinal absorption with higher levels of 
the aglycone detected than the glucuronides (Spencer et a l, 1999).
All the in vitro techniques employed to study the absorption of flavonoids 
showed some discrepancies in the results obtained (Table 1.12). As mentioned before, 
various factors can contribute to this, particularly the set up of the experiments and 
control o f the physiological conditions. Therefore, at this point in time, it is difficult to 
come to a definite conclusion regarding the extent of flavonoid uptake from the small 
intestine and the factors influencing them. It appears that only a very limited amount of 
flavonoids was transported (Noteborn et a l, 1997, Spencer et a l, 1999), suggesting low 
bioavailability of these compounds. However, this cannot be directly compared with in 
vivo system as lower absorption is expected from in vitro systems due to the lack of 
blood supply and other physiological conditions.
1.13.5 Mechanisms of flavonoid absorption from the small 
intestine
Hollman and his colleagues (1995) in their absorption study, found that quercetin 
glycosides flom onions were better absorbed than the aglycone. They proceeded to 
postulate that the SGLTl might be involved in the transport of quercetin glucosides.
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Indeed, SGLTl has been shown to be able to transport naphthyl glycosides in addition to 
glucose, their primary substrate (Mizuma et al., 1994). A few studies have investigated 
this hypothesis although no strong evidence was obtained. One study reported 
interaction of several quercetin glucosides (1 mM) including quercetin-3,4'-diglucoside, 
quercetin-3-glucoside and quercetin-4-glucoside with SGLTl based on an everted rat 
gut model (Gee et al., 1998). However, in contrast to this, quercetin-3-glucoside as well 
as quercetin aglycone behaved as glucose transport carrier inhibitors at flavonol 
concentration of 10 pM (Noteborn et al., 1997). It is rather puzzling that at low 
concentration, quercetin and its glucosides can inhibit SGLTl but not so at high 
concentrations suggesting possible discrepancies in the two methods employed.
Obviously, more studies are needed in this area, using different approaches. 
Phloridzin, an inhibitor of SGLTl could be employed to block the transporter and thus 
study their influence on flavonol glucosides uptake. As yet, it cannot be conflimed that 
quercetin glucosides are transported by SGLTl in the small intestine.
1.13.6 Limitations of i n  v i t r o  techniques to  study intestinal 
absorption
Obviously, with in vivo techniques, the physiological parameters are maintained, 
such as blood flow and hormone levels. However, with in vitro methods, it is difficult to 
maintain the exact physiological conditions and admittedly, some of it will be lost. Thus, 
the relationship between the transport mechanisms and the overall absorption may not be 
clear. Preparations of intestinal tissues from animals are also an important determinant 
particularly in maintaining tissue viability. Furthermore, speed and the use of well- 
oxygenated buffer are crucial in working with surviving intestines. However, the 
importance of this type of study cannot be denied in order to evaluate the exact 
mechanism and the extent of flavonoid absorption from the intestine. Researchers will 
need to be aware of the confounding factors and limitations of such studies.
8 0
1 .1 3 .7  C onclusion
The potential for flavonoids to provide beneficial health properties is very 
promising. The next step is the determination of their absorption and metabolism. Of 
particular importance is the ability of flavonoids to provide protection at the levels of 
dietary intake rather than at pharmacological dose. Although substantial research have 
been carried out on this field, several gaps or loopholes still exist particularly on the 
mechanism of absorption and the fate of these compounds following their absorption. 
Inevitably, the flavonoids that circulates in the blood stream, either as the unchanged 
compound or as the metabolites will have the biggest impact on human health. Thus, 
evaluation of the factors influencing the mode and extent of flavonoid uptake from the 
small intestine together with their metabolism will provide a better understanding on the 
interaction between these compounds and the biological system.
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Aims of Study
CHAPTER 2: AIMS OF STUDY
The widespread potential of flavonoids in humans particularly as antioxidants is 
widely recognised. This has opened up the prospect for more research especially 
regarding their absorption and metabolism. As yet, information is still limited and 
further studies are required to provide a better understanding of their beneficial health 
properties in vivo.
Therefore, the main objectives of this thesis were:
1. To investigate the extent of accumulation of flavonols in plasma and their excretion 
in urine following consumption of a high-flavonol food.
2. To establish the mode and extent of flavonol absorption from the small intestine and 
evaluate the effect of structural modification as well as the nature/position of sugar 
moiety on their absorption.
3. To investigate the influence of flavonol glycoside structure on the extent of their 
metabolism by the liver.
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CHAPTER 3: MATERIALS AND METHODS
This chapter describes the general materials and methodologies applied in 
conducting experiments. An automated high performance liquid chromatograph system 
(HPLC) was extensively used for the analysis of flavonoids from various sources. 
Methods for extracting flavonoids from plant tissues as well as biological samples are 
explained. In addition, optimization of flavonoid analysis in plasma is also detailed in 
this chapter as information obtained is useful for the feeding studies described in Chapter
4.
3.1 MATERIALS
3.1.1 Flavonoid standards
Quercetin-3,4 '-diglucoside, quercetin-4 -glucoside and isorhamnetin-4'- 
glucoside were a gift from Dr T. Tsushida, National Food Research Institute, Ibaraki, 
Japan. Kaempferol, quercetin, and morin were obtained from Sigma Aldrich (Poole, 
Dorset, UK). Quercetin-3-glucoside and isorhamnetin were purchased from Apin 
Chemicals Ltd. (Oxon, UK).
3.1.2 HPLC solvents
Methanol and acetonitrile were of HPLC grade and obtained from Rathbum 
Chemicals Ltd (Walkerburn, Scotland). Aluminium nitrate nonahydrate and 
trifluoroacetic acid were purchased from Sigma Aldrich (Poole, Dorset, UK). Glacial 
acetic acid was obtained from Fischer Scientific (Leicestershire, UK).
3.1.3 Plant Materials
Yellow onions for flavonol analysis and the human feeding trials were purchased
at different dates at Safeway pic. (Byres Road, Glasgow). Previous analyses have shown
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that the flavonol content of the same cultivar of onions did not vary significantly from 
month to month (Crozier et al., 1997).
3.2 METHODS
3.2.1 Flavonoid analysis by High Performance Liquid
Chromatography
Samples were analysed using a Shimadzu (Kyoto, Japan) LC-lOA series 
automated liquid chromatograph comprising a SCL-lOA system controller, two LC-lOA 
pumps, a SIL-IOA auto injector with sample cooler, a CTO-1 OA column oven and SPD- 
lOA UV-VIS detector and an RF-lOA fluorimeter linked to Reeve Analytical (Glasgow, 
UK) 2700 data handling system. Reversed phase separations were carried out at 40°C 
using a 150 x 3.0 mm i d., 4 um Genesis Cig cartridge column fitted with a 10 x 4.0 mm 
i.d. Ci8 Genesis guard cartridge in an integrated holder (Jones Chromatography, Mid- 
Glamorgan, UK). The mobile phase was a 25 min, 20-40% gradient of acetonitrile in 
water adjusted to pH 2.5 with trifluoroacetic acid, eluted at a flow rate of 0.5 ml/min. 
Column eluent was first directed to the SPD-lOA absorbance monitor operating at 365 
nm, after which post-column derivatization was acliieved by the addition of methanoiic, 
O.IM aluminium nitrate containing 7.5% glacial acetic acid, as described by Hollman et 
al ( 1996)^an^,ppmped at a flow rate of 0.5 ml/min by a pulse-free Model 9802 preci^n^ 
mixer/splitter (Reeve Analytical). The mixture was directed to a RF-lOA fluorimeter 
and fluorescent flavonol complexes detected at excitation 420 nm and emission 485 nm. 
The limit of detection at A365 nm was <5 ng and linear 5-250 ng calibration curves were 
obtained for morin, quercetin, kaempferol, isorhamnetin, quercetin-3,4'-diglucoside, 
quercetin-3-glucoside, quercetin-4'-glucoside and isorhamnetin-4'-glucoside. The
fluorescence intensity of the individual flavonoid derivatives varied, however, 0.1-100 
ng linear calibration curves were obtained for morin, quercetin, kaempferol, 
isorhamnetin, quercetin-4'-glucoside and isorhamnetin-4'-glucoside.
Figure 3.1 illustrates typical HPLC traces of standards of flavonol aglycones and 
flavonol conjugates detected at absorbance 365 nm on the UV detector (Figure 3.1 A) 
and after post-column derivatization, detected by the fluorimeter (Figure 3.1 B). Peaks
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Figure 3.1; Gradient reverse phase HPLC analysis of flavonols.
Column: 150 x 3.0 mm i.d, 4-jim Genesis Cis cartridge column with a 10 x 4.0 mm 4-].im Genesis Cjg 
guard cartridge. Mobile phase: 20 min gradient of 20-40% acetonitrile in water containing 0,5% 
trifluoroacetic acid. Flow rate; 0.5 ml/min. Detector: absorbance monitor operating- at 365 nm and, after 
on-line post-column derivatization with methanoiic aluminium nitrate, a fluorimeter operating at 
excitation 420 nm and emission 485 nm. Samples: (A) 50 ng flavonol standards: (1) quercetin-3,4'- 
diglucoside, (2) quercetin-3-glucoside, (3) quercetin-4'-glucoside, (4) isorhamnetin-4'-glucoside, (5) 
morin, (6) quercetin, (7) kaempferol and (8) isorhamnetin detected at Agg; (B) 'as (A) but with 
fluorescence detection after post-column derivatization. The numbers corresponded with peaks for 
standards listed in (A)
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for all the flavonol standards could be detected at Asesnm whereas following post-column 
derivatization, the only flavonols that form fluorescent complexes were morin, quercetin, 
kaempferol, isorhamnetin, quercetin-4'-glucoside and isorhamnetin-4'-glucoside.
3.2 .2  Flavonol extraction from sam ples
3.2.2.1 Hydrolysis of flavonol conjugates in samples
The optimization of acidic conditions for the hydrolysis of flavonol conjugates in 
a range of plant tissues has been described by Hertog et al (1992) following an earlier 
detailed study by Harborae (1965) on the release of free flavonols by acid and enzymic 
hydrolyses. For this study, 600 pi of plasma, 750 pi of urine and 20 mg of lyophilised 
fried onions were hydrolysed .in a total of 2 ml of 50% methanol containing 1.2 M HCl 
and 20 mM sodium diethyldithiocarbamate as an antioxidant. The procedure was 
performed in a 3 ml glass v-vial whereby a teflon-coated magnetic stirrer was placed in 
the vial, which was then tightly sealed with a PTFE-faced septum prior to heating in a 
Reacti-Therm Heating/Stirring Module (Pierce, Rockford, II, USA). Hydrolysis was 
carried out at 90°C for 2 h (urine and fried onions) and 3 h (plasma). Extract aliquots 
were taken before acid hydrolysis to allow for the quantification of flavonol conjugates 
as well as any free flavonols present. Following acid hydrolysis, samples were 
centrifuged for 10 min at 3000 x g and the clear supernatant used to quantify for flavonol 
content.
In the case of onion hydrolysis, morin was used as the internal standard whereby 
10 pg of the standard was added to a total volume of 2 ml in the hydrolysis mixture and 
hydrolysis performed as mentioned above. Recovery of the morin internal standard was 
approximately 74% following a 2 h acid hydrolysis, indicating roughly 26% losses of 
flavonols from hydrolysis.
Extract aliquots of 75 pi taken both before and after acid hydrolysis, were made 
up to 250 pi with distilled water containing 0.5% trifluoroacetic acid (TFA) prior to 
analysis of 100 pi volumes (fried onions) and 200 pi volumes (plasma and urine) by
8 6
gradient elution reversed phase HPLC. Figure 3.2 shows a simplified diagram for the 
extraction and HPLC analysis of flavonols in plant tissues and biological samples.
The non-hydrolysed samples will contain all the flavonoid conjugates as well as 
any free flavonoids present whereas the acid hydrolysed samples will contain the 
aglycone as well as the free flavonoids liberated from their sugar conjugates. Therefore, 
the amount o f  conjugated flavonoids can be estimated by subtracting the levels o f  free 
flavonoids in the non-hydrolysed samples from total flavonoids obtained in the 
hydrolysed samples.
Conjugated flavonoids = Total flavonoids _ Free flavonoids
(Hydrolysed samples) (Non-hydrolysed samples)
3.2.2.2 Stability of flavonols in plasma during acid hydrolysis
For the routine analysis o f  flavonols in plasma, morin could not be used as the 
internal standard to account for losses that occur during acid hydrolysis. This is due to 
the presence o f  contamination peaks co-eluting with the morin internal standard which 
would aflect the accuracy o f  the recovery o f  the standard. Therefore, a separate 
experiment was performed to establish the stability of flavonols in plasma during the 
hydrolysis process. For this purpose, standards of quercetin, kaempferol and 
isorhamnetin (2 pg) were added into 600 pi of plasma containing 50% methanol and 
1.2M HCl in a total volume o f 2 ml. Plasma samples were then subjected to acid 
hydrolysis as mentioned in Section 3.2.2.1. Aliquots o f  300 pi samples were taken at 1 
h, 2 h, 3 h and 4 h during the hydrolysis process and content o f  the tlavonol standards 
analysed.
8 7
Plant tissues Biological fluids
Lyophilisation j
Acid hydrolysis
1.2 M HCl 
' 50% Methanol
' 90°C 
' 9-1 h
HPLC analysis
• 100-200 pi injection of  non-hydrolysed and acid hydrolysed samples
•  20-40% gradient o f  acetonitrile in water (pH 2.5)
• Flow rate = 0.5 ml/min
IJV detector
(365 nm)
Post-column chelation
(Methanol containing aluminium nitrate 
and 7.5% glacial acetic acid)
Fluorimeter
(Excitation = 420 nm) 
(Emission = 485 nm)
Figure 3.2: a sim plified diagram  of flavonol extraction and HPLC analysis
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3.2.3 The effect of temperature and storage time on the
flavonol content of plasma
Some of the plasma samples from human volunteers collected after they had 
ingested 300 g of fried onions were used for this study (see section 4.2.1). The plasma 
samples were divided into two groups and each group of samples was stored at either -  
20°C or -80°C. Flavonols in the plasma samples were analysed following a 1 week, 5 
weeks and 3 months storage and after being left for 3 h at room temperature. The 
procedure for acid hydrolysis of the samples is described in section 3.2.2.1. Following 
acid hydrolysis, the flavonol content of the plasma samples was analysed on the HPLC 
system (section 3.2.1).
3.3 RESULTS
3.3.1 Stability of flavonols in plasma during acid
hydrolysis
Results of the stability of flavonols in plasma during acid hydrolysis are 
illustrated in Figure 3.3. The content of quercetin, kaempferol and isorhamnetin appear 
to increase from 1 h to 2 h hydrolysis after which the level stabilized before decreasing at 
the 4 h time point. Overall, quercetin, kaempferol and isorhamnetin were stable during 
acid hydrolysis for up to 3 h, after that, degradation of the standards was observed. The 
low recoveries of quercetin, kaempferol and isorhamnetin at the 1 h time point could be a 
result of some of the flavonols still binding to plasma protein. Boulton et al (1998) 
reported extensive binding of quercetin to plasma proteins and the same may be true for 
kaempferol and isorhamnetin. Therefore, a 1 h hydrolysis of plasma is not sufficient to 
liberate the flavonols binding to plasma proteins.
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Figure 3.3: T he stability o f flavonols in plasma during acid hydrolysis
Standards of quercetin, kaempferol and isorhamnetin (2 pg) were added into plasma 
samples and subjected to acid hydrolysis for 4 h and stability of the added standards were 
estimated at every hour. Results are expressed as concentration (pg/ml ± standard error) 
and percentage recovery.
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3.3.2 The effect of temperature and storage time on the 
fiavonol content of plasma
Table 3.1 summarizes the effect of temperature and storage time on the flavonol 
content of plasma. Free quercetin in plasma was stable up to 5 weeks in storage with 
concentration ranging from 8.1 to 9.8 ng/ml. During these 3 storage times, the levels of 
conjugated quercetin did not change significantly and remained the same. This was 
evident in both samples stored at -20°C and -80°C. When left at room temperature for 3 
h, levels of free quercetin increased by about 6 ng/ml although conjugated quercetin was 
the same as in the other 3 storage times. The slight increase in free quercetin could be a 
result of low level hydrolysis of conjugated quercetin.
There was not much difference in the content of conjugated kaempferol and 
isorhamnetin in the 4 storage times although the level of conjugated isorhamnetin 
analysed 1 week after storage at -80°C was slightly lower than the others. There were 
no detectable levels of free kaempferol and isorhamnetin in all the samples analysed.
Overall, there was no significant difference in the flavonol content of plasma 
stored at -20°C, -80°C and at room temperature for 3 h. Generally, flavonols in plasma 
are stable during storage for up to 3 months. The levels of free quercetin were slightly 
higher when left at room temperature for 3 h. Thus, plasma samples analysed within 3 
months will still give reliable flavonol values.
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3.4 Conclusion
Acid hydrolysis of plant tissues and biological fluids is widely used as one of the 
procedure for the hydrolysis of conjugates of flavonoids (Hertog et al., 1992, Hollman et 
al., 1995). Flavonoid standards are generally stable up to 3 h when heated at 90°C in the 
presence of 1.2M HCl. The stability o f flavonols in plasma up to 3 months in storage 
provides the ease in sample analysis as immediate analysis is not required. A study 
reported that quercetin added to plasma samples was stable for 5 h at 37°C and for 2 
months when stored at -20°C (Liu et al., 1995). HPLC procedure is also a very reliable 
method for the separation and identification of flavonols. The development of the post­
column derivatization procedure (Hollman et a i, 1996) has enabled the estimation of 
minute quantities of flavonols normally present in biological fluids due to increased 
sensitivity and selectivity. Acid hydrolysis of samples and HPLC analysis were 
commonly used throughout this PhD project and this made up the main methods used in 
this thesis. Other methods relevant to each project will be described in detail in the 
relevant result chapter.
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CHAPTER 4: ABSORPTION AND EXCRETION OF
FLAVONOLS INCLUDING CONJUGATED FLAVONOLS BY 
HUMAN VOLUNTEERS AFTER THE CONSUMPTION OF 
ONIONS.
4.1 Introduction
Recent evidence has strongly supported the antioxidative role of flavonoids and their 
protections against LDL oxidation (de Whalley et al., 1990, Vinson et al., 1995). Quercetin, 
which in conjugated forms is commonly present in fruits and vegetables in high 
concentrations, possesses strong antioxidative properties (Rice-Evans et a i, 1996). 
Epidemiological evidence suggests a protective effect of flavonoid intake against coronaiy 
heart disease and to a lesser extent, against cancer (Chapter 1, section 11.10). The average 
intake of all flavonols has been estimated at 23 mg/d in the Netherlands diet with tea and 
onions being the major sources at 48% and 29% of total intake respectively (Hertog ei a i, 
1993). Estimating the intakes of flavonoids and the major dietary sources is not enough if 
their bioavailability is not known, From the estimated intake of 23 mg/d, it is important to 
know how much of it is actually made available or capable of intestinal absorption and 
subsequently utilise by the body. Determination of the bioavailability of different types of 
flavonoids can be used to identify foods containing the highly bioavail able flavonoids, 
which when consumed, will accumulate in the bloodstream and provide potential health 
benefits.
The absorption and metabolism of individual flavonols in man is however still 
poorly understood. Attempts to investigate their absorption have shown conflicting results. 
It was previously speculated that only free flavonols were absorbed and not the glycosides 
due to their conjugation to sugar residues (Kuhnau, 1976), However, recent research has 
reported the absorption of mtin in human plasma (Paganga and Rice-Evans, 1997) while 
data obtained with ileostomy patients has been interpreted as indicating that conjugated 
forms of quercetin may be better absorbed than the aglycone (Hollman et a i, 1995).
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Onions contain high concentrations of flavonols in the form of quercetin-3,4 
diglucoside and quercetin-4'-glucoside as well as smaller amounts of quercetin-3-glucoside, 
quercetin-7,4'-diglucoside, quercetin-7-glucoside and isorhamnetin-4'-glucoside (Tsushida 
and Suzuki, 1995, Price and Rhodes, 1997; Figure 4.1) . Onions therefore are useful 
materials for the investigation of the absorption of flavonols as recently developed HPLC 
techniques (Crozier et al., 1997) with post-column derivatization (Hollman et a i, 1996) can 
be used to quantify the overall levels of free and conjugated quercetin and isorhamnetin. 
This sensitive and selective method of analysis can also be used to monitor trace levels of 
quercetin-4'-glucoside and isorhamnetin-4'-glucoside in body fluids and, as such, facilitates 
more detailed studies on the absorption of flavonol conjugates than has previously been 
achieved. The aim of this study was to investigate the extent of accumulation of flavonols in 
plasma and their excretion in urine after a meal of lightly fried onions and to establish 
whether any of the different tlavonol conjugates present in the dietaiy supplement were 
absorbed without undergoing structural modifications. At the same time, the stability of the 
onion flavonols was investigated in an in vitro model of small intestinal digestion and 
colonic fermentation experiments.
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Figure 4.1: Structures o f flavonol conjugates detected in onions
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4.2 Materials and Methods
4.2.1 study design
Five healthy volunteers (1 male, 4 female), mean age 29.4 years (range 23-37 y), 
who were not on any medication and were non-smokers participated in this study. All 
subjects gave a written informed consent. Volunteers were asked to follow a low flavonoid 
diet for 4 days prior to the experiment and this included avoiding foods and beverages 
containing more than 15 mg/kg of flavonoids (Hertog et aL, 1992; See Appendix 1). On day 
4, after an overnight fast, volunteers were fed 300 g of lightly fried onions between 9.30 to 
10.00 a.m. An i.v cannula was inserted into each subject’s arm and venous blood samples 
were withdrawn at 0, 0.5, 1, 1.5, 2, 3, 4, 5 and 24 h after completing the meal. 10 ml of 
blood were collected at each time point into heparinised tubes and immediately centrifuged 
at 3000 X g for 10 min at 0°C. Aliquots of 1 ml plasma were placed into eppendorf tubes 
and stored at -80°C until analysis. Volunteers also collected all their urine over a 24 h 
period following the meal and collection was divided into 3 time points, 0-6 h, 6-12 h and 
12-24 h. Urine was collected into plastic containers which were kept in a cooler on ice. 
Aliquots of 20 ml urine at the various time points were stored at -80°C prior to analysis. 
The study protocol was approved by the University of Glasgow Human Ethics Committee 
for Non-Clinical Research.
4.2.2 Preparation of Onions
Yellow onions were purchased from Safeway pic. (Byres Road, Glasgow). 
Following removal of the dry outer scales, the onions were chopped into slices and lightly 
fried in olive oil before 300 g samples were consumed by the volunteers. Previous analyses 
have shown yellow and red onions to contain much higher levels of flavonols than white 
onions (Crozier el al.  ^2000). The same group also showed that much more extensive frying 
of onions resulted in only a 21% loss of flavonols (Crozier et aL, 1997). Volunteers 
consumed the onions over a period of 20 min after collection of the fasting blood sample. 
Triplicate samples of fried onions from each feeding experiment were lyophilised for 
quantitative analysis of their flavonol content.
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4.2.3 I n  V f t r o  digestion and fermentation of fried onions^
The digestion or intestinal breakdown of flavonols in onions was investigated in an 
in vitro model. Yellow onions were purchased from Safeway pic (Byres Road, Glasgow). 
The dry skin was removed before they were chopped into slices and a 1 kg sample lightly 
fried in 250 ml olive oil. 50 g of fried onions were treated with 1 g of pepsin in 50 ml of 0.1 
M HCl (pH 1) for 1 h at 37°C in a shaking water bath. This was followed by the addition of 
30 ml of 0.1 M NaOH (pH 7.0-7.5) containing 10 g of Creon 25000 pancreatin (Solvay 
Healthcare, UK). Digestion was continued for a further 3 h.
Colonic bacterial metabolism of flavonoids was tested in an in vitro model modifled 
from the method of Adiotomre et al (1990). Faecal samples were obtained from 4 healthy 
volunteers and processed within 1 h of defecation. A 32% faecal slurry was prepared in 
phosphate buffer, pH 7.0. 1 ml faecal slurry was added to 9 ml of pre-reduced fermentation 
medium (pH 7.0) containing basic salts and 100 mg of either digested or undigested fried 
onions. Cultures were incubated in anaerobic jars at 37°C for 24 h. In addition, a control 
culture without onions was carried out.
Following the digestion and fermentation processes, samples were immediately 
frozen and lyophilised, after which they were ground to fine powder and stored at -20°C 
prior to analysis.
4.2 .4  Flavonoid extraction from sam ples
Extraction and hydrolysis procedure of flavonoids from plasma, urine, lyophilised 
onions, digested and fermented onions are described in section 3.2.2.
' The in vitro digestion and fermentation of fried onions was performed by Mr Khalid Khan, Department of 
Human Nutrition, Yorkhill Hospitals.
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4.2 .5  Flavonol analysis by high performance liquid
chromatography
The separation and quantification of flavonols in the samples were performed on the 
high performance liquid chromatograph system as detailed in section 3.2.1.
Where necessary, identification of flavonols in the biological samples and plant 
materials were perfonned by co-chromatography of the samples with flavonol standards. 
This was carried out on the HPLC system.
4.3 Results
4.3.1 Flavonols in fried onions
Quantitative estimates of quercetin-3,4 '-diglucoside, quercetin-4'-glucoside,
isorhamnetin-4'-glucoside, quercetin, isorhamnetin and kaempferol in the five lightly fried 
onions consumed by the volunteers are described in Table 4.1. There was a variation in the 
flavonol content of the different onion samples which were purchased over a 6-month period 
and this is in keeping with previous observations (Crozier et a i, 1997). The levels of free 
quercetin for example, varied from as low as 0.41 ± 0.03 mg/g fresh weight in one sample to 
as high as 7.4 ± 0.2 mg/g fresh weight in another. A 3 to 6 fold difference was observed 
between the lowest and the highest values of the other flavonols in samples of the five 
lightly fried onions. In all instances, quercetin-3,4'-diglucoside and quercetin-4'-glucoside 
were the major flavonols present contributing approximately 71% and 25% of total 
flavonols respectively. At the same time, lower levels of isorhamnetin-4'-glucoside was 
also detected together with the aglycone forms of quercetin, isorhamnetin and kaempferol. 
The flavonol aglycone represented less than 1% of the total flavonols in the onion samples.
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Our Î-ÏPLC procedure provided an effective separation of flavonol standards with 
quercetin-3,4'-diglucoside, quercetin-3-glucoside, quercetin-4'-glucoside, isorhamnetin-4'- 
glucoside, morin, quercetin, kaempferol and isorhamnetm being detected with an absorbance 
monitor operating at 365 nm (Figure 4.2 A). With the exception of quercetin-3,4 
diglucoside and quercetin-3-glucoside, ah of the above compounds form fluorescent 
complexes following a post-column reaction with aluminium nitrate (Figure 4.2 B). This 
method provided a more sensitive and selective approach for the identification of fîavonols. 
Figure 4.2 C and D illustrated typical HPLC traces obtained for the analysis of unhydrolysed 
fried onion extracts. Peaks that co-chromatographed with quercetin-3,4'-diglucoside, 
quercetin-4 -glucoside, isorhamnetin-4 '-glucoside and morin internal standard were detected 
at A365nm (Figure 4.2 C) whereas peaks that corresponded to the 4'-glucosides of quercetin 
and isorhamnetin as well as small amounts of quercetin and kaempferol were present after 
postcolumn derivatization (Figure 4.2 D).
4.3,2 Identification of flavonols in piasma and urine
Typical ITPLC traces of plasma after postcolumn derivatization collected at 0 and 1.5 
h after the ingestion of onions are illustrated in Figures 4.3 C and D. The 0 h sample of 
plasma contained only very minor fluorescent components and there were no peaks that co­
chromatographed with the flavonol standards. On the other hand, plasma collected at 1.5 h 
after eating 300 g of fried onions contained isorhamnetin-4 -glucoside peak in far higher 
sensitivity than quercetin-4'-glucoside which was present in only trace quantities as a 
shoulder on an impurity (Figure 4.3 D) despite being found in onions in much larger 
amounts than the isorhamnetin conjugate (Table 4.1 ). In some plasma samples, kaempferol 
and isorhamnetin were also found but in trace amounts close to the limit of detection. The 
major onion flavonol, quercetin-3,4'-diglucoside, does not fluoresce following postcolumn 
derivatization and was not detected at Asesnm in any of the plasma samples analysed. This 
does not necessarily mean it was not present in levels broadly comparable to quercetin-4- 
glucoside because the limit of detection at A365nm for quercetin-3,4 -diglucoside was 500 
ng/mi while postcoiumn derivatization enabled quercetin-4'-glucoside to be monitored at
1 0 1
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Figure 4.2; Gradient reverse phase HPLC analysis of flavonols in onions.
Column: 150 x 3.0 mm i.d. 4-^m Genesis Gig cartridge column with a 10 x 4.0 mm 4-|im Genesis Cjg guard 
cartridge. Mobile phase: 20 min gradient of 20-40% acetonitrile in water containing 0.5% trifluoroacetic acid. 
Flow rate: 0.5 ml/min. Detector: absorbance monitor operating at 365 nm and, after on-line post-column 
derivatization with methanolic aluminium nitrate, a fluorimeter operating at excitation 420 nm and emission 
485 nm. Samples: (A) 50 ng flavonol standards: ( 1 ) quercetin-3,4'-diglucoside, (2) quercetin-3-glucoside, (3) 
quercetin-4'-glucoside, (4) isorhamnetin-4'-glucoside, (5) morin, (6 ) quercetin, (7) kaempferol and (8 ) 
isorhamnetin detected at (B) as (A) but with fluorescence detection after post-column derivatization;
(C) aliquot of a non-hydrolysed extract of yellow onions detected at Ag^ fnm; (D) same as (C) but with post- 
column derivatization and fluorescence detection. The numbers corresponded with peaks for standards listed 
in (A).
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Figure 4.3: Gradient reverse phase HPLC analysts of flavonols in plasma and urine.
Column; 150 x 3.0 mm i.d. 4-p.m Genesis C,R cartridge column with a 10 x 4.0 mm 4-jiim Genesis Cig guard 
cartridge. Mobile phase: 20 min gradient of 20-40% acetonitrile in water containing 0.5% trifluoroacetic acid. 
Flow rate: 0.5 ml/min. Detector: absorbance monitor operating at 365 nm and, after on-line post-column 
derivatization with methanolic aluminium nitrate, a fluorimeter operating at excitation 420 nm and emission 
485 nm. Samples: (A) 50 ng flavonol standards: (1) quercetin-3,4'-diglucoside, (2) quercetin-3-glucoside, (3) 
quercetin-4'-glucoside, (4) isorhamnetin-4'-glucoside, (5) morin, (6 ) quercetin, (7) kaempferol and (8 ) 
isorhamnetin detected at A3 6 5  (B) as (A) but with fluorescence detection after post-column derivatization;
(C) aliquot of a non-hydrolysed plasma collected immediately prior to the consumption of 300 g of lightly 
fried onions, with post-column derivatization and fluorescence detection; (D) as C but plasma collected 1.5 h 
after eating fried onions; (E) aliquot of a non-hydrolysed urine after consumption of fried onions with post- 
column derivatization and fluorescence detection. The numbers corresponded with peaks for standards listed 
in (A).
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concentrations as low as 10 ng/ml. In all instances, identifications of quercetin-4 
glucoside, isorhamnetin-4'-glucoside, quercetin, kaempferol and isorhamnetin were 
confirmed by co-chromatography and the peaks corresponded with the flavonol standards 
(Figure 4.3 A and B).
Figure 4.3 E showed typical HPLC traces obtained for the analysis of flavonols in 
urine after ingestion of the fried onions, detected following post-column derivatization. The 
trace was quite similar to plasma collected at 1.5 h (Figure 4.3 D) with the presence of 
isorhamnetin-4'-glucoside in higher quantities than quercetin-4'-glucoside which was a 
shoulder on an impurity peak. No flavonol peaks in both plasma and urine samples were 
detected on the UV detector at A.^ 6 5nm. This is due to the high limits of detection of flavonols 
and the UV detector is not sensitive enough to detect flavonols which were nonnally present 
in low levels in biological samples.
4.3.3 Baseline flavonol levels in plasma of volunteers on a 
normal diet
A separate study was performed whereby three healthy subjects who participated in 
the fried onions study were asked to follow their normal diet for five days, after which a 
fasting blood sample was collected on the 6'^ ’ day. This was to determine the baseline level 
of flavonols of subjects on a nonnal diet. Table 4,2 represents the flavonols detected in 
plasma of the three subjects. Quercetin and isorhamnetin were detected in plasma although 
there were no detectable levels of isorhamnetin in subject 1. The conjugated forms of 
flavonols were predominant compared to the aglycones. Quercetin was the main flavonol, 
contributing almost 80% of the total flavonols. The concentration of quercetin in these 
subjects is in agreement with a study reporting a mean baseline value of 28.4 ng/ml in 
plasma of 5 subjects following consumption of fried onions (McAnlis et al., 1999).
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Table 4.2: flavonol content of plasma following a normal diet
Results expressed as ng/ml ± standard error
Subject Free
quercetin
Conjugated
quercetin
Free
isorhamnetin
Conjugated
isorhamnetin
1 2.22+ 1.15 18.91 ±0.56 n.d. n.d.
2 6.45 ± 0.58 18.85 ±0.73 n.d. 5.87 ± 1.07
3 10.55 ±2.07 13.20 ±2.81 n.d. 3.96 ±0.38
n=J
05
4 .3 .4  Flavonol accum ulation in plasma
The fried onion supplement was well accepted and tolerated by the human volunteers 
and no adverse effects were reported. The five subjects followed a low-flavonol diet for 
three days and fasted overnight prior to being fed the onions. The time course profiles of the 
appearance of free and conjugated quercetin, quercetin-4'-glucoside and isorhamnetin-4 
glucoside in plasma are presented in Figures 4.4 A and B. As the amounts of flavonols in 
the onions consumed varied (see Table 4.1), flavonol levels in the plasma are expressed as 
percent of the amount ingested.
Due to the significant variation in the accumulation of flavonols in plasma of the five 
subjects, the profile of each individual was illustrated (Figure 4.4 A and B). Despite 
following a low flavonol diet 3 days before the experiment, trace levels of free quercetin 
could be detected in the fasting (0 h) plasma samples of subjects 2 and 5 (9.9-11.4 ng/ml) 
(Figure 4.4A). Low levels of conjugated quercetin (6.8 ±2.8 ng/ml) was also present in the 
0 h sample of subject 2. Levels detected in fasting plasma samples were much lower than 
baseline plasma levels of subjects on a normal diet (Table 4.2). This indicates that the low 
flavonol diet managed to eliminate most of the flavonols in the circulation. In other 
instances, there were no detectable quantities of flavonols in the fasting plasma samples. 
After 24 h, only conjugated quercetin could still be detected (above the baseline) in plasma 
of the 5 subjects whereas there were no detectable levels of the other flavonols.
Subjects 1, 2 and 3 exhibited similar profiles with a rapid increase of flavonol levels 
after onion consumption followed by a rapid decline in their concentration. On the other 
hand, flavonols in subjects 4 and 5 appeared to have a second peak concentration later on in 
the time course of the experiment and had a slower decline in flavonol content than subjects 
1, 2 and 3. Based on the profile of flavonol accumulation in plasma of the five subjects, the 
pattern of flavonol accumulation could be divided into 2 groups, the first being rapid 
absorption followed by rapid decline (as in subjects 1,2 and 3) and the second being 
moderate absorption and slower decline in flavonol levels (subjects 4 and 5). Subjects in the
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Figure 4.4 A: Free and conjugated quercetin in plasma collected from five human volunteers 
after the ingestion of300 g of lightly fried onions.
Data expressed as percentage of the intake based on flavonol content of onions ± standard error (n=5) and 
calculated on the basis of 3000 ml of plasma per person.
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Figure 4.4 B: Quercetin-4'-glucoside and isorhamnetin-4'-glucoside in plasma collected from 
five human volunteers after the ingestion of300 g of lightly fried onions.
Data expressed as percentage of the intake based on flavonol content of onions ± standard error (n=5) and 
calculated on the basis of 3000 ml of plasma per person.
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latter category appeared to have lower values of flavonols at peak plasma concentration 
when expressed as a proportion of intake compared to the first category. Overall, the 
absorption of flavonols was moderately rapid with peak plasma concentrations being 
reached in the five subjects at times ranging from 0.5-4.0 h after ingestion of the fried 
onions, although in most cases, a figure of 1.0-2.0 h was typical (Table 4.3).
There was a large variation in the profile for plasma accumulation of free quercetin 
among the 5 volunteers with subjects 1, 2 and 3 showing peak concentration as percentage 
of ingestion in the range of 12-53% whereas with subjects 4 and 5, it was between 1.1-2.3%, 
a difference of approximately 15 fold (Figure 4.4A). Similar profiles were observed for 
conjugated quercetin with subjects 1,2 and 3 showing higher peak plasma concentration 
expressed as percentage of ingestion (0.8-2.0%) compared to subjects 4 and 5 (0.6%). It is 
notable that compared with the levels present in the ingested onions, isorhamnetin-4'- 
glucoside accumulated in plasma in amounts ca. 10 times greater than conjugated quercetin 
and 50-fold more than quercetin-4 -glucoside. This was evident with all five subjects 
(Figure 4.4). In addition to free and conjugated quercetin, variations was also noticed in the 
accumulation of 4'-glucosides of isorhamnetin and quercetin, as a percentage of the amount 
ingested, between the five subjects. With subjects 2 and 3, the peak isorhamnetin-4'- 
glucoside level was ca. 16% and that of quercetin-4'-glucoside ca. 0.2 -0.4 % while the 
equivalent figures for subject 5 were ca. 5% and ca. 0.1% respectively (Figure 4.4 B).
The mean values for the key features of flavonol accumulation in plasma are 
presented in Table 4.3. A peak concentration of 452 ± 100 ng/ml was obtained for the 
overall level of quercetin conjugates while with quercetin-4'-glucoside it was 45 ± 11 ng/ml, 
which was less than 10% of the total quercetin conjugate concentration. The mean 
maximum concentration of isorhamnetin-4 -glucoside was 370 ± 91 ng/ml which when 
expressed as a proportion of intake from the onions was 10.7 ± 2.6% compared to values of 
0.13 ± 0.03% and 0.97 ± 0.21% from quercetin-4'-glucoside and quercetin conjugates, 
respectively. In addition to the conjugated flavonols, we could also detect the accumulation
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Table 4.3: Mean values ± standard error of key features of flavonol accumulation in 
plasma following the consumption of 300 g of lightly fried onions by five subjects.
Flavonol Intake
(mg)
Peak plasma 
concentration 
(ng/ml)
Time of peak 
plasma 
concentration 
(h)
Peak plasma 
concentration as a 
proportion of intake* 
(%)
Quercetin-4'-
glucoside
102 ± 2 2 45  ±  11 1.3 + 0.2 0 .13  ± 0 .0 3
isorhafnnetin-4’-
glucoslde
10.5 ± 1.5 370  ± 91 1.8 ± 0 .7 10.7 ± 2 . 6
Free quercetin 2.8 ± 1 . 3 37 .5  ± 9 .5 1.7 ± 0 . 6 17.4 ± 9 . 6
Conjugated
quercetin^
139 ± 2 5 452 ± 100 1.9 ± 0 . 6 0.97  ± 0 .2 1
^Calculated on the basis of 3000 ml plasma/person. 
“ Determined following acid hydrolysis.
10
of trace amounts of free quercetin in plasma although at peak concentration, the levels were 
much lower than the other flavonols detected, i.e ca 10% of conjugated quercetin. However, 
the levels of free quercetin detected could be a result of hydrolysis of very large pool of 
conjugated quercetin rather than their direct absorption or metabolism.
The area under the curve for plasma accumulation of the different flavonols after the 
fried onion meal was estimated (Table 4.4). Conjugated quercetin showed the highest AUG 
whereas free quercetin had the lowest. The relative accumulation of quercetin-4'-glucoside 
and free quercetin was 5% that of conjugated quercetin. On the other hand, isorhamnetin- 
4 '-glucoside showed bioavailability approximately 50% that of conjugated quercetin.
4.3.5 Urinary excretion of flavonols
Similar to plasma, there was a higher excretion of isorhamnetin-4'-glucoside with a 
percentage excretion of 17.4 ± 8.3% compared to 0.2 ± 0.1% for quercetin-4'-glucoside 
(Table 4.5). Free quercetin and isorhamnetin were also detected in urine of the five subjects 
with percentage excretion of 30.2 ± 11.8% and 12.0 ± 9.0% respectively. Again, figures for 
free quercetin and isorhamnetin could be exaggerated because of large conjugate pools with 
trace levels of hydrolysis. Quercetin conjugates in the hydrolysed samples showed a 
percentage excretion of 0.8 + 0.4% which was 4 times the percentage excretion of quercetin- 
4 -glucoside. In most cases, a high proportion of the flavonols was excreted in the first 
collection period (0-6 h) whereby approximately 57% of the cumulative excretion were 
reached. Urine samples from the last collection period, contained on average, 4% of the 
total daily output of the flavonols indicating that the peak of urinary flavonol excretion lay 
well within the 12 h period.
I l l
Table 4.4: Area under the curve of flavonols in plasma following ingestion of 300 g of 
fried onions.
Flavonol Peak piasma concentration 
(ng/ml)
AUC o-24h 
(h.ng/ml)
Quercetin-4’-glucoside 45 ±11 211 ±36
lsorhamnetin-4’-glucoside 370 ±91 1617 ±524
Free quercetin 37.5 ±9.5 149 ± 30
Conjugated quercetin^ 452 ± 100 3331 ±700
“ Determined following acid hydrolysis 
n=5 ± standard error
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Table 4.5: Mean values ± standard error for the excretion of flavonols in urine 
following the consumption of 300 g of lightly fried onions by five subjects.
Results expressed as pg ± standard error.
Flavonol Intake
(mg)
Excretion period Total excreted 
as a proportion 
of intake 
(h)
0-6 h 6-12 h 12-24 h
Quercetin-4’-
glucoside
102 ± 2 2 1 0 0 + 2 7 65 ± 4 3 4.8  ± 2 . 6 0.2 ± 0 .1
lsorhamnetin-4’-
glucoside
10.4 ± 1.5 1175 ± 482 620 ± 374 23 ± 15 17.4 ± 8 . 3
Quercetin 2 .8  ± 1.3 134.9 ± 4 6 .7 1 0 1 .7 ± 6 1 .6 5.6  ± 2 . 3 30.2 ± 11.8
isorhamnetin. 0 .10  ± 0 .0 6 4 . 6 ± 2 . 1 3.9 ± 1.8 0.3 ± 0 . 2 12.0 ± 9 . 0
Conjugated
quercetin^
139 ± 2 5 661 ± 2 8 1 348 ± 184 66  ± 2 9 0.8 ± 0 .4
n.d. = not detected
“ Determined following acid hydrolysis
4.3.6 I n  v i t r o  digestion of fried onions
Table 4.6 shows the flavonol content of fried onions before and after in vitro 
digestion. There was no significant difference in the flavonol content of onions before and 
after digestion. However, a slight decrease was observed in the levels of conjugated 
quercetin including quercetin-3,4'-diglucoside and quercetin-4'-glucoside analysed in the 
nonhydrolysed samples. The levels of free quercetin were slightly higher after digestion 
compared to before. This suggests hydrolysis of trace amounts of the glucosides to liberate 
free quercetin. Isorhamnetin-4'-glucoside was the most stable compound with only 7% 
losses occurring during the digestion process. Overall, flavonols in fried onions are 
generally stable to the acidic and alkaline conditions of digestion with approximately 7-18% 
losses observed.
4.3.7 I n  v i t r o  fermentation of fried onions
In vitro fermentation was performed on the digested as well as the undigested fried 
onions (Table 4.6). Following fermentation, there were no detectable levels of quercetin- 
3,4'-diglucoside and quercetin-4'-glucoside in both the undigested as well as the digested 
onions. The levels of free quercetin did not increase after fermentation and less than 3% of 
conjugated quercetin was recovered following the fermentation process. As for 
isorhamnetin-4'-glucoside, there was almost complete degradation with less than 2% 
recovered after fermentation. Overall, fenuentation of fried onions led to the disappearance 
of conjugated flavonols including quercetin-3,4'-diglucoside, quercetin-4'-glucoside and 
isorhamnetin-4 '-glucoside.
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4.4 Discussion
Although the literature contains much infonnation on the seemingly low levels of 
absorption of the aglycone quercetin in a variety of rat test systems, there are few studies on 
the absorption of flavonol conjugates, the typical constituents of foods, by humans (see 
Chapter 1, section 1.11). Hollman and co-workers (1995) have investigated the absorption 
of quercetin glucosides by humans with an ileostomy. The subjects were fed quercetin 
glucoside-rich onions, rutin or free quercetin, after which the flavonol content of ileostomy 
effluent and rutin were monitored over a 13 h period. In vitro incubations of the three 
sources of flavonols with gastrointestinal fluids showed minimal degradation and extremely 
low levels of flavonols were excreted in urine. After corrections for sample handling losses 
and low level degradation in the ileostomy bag, absorption was estimated by subtracting the 
flavonol content of the ileostomy effluent from the oral intake. This albeit indirect 
procedure, indicated surprisingly high levels of absorption, 52% of onion quercetin 
glucosides, 17% for rutin and 24% for quercetin. Subsequently, the same group, who 
analysed samples only after acid hydrolysis, which does not allow distinction between free 
and conjugated quercetin pools, monitored flavonol levels in plasma after the ingestion of 
onions (Hollman et al., 1996). The time course profiles obtained with two volunteers were 
similar to those obtained in the present study (Figure 4.3), as was the peak quercetin (free 
plus conjugated) plasma concentration of 196 ng/ml. This is equivalent to ca. 0.9% of the 
flavonol content of the ingested onion flavonols and comparable to figures in Table 4.3. 
However, our results presented a more reliable figure as more subjects were used (n=5) 
compared to 2 in the study by Hollman et al. Detection of low plasma concentrations imply 
that quercetin/quercetin conjugates, if they are absorbed into the bloodstream in the 
quantities reported by Hollman et al. (1995), are being rapidly metabolised and/or removed 
from the bloodstream, presumably by the liver.
In the present study, it has been demonstrated for the first time that the onion
flavonol glucosides, quercetin-4'-glucoside and isorhamnetin-4'-glucoside accumulate in the
bloodstream and are excreted in urine without seemingly undergoing structural modification.
The main flavonol in onions, quercetin-3,4'-diglucoside, was not detected in body fluids but
this is likely to be a consequence of the relative lack of sensitivity of the HPLC detection
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systems for this conjugate. The level of quercetin released from conjugated forms by acid 
hydrolysis, although low, was invariably several-fold higher than the concentration of 
quercetin-4'-glucoside in both plasma and urine (Table 4.3 and 4.5). This may be due to the 
presence of metabolites such as quercetin glucuronide and sulphate conjugates, which 
release free quercetin when acid hydrolysed (Hollman et a i, 1996, 1997), as would trace 
levels of quercetin-3,4'-diglucoside, which may also have been present. However, when 
compared to the levels present in the ingested onions, it is evident that isorhamnetin-4'- 
glucoside accumulated in both piasma and urine in proportionally far higher amounts than 
quercetin-4'-glucoside and other quercetin conjugates (Table 4.3 and 4.5). Further study is 
required to determine whether this is due to more effective absorption of the isorhamnetin 
conjugate or whether it is a consequence of the absorbed quercetin conjugates being 
removed from the bloodstream more rapidly than isorhamnetin-4'-glucoside. There is 
however, an alternative possibility that at least part of the isorhamnetin-4'-glucoside pool is 
formed by 3'-0-methylation of quercetin-4'-glucoside. Isorhamnetin is one of a number of 
metabolites that appear in the bile of rats after oral intake of quercetin (Manach et a i, 1996).
After the consumption of onions, flavonols accumulated rapidly in plasma with peak 
concentrations being reached within 1-2 h in most instances (Table 4.3, Figure 4.4). This 
observation agrees with previous findings by Hollman et aL (1996) discussed above and 
implies that absorption of flavonol conjugates occurs primarily from the stomach and/or the 
small intestine. The variation in the profile of absorption of the subjects (Figure 4.4) may be 
due to the differences in their intestinal physiology and habitual diet, which influence the 
extent of flavonol absorption, or alternatively they could be a consequence of different rates 
of metabolism/sequestration of the absorbed conjugates. Interestingly, the mean peak 
plasma concentration for conjugated quercetin and isorhamnetin-4'-glucoside (Table 4.3) 
are both in excess of the levels of p-carotene that are typically found in human plasma 
(Stocker and Frei, 1991).
Based on the in vitro digestion of fried onion, the onion flavonols were generally 
stable to the acidic and alkaline condition in the small intestine, leaving the flavonols 
unchanged for absorption. This also suggests that no modification or degradation of 
flavonols occurred in the small intestine. The same observation was reported by Hollman et
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al (1995), In vitro fermentation of onions resulted in almost complete degradation of 
flavonols by the feecal microorganisms. This suggests that no absorption of the unchanged 
flavonols take place in the large intestine. Hydrolysis of the conjugated flavonols by 
enzymes of faecal bacteria should have led to the increase in levels of free flavonols (Table 
4.6). However, this was not the case and there were low levels of free flavonols present 
following fermentation indicating the free flavonols were also subjected to degradation by 
the microorganisms. The ability of colonic microorganisms to metabolise flavonoids to 
phenolic acids is widely recognised (Griffiths, 1982, Hackett, 1986). Quercetin for example 
undergoes ring fission to form phenolic acids (Booth et aL, 1956, Nakagawa et aL, 1965).
The presence of flavonols in urine indicated their absorption from the small intestine. 
However, the levels obtained are not directly comparable to the values in plasma because 
absorbed flavonols maybe metabolised or sequestered in other parts of the body.
In this study, based on the AUC values, conjugated quercetin appears to be the most 
bioavailable flavonol relative to the other flavonols detected after the onion meal (Table 
4.4). The value for conjugated quercetin is similar to the ones reported by Hollman (1997). 
Conjugated quercetin in the hydrolysed samples may contain other glycosides, glucuronides 
or sulphates in addition to quercetin-4 -glucoside, contributing to the high AUC observed. 
Although ideally, determinations of absolute bioavailability require AUC for both 
flavonoids administered intravenously and orally, this is not always practical. However, 
relative bioavailability of various flavonoids can be estimated based on AUC from oral dose.
In their reports on the absorption of flavonols derived from onions and other 
vegetables, the Dutch group fitted data on flavonol levels in plasma and urine into a two- 
open compartment model using the equation C(t)=Ae'*'^+Be'“*+Ce'^  ^ (Shargel and Yu, 1992) 
where t equals time and k is the absorption rate constant and a  and P being the slope for the 
distribution and elimination phases respectively. The different parameters calculated from 
the equation were used to estimate the half-lives of the absorption, distribution and 
elimination phases and the bioavailability of total quercetin was calculated by comparing the 
areas under the percentage flavonol ingested-time curve (Hollman et aL, 1996, 1997). The 
validity o f such extrapolations is, however, open to question. Although the figures for
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isorhamnetin-4'-glucoside were higher, the peak quercetin levels detected in plasma and 
urine were low, ca. 1% of the amounts in the ingested onions. Homeostasis of plasma 
flavonol pools is almost certainly in a state of flux because o f the combined effects of 
transport through the gut wall into the bloodstream and removal by sequestration, 
metabolism and excretion. In the circumstances, figures obtained from the two-open 
compartment model are likely to be of little value until much more is known about the 
underlying physiological and metabolic events.
Information regarding the mechanism of absorption of flavonols is still not well 
understood. It has been postulated that the Na^-glucose co-transport system may play a role 
in flavonol absorption (Hollman, 1997). This co-transport system is involved in the 
transport of glucose across the intestinal wall (Mizuma et aL, 1994) and since the present 
study has provided unequivocal evidence for the absorption of the flavonol glucosides, the 
possible involvement of this method of transport merits investigation.
4.5 Conclusion
In conclusion, this study has shown that following the ingestion of lightly fried 
onions, there is a proportionally higher accumulation of quercetin and isorhamnetin-4 
glucoside than quercetin conjugates, including quercetin-3,4'-diglucoside and quercetin-4'- 
glucoside, in plasma and urine of humans. This is likely to be a consequence of either 
preferential absorption of isorhamnetin-4'-glucoside or, a post-absorption conversion of 
quercetin-4'-glucoside to isorhamnetin-4'-glucoside via 3 '-0-methylation. Distinguishing 
between these processes and clarification of the mechanisms involved requires frirther 
detailed metabolic studies including using radiolabelled flavonols. Identification of 
flavonols that are highly absorbable can be used to encourage increased consumption of 
food containing high levels of these compounds, which when consumed will accumulate in 
the blood stream.
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CHAPTER 5: THE UPTAKE OF INDIVIDUAL 
FLAVONOLS IN AN EVERTED RAT GUT MODEL
5.1 In troduction
Investigation of the absorption of flavonols is crucial in evaluating their 
biological role. The process that occurs during the movement of flavonols across the 
intestinal membrane is the first important step in determining how much of the ingested 
compound is absorbed. In vivo studies with animals and humans have described 
absorption of dietary as well as non-dietary flavonols (see section 1.11). Studies with 
ileostomy volunteers demonstrated higher absorption of quercetin glycosides (52%) than 
the aglycone quercetin (24%) (Hollman et ai., 1995). At the same time, there is a 
preliminary report on the presence of rutin in plasma of non-supplemented subjects 
(Paganga and Rice-Evans, 1997). On the other hand, conjugated quercetin was detected 
in plasma of human volunteers following the consumption of rutin-rich cherry tomatoes 
(Crozier et al., 2000). The absorption of specific flavonols is not known apart from our 
study which detected accumulation of higher levels of isorhamnetin-4'-glucoside in 
plasma compared to quercetin-4'-glucoside following ingestion of fried onions (Aziz et 
a i,  1998).
In vivo experiments to investigate intestinal absorption of flavonols are complex 
due to the difficulty of sampling the absorbed flavonols from the serosal side of the 
gastrointestinal tract. Ultimately, in vitro systems provide the best approach in 
evaluating the relative rate and extent of absorption of individual flavonols from the 
small intestine (see Chapter 1, section 1.13.3). This chapter describes the use of an 
everted rat gut model to investigate the intestinal transport of several flavonols.
The everted intestine method employed in this study is well established and is 
widely used to investigate in vitro intestinal transport. This model which uses rat 
intestine, originally developed by Wilson and Wiseman (1954) is capable of surviving in 
vitro over extended periods of time. It has the advantage that several segments can be 
obtained fi-om one animal, allowing randomisation as well as several replicates to be
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performed. In addition, the ability to incubate everted segments in the mucosal buffer 
allows the ease of testing various compounds as these can be added into the incubation 
media. Also, eversion of the intestine exposes the highly active mucosal cells to the 
well-oxygenated incubation media, thus prolonging the viability of the absorptive cells.
The objective of this study was to evaluate the effect of stiuctural modification of 
the flavonol molecule on their uptake across the rat intestine. At the same time, the 
influence of different sugars and their position on the flavonol molecule was determined. 
The flavonols tested were quercetin-3,4'-diglucoside, rutin, quercetin-3-glucoside, 
quercitrin, quercetin-4'-glucoside, isorhamnetin-4'-glucoside and quercetin (Figure 5.1). 
These flavonols showed variation in terms of position and type of sugar moiety attached 
to the molecule as well as the presence of a methoxy group (isorhamnetin-4'-glucoside). 
Information obtained will be useful to establish if there is any preferential uptake of 
flavonols and subsequently .determine their potential to act as antioxidants and their role 
in promoting human health.
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Figure 5.1: The chem ical structures o f the flavonols em ployed in the everted rat 
intestine model for investigation o f their intestinal transport.
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5.2 Materials and methods
5.2.1 Preparation of Krebs incubation buffer
All incubation experiments were done in Krebs-Ringer buffer. The Krebs 
incubation media were made up of 113.3 mM NaCl, 4.83 mM KCl, 1.214 mM KH2PO4 , 
1.205 mM MgS0 4 , 16.96 mM NaHCOs, 10.18 mM Na2HP0 4 , 0.645 mM CaCb 
(Mizuma et al., 1994).
5.2.2 Preparation of rat intestinal tissu es
Sprague-Dawley rats (male and female) were obtained from the animal unit at the 
Central Research Facility, University of Glasgow. Their average weight was 298 g. 
Animals followed the standard rat and mouse expanded diet obtained from B and K 
Universal Limited (Hull, UK) and water was provided ad lib. The non-fasted rats were 
stunned by a blow to the head prior to killing by cervical dislocation. An incision was 
made on the abdomen and the small intestine was immediately removed by cutting from 
the upper end of the duodenum to the upper end of the colon and was kept on ice-cold 
saline gassed with 95% O2 and 5% CO?. The small intestine was cleaned by removal of 
fatty tissues and mesentery. Eversion was carried out by tying one end of the segment 
onto a piece of glass rod (30 cm length, 2 mm diam) and pushing the intestine into the 
rod until the mucosal side was exposed (Mizuma et al., 1994). The segments were then 
cut to the desired length (6-10 cm) and placed in ice-cold saline infused with 95% O? and 
5% CO2 . Before the start of incubation, the segments were ligatured at both ends after 
the insertion of plastic cannulas, which in turn were connected to 3-way taps. A 1 ml 
plastic disposable syringe could then be conveniently attached to the 3-way taps for 
rinsing the segments as well as sampling from the serosal side.
5.2.3 Incubation procedures for the everted segm ents
The incubation procedure was performed according to the method of Mizuma et
al. (1994) with slight modifications. Briefly, after rinsing with Krebs buffer, the
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segments were filled with buffer using a 5 ml syringe and the tissue was placed in a 50 
ml beaker containing 20 ml Krebs incubation buffer with or without flavonol standards. 
The incubation medium was continuously gassed with 95% 0% and 5% CO2 and placed 
in a 31°0 water bath. Using the 1 ml syringe, approximately 150 pi was sampled from 
the serosal side and the same volume of oxygenated Krebs was replaced. Sampling was 
performed at 5 min intervals over a 30-minute incubation period. The same volume of 
sample was also taken from the incubation media at the start and the end of the 
incubation experiment. The samples were then subjected to flavonol extraction. 
Between five and eight segments were used for each experiment.
5.2.4 Uptake of individual flavonols
Standards of quercetin-3,4'-diglucoside, quercetin-3-glucoside, quercitrin, rutin, 
quercetin-4'-glucoside, isorhamnetin-4'-glucoside and quercetin aglycone were 
employed to establish the effects of structural modification on flavonol uptake by the 
small intestine. A concentration of 10 pM was used for each compound and standards 
were dissolved in methanol. The percentage of methanol in the incubation media was 
kept at a minimum (<0.7%).
The 10 pM concentration used for each flavonol was estimated based on the 
reported daily quercetin intake of 16.3 mg (Hertog et al., 1993). Assuming a gastric 
fluid volume of 100 to 500 ml and complete availability of flavonoids in the intestine, 
the final concentration of quercetin will roughly be between 100 to 500 pM in the 
intestine. Considering a divided intake of flavonoids throughout the day as well as the 
use of segments of rat intestine with less fluid volume, a flavonol concentration of 10 to 
50 pM was considered a physiological level. In addition, variability in the extraction of 
the different flavonols as well as fluid volumes along the intestine should also be 
considered.
Control experiments were performed without addition of flavonols in the 
incubation media. Similar sampling procedure as the test samples was carried out. This 
is to establish that no peaks corresponding to the added flavonols appear during the 
incubation process.
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5.2.5 Uptake of flavonol conjugates added into the sam e 
incubation media
A separate experiment was performed to establish if any competition existed 
between the uptake of flavonols across the rat intestinal wall when several were present 
together in the incubation media. For this purpose, standards of quercetin-3,4'- 
digiucoside, quercetin-3-glucoside, quercetin-4'-glucoside and isorhamnetin-4'-
giucoside were added into the same incubation media. A 10 pM concentration of each 
flavonol was used. Incubation of the intestinal segments and sampling procedure is as 
described in section 5.2.3.
5.2.6 Flavonol extraction from serosal and mucosal 
sam ples
Flavonols in the serosal and incubation media (150 pi) were extracted in 50% 
methanol. Samples were centrifuged for 5 min at 5000 x g and extract aliquots of 75 pi 
were taken and made up to 250 pi with distilled water containing 0.5% trifluoroacetic 
acid. Volumes of 200 pi were subsequently analysed by gradient elution reversed phase 
HPLC as described in section 3.2.1
5.2.7 Statistics
Where necessary, results were compared by Mann Whitney U non-parametric 
statistical test. The Minitab version 12.21 statistical software for Windows was used for 
all analyses.
5.3 Results
All the flavonols used in this study could be detected on the serosal side 
following incubation of the jejunal segments in incubation media containing the 
appropriate flavonol standards. Control samples run without the presence of flavonols in
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the incubation media did not show any contaminating peaks co-eluting with the flavonols 
tested in this experiment. The profiles for the uptake of the flavonols across the 
intestinal wall over the 30 min time course are illustrated in Figure 5.2. For the sake of 
clarity, as well as comparative purposes, the uptake of flavonols was expressed as 
pmoles of flavonol detected in the serosal samples per 10 cm of jejunal segments. The 
profiles for the uptake of the different flavonols showed some variation. In most cases, a 
linear-like profile was observed for uptake of most of the flavonols. In this instance, the 
amount of flavonols transferred was still increasing and had not reached its maximum 
values at the 30 min time point. On the other hand, two of the test flavonols, 
isorhamnetin-4'-glucoside and quercetin aglycone showed a sigmoid profile with slower 
initial uptake, followed by a rapid increase and subsequently reaching a maximal value 
where it plateau-ed at this point (Figure 5.2).
In most instances, flavonols could already be detected in the serosal samples at 
the 5 min time point. The uptake of isorhamnetin-4'-glucoside and quercetin appeared to 
reach their maximal values in the serosal side after 20 to 25 min incubation. When 
transport of flavonols was expressed as cumulative uptake over the 30 min incubation 
period, the uptake of quercetin-3,4'-diglucoside was highest, followed in descending 
order by rutin, quercetin-3-glucoside, quercitrin, quercetin-4'-glucoside, isorhamnetin- 
4 '-glucoside and lastly, quercetin (Table 5.1). The above observations corresponded 
with the rate of uptake of the flavonols (Table 5.1). Quercetin-3,4'-diglucoside showed 
the highest rate of uptake (2.99 ± 0.62 nmoles/10 cm/h) whereas quercetin had the lowest 
(0.01 ± 0.006 nmoles/10 cm/h). With the exception of rutin and quercetin-3-glucoside, 
the rate of uptake of quercetin-3,4'-diglucoside was significantly different from the other 
flavonols tested (P<0.05, Table 5.1).
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Figure 5.2: The profiles for the uptake of individual flavonol across the epithelial 
membrane over a 30 min time course.
Results are expressed as pmoles of flavonols detected in the serosal samples per 10 cm of jejunal 
segments.
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Table 5.1: The main features of the uptake of flavonols across rat intestinal segment
Flavonol Rate of uptake 
(nmoles/1 Ocm/hr)
Cumulative 
uptake 
(nmoles/10 cm)
Recovery in 
incubation media 
(%)
95% o r
Quercetin-3,4’- 
diglucoside
2.99 ± 0.62 1.80 ±0.38 92 ± 2
Rutin 1.83 ±0.26 1.12±0.13 81 ±3 (-0.87, 3.09)
Quercetin-3-
gtucoside
1.56 + 0.34 0.83 ±0.17 85 ±2 (-0.12, 3.14)
Quercitrin 0.77 ± 0.07 0.64 ± 0.06 94 ±2 (0.47, 3.99)
Quercetln-4’-
glucoside
0.32 ± 0.08 0.19 ±0.04 63 ± 8 (1.12, 4.38)
lsorhamnetin-4’-
giucoslde
0.22 ± 0.04 0.10 ±0.04 48 ±16 (1.15, 4.41)
Quercetin 0.01 ±0.006 0.01 ± 0.003 3 4 ± 8 (1.35, 4.63)
Flavonol 
conjugates mix
95% cl'’
Quercetin-3,4’- 
dlglucoslde
2.63 ±0.12 1.56 ±0.17 97 ±0.1 (-1.24, 2.06)
Quercefin-3-
glucoslde
3.03 ± 0.47 1.84 ±0.41 89 ± 2 (-3.24, 0.27)
Quercetin-4’-
glucoslde
0.49 ±0.13 0.29 ± 0.09 44 ±21 (-0.60, 0.21)
lsorhamnetin-4’-
glucoside
0.34 ± 0.04 0.23 ± 0.03 47 ±7 (-0.30, 0.04)
= 95% Cl for significant difference between the rate of uptake between quercetin-3,4’- 
diglucoside and the other flavonols tested.
 ^= 95% Cl for significant difference between the rate of uptake between individual flavonol and 
flavonol conjugates in the same incubation media.
n = 5-8 segments ± SEM
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Figure 5.3 (C and D) shows an example of a typical HPLC trace of a serosal 
sample collected 30 min following incubation of an everted segment with quercetin-3- 
glucoside. Peak 2, detected by the UV monitor (Figure 5.3 C) co-chromatographed with 
quercetin-3-glucoside standard (Figure 5.3 A). Except for possibly some trace 
impurities, no other putative metabolite peaks were present on the UV trace (Figure 5.3 
C). When the same sample was analysed by the fluorimeter following post-column 
derivatization, trace levels of non-polar peaks were detected (Figure 5.3 D), none of 
which correspond to reference compounds (Figure 5 A and B). Free quercetin was not 
present, suggesting that deglycosylation of quercetin-3-glucoside was at best a peripheral 
event. No early eluting peaks were present in Figures 5.3 C and D indicating that 
quercetin-3-glucoside was not converted to giucuronide conjugates.
5.3.1 Uptake of flavonol conjugates from the sam e 
incubation media
Figure 5.4 illustrates the profiles for the uptake of the four flavonol conjugates 
following incubation of jejunal segments in incubation media containing all four 
flavonols. Quercetin-3,4'-diglucoside and quercetin-3-glucoside presented linear 
profiles for their uptake whereas isorhamnetin-4'-glucoside and quercetin-4'-glucoside 
showed an initial slow uptake. Uptake of flavonol conjugates in a mixture in the 
incubation media was compared to uptake of individual compounds. When incubation 
was performed with all four flavonol conjugates, the uptake of quercetin-3-glucoside was 
slightly higher compared to its estimated uptake as an individual flavonol. However, this 
difference was not statistically significant (Table 5.1). The relative rate of uptake of 
quercetin-3,4 ' -diglucoside, quercetin-4'-glucoside and isorhamnetin-4'-glucoside 
remained similar between the two experiments (P>0.05). Quercetin-3-glucoside showed 
the highest rate (3.03 ± 0.47 mnoles/10 cm/h) followed by quercetin-3,4'-diglucoside, 
quercetin-4'-glucoside and isorhamnetin-4'-glucoside with values of 2.63 ± 0.12, 0.49 ± 
0.13 and 0.34 ± 0.04 mnoles/10 cm/h respectively.
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Figure 5.3: Gradient reverse phase HPLC analysis of flavonols in serosal samples
Coluinn: 150 x 3.0 mm i.d. 4-pm Genesis Cig cartridge column with a 10 x 4.0 mm 4-jim Genesis Cig
guard cartridge. Mobile phase: 25 min gradient of 15-40% acetonitrile in water containing 0.5%
trifluoroacetic acid. Flow rate: 0.5 ml/min. Detector: absorbance monitor operating at 365 nm and, after
on-line post-column derivatization with methanolic aluminium nitrate, a fluorimeter operating at
excitation 420 nm and emission 485 nm. Samples: (A) 100 ng flavonol standards: (1) rutin, (2) quercetin-
3-glucoside, (3) quercitrin, (4) myricetin, (5) morin, (6 ) quercetin, (7) apigenin, (8 ) kaempferol and (9)
isorhamnetin detected at A363 nmi (B) as (A) but with fluorescence detection after post-column
derivatization; (C) aliquot of a non-hydrolysed serosal samples collected 30 min after incubation with
quercetin-3-gluoside, detected at A365 (B) as C but with post-column derivatization and fluorescence
detection. The numbers corresponded with peaks for standards listed in (A).
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5.3.2 Percentage absorption and residuals of flavonols
The amount of flavonols remaining in the incubation media at the end of the 30 
min incubation period was determined. The residual flavonols remaining after 30 min 
was high in most instances with more than 80% detected in the incubation media (Table 
5.1). However, compared to the low levels detected in the serosal samples, recoveries of 
quercetin-4'-glucoside, isorhamnetin-4'-glucoside and quercetin in the incubation media 
were low (<60%). This was observed in experiments with the individual flavonols as 
well as when all the flavonol conjugates were present in the incubation buffer.
Overall, compared to the amount of flavonol present in the incubation media, the 
total amount transferred to the serosal side at the end of the incubation period was low, 
with less than 0.5% being transported across the gut wall.
5.4 Discussion
Previous in vivo studies with humans and animals reported variation in the 
absorption of different flavonoids. Hollman et ai (1995) reported higher absorption of 
quercetin glucosides (52%) compared to quercetin aglycone (24%). Rutin, a quercetin 
conjugate with glucose-rhamnose sugar moiety had an even lower absorption at 17% 
(Hollman et ai, 1995). In a recent report, it has been shown that quercetin-3-glucoside 
accumulates in plasma much more rapidly than rutin (Hollman et a i, 1999). In our 
study, we detected higher levels of isorhamnetin-4'-glucoside than quercetin-4'- 
glucoside in plasma after a fried onion meal to human volunteers (Chapter 4). 
Isorhamnetin-4'-glucoside was only a minor flavonol in onion whereas quercetin-4'- 
glucoside was present in much higher concentrations. In addition to flavonols, 
flavonoids from the sub-class catechins were also absorbed at different rates with 3-0- 
methyl-(+)-catechin being absorbed (Hackett et al, 1985) more effectively than (+)- 
catechin (Hackett et al, 1983). This observation implies the possible influence of the 
structural modification of flavonol on their intestinal absorption. At the same time, the 
nature/position of sugar moiety on flavonols may also affect the extent of their 
absorption.
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However, it is not always straightforward to detennine the extent of intestinal 
absorption of flavonols based on in vivo feeding experiments. Various physiological 
factors can play a role in flavonoid absorption. In in vivo experiments, absorbed 
flavonoids are subject to modification and metabolism reactions, producing metabolites 
different from the original compound The rate and extent of metabolism of the absorbed 
flavonoids may vary from one flavonoid to the other. Thus, the concentration of 
flavonoids in plasma may not be directly related to their rate of absorption due to the 
influence of metabolic processes. A high plasma flavonoid concentration could mean 
two things; either it is a consequence of their effective uptake from the intestine or their 
less effective metabolism or removal from the bloodstream. Clearly, in vivo methods 
using plasma measurements are not ideal in evaluating flavonoid absorption from the 
small intestine. Rather, they give a measure of their relative absorption compared to 
other flavonoids.
With this in mind, researchers have developed various in vitro methods to study 
the uptake of compounds across the intestinal wall. Although the advantages far 
outweigh the disadvantages, limitations may still arise while using in vitro intestinal 
preparations. Removal of intestine from the animal will result in loss of blood supply, 
subsequently causing loss of nucleotides from the mucosal cells and a decrease in the 
rate of oxygen consumption (Bronk and Leese, 1973). To overcome this problem, 
efforts were made to ensure minimal loss of intestinal function. This included placing 
the extracted intestinal tissue in well-oxygenated medium immediately after removal 
from the animal to ensure an uninterrupted oxygen supply. In addition, all our in vitro 
experiments were completed in the shortest time possible to minimise loss of tissue 
viability. With this method, the extent of absorption of various flavonols can be 
determined and their possible biological response investigated. Also the structure- 
absorption relationship of flavonols can be evaluated.
5.4.1 Structural modification and flavonol transport
All flavonols employed in this study could be detected in the serosal side 
indicating they were able to undergo transepithelial transport, i.e. crossing the luminal as 
well as the basolateral membrane. We found clear a distinction in the uptake of different
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flavonols. The glycosides of quercetin were more highly absorbable than isorhamnetin- 
4'-giucoside. However, variation in the amount transported was also observed among 
the different glycosides of quercetin. Quercetin-3,4 '-diglucoside and quercetin-3-
glucoside were both absorbed rapidly in contrast to quercetin-4'-glucoside and 
isorhamnetin-4'-glucoside which in turn are both absorbed more effectively than 
quercetin (Figures 5.2 and 5.4). It would therefore appear that a C-4' glucose moiety 
attached to quercetin results in an improved rate of absorption compared to the aglycone. 
However, the presence of a C-3 glucose markedly enhances the transport of quercetin 
conjugates. 3 '-0-methylation, as observed in isorhamnetin-4 '-glucoside did not seem to 
greatly affect its transport when compared to quercetin-4'-glucoside (P<0.05). Two 
published studies, one using perfusion of the rat intestine and CaCo-2 cells (Noteborn et 
al., 1997) and the other using CaCo-2 cells (Walgren et al., 1998) reported no absorption 
or only trace absorption of querccetin-4'-glucoside.
When rhamnose was present instead of glucose at C-3, as in quercitrin, the rate of 
uptake appeared lower than that of quercetin-3-glucoside, although this difference was 
not significant (P>0.05). Nevertheless, when both rhamnose and glucose were present at 
C-3, as in rutin, uptake was higher than quercitrin (P<0.05). This suggests that in 
addition to their position on the flavonol molecule, type of sugar moiety also plays a role 
in influencing the rate of uptake of flavonol glycosides. These observations would imply 
a structural specificity of the carrier responsible for flavonol uptake across the intestinal 
wall, assuming flavonol transport is carrier-mediated. Possibly, a glucose moiety at C3 
of flavonol glucosides increased their affinity for interaction with the carrier protein for 
their uptake.
Results obtained in this study were in agreement with a previous study by Gee et 
al. (1998). These authors used a slightly different method to study intestinal absorption 
whereby transport of several flavonol glucosides were determined based on their ability 
to displace preloaded [‘'^C]galactose in everted segments of rat jejunum. Thus, they did 
not directly measure concentrations of flavonols transported, but the amount of 
[^"^C]galactose displaced by the flavonols. They found that cumulative efflux of 
[^'^C]galactose was highest when everted sacs were incubated with quercetin-3,4'- 
diglucoside, and this was followed by quercetin-3-glucoside and rutin. Efflux of 
galactose by quercetin-4'-glucoside was lower than the above flavonol glucosides. The
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same was also observed for quercitrin which had a lower cumulative efflux than 
quercetin-4'-glucoside. This further supports the proposed importance of glucose in 
enhancing intestinal transport of flavonol glucosides and that glucose substitution at C-4' 
of flavonol conjugates can substantially reduce intestinal transport of these flavonols.
In contrast to this, a study on intestinal absorption of flavonoids reported 
glucuronidation of several flavonoids, in particular quercetin-3-glucoside and quercetin 
following perfusion of the rat gut with these compounds (Spencer et al., 1999). 
However, at the 10 pM concentration used in our study, we did not detect the presence of 
giucuronide peaks. This was evident from the HPLC traces of serosal samples following 
incubation with quercetin-3-glucoside (Figure 5.2 C). The HPLC trace detected by the 
LTV monitor at Absses nm only showed a peak corresponding to quercetin-3-glucoside 
(peak 2). If glucuronides of quercetin-3-glucoside were formed with more polar 
characteristics than the parent compound, these metabolites would elute from the 
reversed-phase HPLC column before quercetin-3-glucoside, but there was no evidence of 
this on the UV trace (Figure 5.3C). Spencer et al (1999) detected the presence of 
glucuronides after 60 min incubation whereas our incubation was performed only up to 
30 min. The incubation time used in this study may be insufficient for the formation of 
giucuronide conjugates and may explain the lack of glucuronides in our study. In 
addition, they also used a higher quercetin-3-glucoside concentration of 47.6 pM 
compared to 10 pM used in our study. Even at this high concentration, glucuronidation 
of quercetin-3-glucoside was low with less than 1.5 nmol detected per 20 cm jejunum per 
5 pmol of the perfused compound. These factors may explain why with the more 
physiologically relevant flavonol concentrations used in our study, there was no evidence 
of the formation of giucuronide metabolites.
With the aglycone quercetin, total uptake was only 0.01 nmoles/10 cm over the
30 min incubation period. These observations again indicate structural-dependence of
the flavonol molecule on their uptake across the rat intestinal wall. More importantly,
the presence of sugar moiety as well as their position greatly determines the extent of
uptake of the flavonols. Existing literature on the uptake of quercetin have shown
varying results. Two previous studies reported in vitro transport of quercetin which
contrasted with our findings (Noteborn et ai, 1997; Walgren et al., 1998). Noteborn et
al (1997), after a 2 h perfusion of rat jejunal segments with quercetin, detected 0.3-0.4%
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absorption of the parent compound, expressed as percentage of the initial dose. Walgren 
and colleagues studied intestinal transport of flavonols using human intestinal epithelial 
Caco-2 cells and reported very high flux of quercetin from the apical to basolateral 
membrane. However, the validity of using a cell-culture method is open to question and 
several factors have to be considered such as reliability and the extent to which the 
results are indicative of in vivo transport. Furthermore, cancerous cells may have several 
structural and physiological changes which can affect the normal absorption process of 
the small intestine. The ability of this cell culture model to successfully mimic a 
biological barrier like the intestinal mucosa has to be carefully assessed. Several factors 
can influence the transport and metabolic properties of cultured cells such as the stage of 
cellular differentiation and the availability of essential nutrients (Meunier et a i, 1995). 
Furthermore, composition of the incubation media e.g. concentration of substrates, 
temperature and pH may influence transport properties of the cells.
In contrast to this, a rat gut perfusion experiment detected uptake of small 
amounts of quercetin, but only 60 min after the start of perfusion (Spencer et al., 1999). 
However, these authors detected the presence of high levels of quercetin glucuronides 
following perfusion with quercetin. We did not detect HPLC peaks likely to correspond 
to glucuronides of quercetin in our study. Furthermore the study described above which 
investigated intestinal transport of quercetin using CaCo-2 cells did not detect peaks 
which may have corresponded to glucuronides of quercetin in the basolateral samples 1 h 
after incubation of quercetin in the apical side (Walgren et al., 1998). But these results 
should be interpreted with caution taking into account the limitations in using cell 
culture. Again, Spencer et al (1999) detected the glucuronides of quercetin only after 60 
min of incubation. Thus, the 30 min incubation period employed in our study may 
exclude any giucuronide formation. We detected low recovery of quercetin in the 
incubation media at the end of the experiment which could be a result of their instability 
during the incubation process. This has been reported in another study whereby low 
recovery of quercetin was detected at the end of the incubation period without evidence 
of the presence of its metabolites (Walgren et a i, 1998).
Two different studies also reported intestinal glucuronidation of flavonoids, this 
time following incubation of luteolin-7-glucoside with everted rat intestinal segments 
(Shimoi et al., 1998) and the other following incubations of chrysin (5,7-
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dihydroxytlavone) with CaCo-2 cells (Walle et ai, 1999). However, the structural 
difference, coupled with usage of a higher substrate concentration (1 mM; Shimoi et aL, 
1998) or difference in method for studying intestinal transport (Walle et al., 1999) may 
explain the differences in the results obtained.
Results obtained from this present study demonstrated the ability of several 
flavonols to undergo intestinal transport without being metabolised by enzymes. At the 
10 pM concentration of test flavonols used, no evidence of glucuronidation and/or other 
metabolic reactions could be seen. In most instances, the published articles which used 
non-physio logical concentration of flavonols (0.05 -  1 mM), reported lower extent of 
glucuronidation of the flavonols (Shimoi et al., 1998, Spencer et al., 1999). If this was 
the case, it would be highly unlikely that glucuronidation could be detected at the 
concentration we used (10 pM) which was reflective of the normal dietary intake of 
flavonoids. Furthermore, the relevance of studies using such high concentrations to 
normal in vivo transport is questionable as such a high concentration is not physiological 
and may affect their uptake. Compounds/metabolites detected could be artefacts which 
under nonnal physiological conditions may not be present. High concentrations may 
also have overloaded the intestinal segments, thus giving a false value of the extent of 
absorption of the flavonols. In some instances, longer incubation time was used (> Ih; 
Noteborn et a i, 1997, Walle et al., 1999, Spencer et al., 1999). When incubation was 
performed up to 1 h, reliability of the method used may be affected due to cell death, loss 
of tissue viability due to prolonged loss of blood supply and reduced oxygen 
consumption.
When the four flavonols, quercetin-3,4'-diglucoside, quercetin-3-glucoside, 
quercetin-4'-glucoside and isorhamnetin-4'-glucoside were added into the same 
incubation media, their rate of uptake across the intestinal wall remained roughly the 
same as when transport of the individual flavonols were investigated (Table 5.1). This 
suggests that transport of these particular flavonols were not dependent on each other and 
interaction or competition for uptake of these flavonols across the intestinal wall did not 
occur. This may also imply that a different mechanism of uptake for these flavonols 
exists. Alternatively, if they were absorbed by the same mechanism, no competition in 
their transport was observed at the 10 pM concentration used in this study.
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Structural modification of flavonoids may alter their stereospecificity, thereby 
possibly influencing their transfer across the intestinal wall. If transport occurs via a 
carrier protein, alteration in flavonol structure may change the binding site for the carrier 
protein, ultimately reducing or inhibiting their transport.
5.5 Conclusion
Results from this study indicated intestinal transport of the flavonol glucosides, 
albeit at different rates. Flavonols, when present as glycosides were more highly 
transported compared to the aglycone. It is likely that the nature/position of the sugar 
moiety, to a certain extent, determine the rate of uptake of the flavonol conjugates. 
Evidence of glucuronidation or sulphation/methylation of quercetin-3-glucoside and the 
other flavonols tested was not seen in our study at the concentration used. Further 
studies are required to determine the mechanism of flavonol transport across the 
epithelial membrane.
138
Investigation of the 
Mechanism of flavonol 
uptake across the Small 
Intestine in an Everted Small 
Intestine Rat Gut Model
ontents
6.1 Introduction 139
6.2 Materials and Methods
6 .2.1
6 . 2.2
6.2.3
6.2.4
6.2.4. J
6. 2. 4.2
6. 2 . 4.3
6. 2. 4.4
6. 2 . 4.5
140
Materials 140
Animal study 140
Incubation procedures for the everted 
segments 140
The mechanism of flavonol uptake by 
the small intestine 141
Effect of substrate concentration on the 
uptake o f quercetin-3-glucoside 141 
The effect o f glucose on the uptake of 
quercetin-3-glucoside across the small 
intestinal wall 141
The effect o f phloridzm on the uptake o f 
quercetin-3-glucoside and quercetin- 
3,4 “^-diglucoside 143
The effect o f phloridzin on the uptake of 
gkfcose 143
The effect of quercetin-3-glucoside on
the- uptake. of[ CJglucose- 143
6.2.5 Flavonol extraction from the mucosal 
and serosal samples and HPLC 
analysis 144
6.2.6 Statistical analysis 145
6.3 Results 145
6.3.1 Uptake of varying concentrations of 
quercetin-3-glucoside 145
6.3.2 The effect of glucose on the uptake of 
quercetin-3-glucoside across the small 
intestine 148
6.3.3 The effect of phloridzin on the uptake 
of [ '^^Cjglucose, quercetin-3-glucoside 
and quercetin-3,4'■-diglucoside 148
6.3.4 The eflect of quercetin-3-glucoside
on the uptake of [ '^^Cjglucose 156
6.4 Discussion 159
6.4. 1  The involvement of SGLTI in the 
transport of flavonol glucosides 159
6.4.2 Percentage recovery following 
incubation experiment 163
6.5 Conclusion 164
CHAPTER 6: INVESTIGATION OF THE
MECHANISM OF FLAVONOL UPTAKE ACROSS THE 
SMALL INTESTINE IN AN EVERTED SMALL 
INTESTINE RAT GUT MODEL.
6.1 Introduction
In view of the overwhelming evidence of the biological and antioxidant potential of 
flavonoids (Chapter 1), research has focused on their absorption and metabolism. Ingested 
flavonoids need to maintain their bioactive form following absorption to provide beneficial 
health properties. The first important stage of flavonol absorption is their passage across the 
wall of the small intestine. As mentioned before in Section 1.13.2, substances can be 
absorbed from the small intestine via active or passive transport. Hydrophilic compounds 
are more likely to be transported via carrier proteins as they are not able to diffuse across the 
lipid phase of the membrane. In contrast, lipophilic compounds do not require carrier 
proteins as they can easily diffuse across the membrane.
Flavonol glycosides are more polar than their aglycones and are thus thought to be 
transported by carrier proteins. It has been proposed that the sodium-glucose co transporter 
(SGLTl) might play a role in the transport of flavonols particularly flavonol glucosides 
(Hollman et ai, 1995). This prompted research to investigate this hypothesis and to date, 
two papers have presented contrasting results. One study showed interaction of several 
flavonol glucosides with SGLTl (Gee et al, 1998) whereas another demonstrated that 
certain flavonol glucosides behaved as glucose carrier inhibitors (Noteborn et al, 1997). 
Clearly more work is needed to further establish the role of SGLTl in flavonol transport 
across the small intestine. The aim of this study was to investigate the mechanism of the 
uptake of flavonols across the small intestine and to further elucidate the involvement of 
glucose transporters in the transport of flavonols.
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Several experiments were performed to establish the mode of transport of flavonol 
glucosides and whether SGLTl played a role in mediating their uptake. In order to identify 
if uptake of flavonol glucosides was carrier or non-carrier mediated, the transport of 
increasing concentrations of flavonoids was investigated. Glucose, together with flavonols 
was used to investigate the possible involvement of SGLTl by measuring the possible 
competition or inhibition for SGLTl. In addition, phloridzin, a known inhibitor of SGLTl 
was used to block this carrier and the effect on uptake of flavonols was measured.
6.2 Materials and Methods
6.2.1 Materials
Standards of quercetin-3-glucoside and quercetin-3,4'-diglucoside were dissolved in 
100% methanol. Phloridzin and glucose were made up in Krebs buffer. Preparation of 
Krebs incubation media was described in section 5.2.1. D[U '^^C] glucose was purchased 
from Amersham (Buckinghamshire, UK) with a specific activity/ of 310 pCi/mmol.
6.2.2 Animal study
The everted rat gut model previously described was used to investigate the 
mechanism of flavonol transport across the small intestine. Preparation of the rat intestines 
and procedure for the eversion of the jejunal segments was as described in Chapter 5, 
section 5.2.2.
6.2.3 Incubation procedures for the everted segm ents
The incubation procedure was performed according to the method of Mizuma et al. 
(1994) with slight modifications. Similar procedures as described in section 5.2.3 were
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applied Sampling from the serosal side was perfonned at 5 min intervals over a 30 minute 
incubation period.
6.2 .4  The mechanism of flavonol uptake by the small
intestine
Several experiments were performed to determine the mode of uptake of flavonols 
from the everted rat jejunal segments. Quercetin-3-glucoside was used in most cases due to 
its high uptake across the intestinal wall and also the availability of this standard. Figure 6.1 
shows a flowchart summarising the various approaches used in determining the mechanism 
of flavonol absorption from the small intestine.
6.2.4.1 Effect of substrate concentration on the uptake of quercetin-3-glucoside
In the first experiment, the rate of uptake of quercetin-3-glucoside from the mucosal 
to serosal side was determined. Everted segments of rat jejunum were incubated in 20 ml of 
Krebs buffer containing quercetin-3-glucoside at concentrations of 1, 5, 10, 50, 100 and 500 
pM. Sampling from the serosal side was performed every 5 min for 30 min according to the 
procedure described in section 5.2.3.
6.2.4.2 The effect of glucose on the uptake of quercetin-3-glucoside across the 
small intestinal wall
Competition for the glucose carrier was studied by measuring the uptake of 
quercetin-3-glucoside in the presence of increasing concentrations of glucose. For this 
purpose, everted segments were incubated in incubation media containing 10 pM quercetin- 
3-glucoside and glucose at concentrations of 0, 1, 10, 50 and 100 mM. Sampling from the 
serosal side was perfonned every 5 min for 30 min as described in section 5.2.3. Eight 
jejunal segments were used for each concentration.
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Carrier- or non-carrier mediated? I
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Measure the rate of uptake of quercetin-3-glucoside
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Does SGLTl play a role in flavonol glucoside transport?
Does flavonol interact with SGLTl? Does flavonol inhibit SGLTl?
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glucose (0, 1, 10, 50, 
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3-glucoside uptake
Measure the effect of 
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Measure the effect of 
quercetin-3-glucoside 
(10, 50, 500 pM)on 
[^ '‘CJglucose uptake
Figure 6.1: A flow chart summarizing the various approaches used to investigate the 
mode of flavonol glycoside absorption from the small intestine
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6.2.4.3 The effect of phloridzin on the uptake of quercetin-3-giucoside and
quercetin-3,4'-diglucoside
The involvement of SGLTl in flavonol uptake was examined by measuring the 
uptake of quercetin-3-glucoside and quercetin-3,4'-diglucoside in the presence of phloridzin. 
Phloridzin is a known inhibitor of SGLTl (Dorando and Crane, 1984). It has the ability to 
bind to the glucose co-transport carrier and inhibits glucose transport. Everted rat jejunal 
segments were incubated in Krebs buffer containing 10 pM quercetin-3-glucoside, in the 
presence or absence of 1 mM and 5 mM phloridzin. In the case of quercetin-3,4'- 
diglucoside, due to limited availability of the flavonol standard, only 1 mM phloridzin was 
used. Everted jejunal segments were suspended in incubation media containing 10 pM 
quercetin-3,4'-diglucoside, with or without ImM phloridzin. The procedure for sampling 
from the serosal side was as described in section 5.2.3.
6.2.4.4 The effect of phloridzin on the uptake of glucose
The reliability of the model was established by measuring the uptake of glucose in 
the presence of 1 mM phloridzin. Everted jejunal segments were placed in the incubation 
buffer containing 1 mM glucose, 3 pCi D[U*‘^ C] glucose and with or without 1 mM 
phloridzin. Sampling from the serosal side was performed every 5 min for 30 min as 
described in section 5.2.3.
One hundred pi of serosal samples and 20 pi of the incubation media were 
transferred to scintillation vials, 5 ml of scintillation cocktail (Optisafe 1, Leicestershire, 
UK) was added to each vial and the amount of radioactivity measured in a liquid 
scintillation counter.
6.2.4.5 The effect of quercetin-3-glucoside on the uptake of [^ ‘*C]glucose
The possibility that flavonols may act as inhibitors of SGLTl was investigated by 
measuring the uptake of glucose in the presence of increasing concentrations of quercetin-3-
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glucoside. In this experiment, the incubation media contained 20 ml of Krebs buffer, 10 
mM glucose, 3 pCi D[U^ '^ C] glucose and quercetin-3-glucoside at concentrations of 10, 50 
and 500 pM. The concentration of flavonols used in this experiment was in keeping with 
the estimated daily intake of dietary quercetin of 16.3 mg/d (Hertog e t  a l . ,  1993). The 
highest concentration of flavonol used at 500 pM was to ensure that enough flavonols were 
available to inhibit SGLTl, if indeed they act as inhibitors of this carrier protein. Incubation 
was performed by placing the everted jejunal segments in incubation media containing the 
compounds understudy. A control experiment was carried out by measuring the uptake of 
10 mM glucose without the presence of quercetin-3-glucoside. Sampling was performed 
according to the method described in section 5.2.3. One hunderd pi of the serosal samples 
and 20 pi of the incubation media were transferred into scintillation vials. 5 ml of Optisafe 
1 scintillation cocktail was added into each vial and the amount of radioactivity measured in 
a liquid scintillation counter.
A preliminary experiment was perfonned to establish the minimal concentration of 
glucose required for the incubation experiments. For this purpose, everted segments were 
incubated in Krebs buffer containing varying concentrations of glucose. 10 mM glucose in 
the incubation medium produced glucose that could be detected in the serosal samples.
6.2.5 Flavonol extraction from the mucosal and serosal 
sam ples and HPLC analysis
Extraction of flavonols from the samples was as described in section 5.2.6. A 200 pi 
volume of the supernatant was subsequently analysed by gradient elution reversed phase 
HPLC (see section 3.2,1).
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6.2.6 Statistical analysis
Where necessary, results were compared by Mann Whitney U non-parametric 
statistical test. Minitab statistical software release 12.21 for Windows, was used for all 
analyses.
6.3 Results
6.3.1 Uptake of varying concentrations of quercetin-3-
glucoside
When quercetin-3-glucoside was used to establish the mechanism of flavonol 
transport across the intestinal wall, the uptake of this flavonol appeared to be concentration 
dependent. Evidence of saturation of the transport of quercetin-3-glucoside was observed in 
the concentration range of 10 pM to 500 pM (Figure 6.2). The rate of uptake of this 
flavonol was linear up to a concentration of 100 pM, after which a hyperbolic curve was 
seen up to 500 pM. When the results were expressed as cumulative uptake over the 30 min 
incubation period, the same trend was observed as that seen in the rate of uptake (Table 6.1). 
The rate of uptake and cumulative uptake of quercetin-3-glucoside increased with 
concentration.
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Figure 6.2: The rate of uptake of quercetin-3-giucoside across everted rat jejuna* segments.
The rate of quercetin-3-glucoside transport was measured by incubating everted segments in incubation media 
containing 0, 1, 5, 10, 50, 100 and 500 fiM quercetin-3-glucoside over a period of 30 min. The rate of uptake is 
expressed as pmoles/10 cm/min ± SEM.
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Table 6.1: Mean values of the key features of quercetin-3-glucoside uptake across rat
jejunal segments
Ouercetin-3-
gliicostde
(mM)
Rate Of uptake 
(nmoles/1 Ocm/hr)
Cumulative
uptake
(nmoles/IOcm)
Recovery-
(%)
1 0.31 ±0.08 0.12 ±0.02 75.86 ±3.81
5 0.95 ± 0.49 1.10 ±0.48 86.82 ± 0.78
10 1.56 ±0.34 0.83 ±0.17 85.00 ± 2.00
50 12.38 ±1.68 8.31 ±0.87 85.40 ± 3.80
100 30.72 ± 11.63 21.69 ±2.88 90.00 ± 1.76
500 68.70 ± 11.88 41.31 ±6.13 89.89 ±4.8
n = 6 - 8  segments ± SEM
“ = residuals of quercetin-3-glucoside remaining in the incubation media at the end of the 30 
min incubation.
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6.3.2 The effect of glucose on the uptake of quercetin-3- 
glucoside across the small intestine
Figure 6.3 shows the uptake of quercetin-3-glucoside over 30 min in the presence of 
glucose at the concentrations indicated. There was no significant difference in the uptake of 
quercetin-3-glucoside with and without the presence of 1 mM, 10 mM, 50 mJVI and 100 mM 
glucose. Although the rate of uptake of this flavonol glucoside decreased slightly in the 
presence of 100 mM glucose (1.21 ± 0.32 nmoles/10 cm/h) compared to without glucose 
(1.56 ± 0.34 nmoles/10 cm/h), these figures were not significantly different (Table 6.2). 
Essentially the same pattern was seen when results were expressed as cumulative uptake 
over the 30 min incubation period.
6.3.3 The effect of phloridzin on the uptake of [^"^C]glucose, 
quercetin-3-glucoside and quercetin-3^4' -diglucoside
[^ '^ C ]  G l u c o s e
Phloridzin, an inhibitor of SGLTl was employed to investigate the possible 
involvement of this carrier on the uptake of flavonol glucosides across the intestinal wall. 
Figure 6.4 shows the profile for the uptake of glucose with and without the presence of 
phloridzin. At the 30 min time point, 2.3% and 3.4% of the radioactivity was transported 
into the serosal side with and without the presence of 1 mM phloridzin, respectively. A 
slight inhibition (33%) in the uptake of glucose was observed when 1 mM phloridzin was 
present in the incubation media (P>0.05). Nevertheless, phloridzin did not fully inhibit the 
uptake of glucose as radioactivity could still be detected in the serosal side at the 30 min 
time point.
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Figure 6 3 : The effect o f glucose on intestinal absorption of quercetin-3-glucoside
Uptake of 10 |iM quercetin-3-glucoside was investigated in the presence of 1 mM, 10 mM, 50 mM and 100 
mM glucose in the incubation media. Results are expressed as pmoles quercetin-3-glucoside detected in the 
serosal samples per 10 cm segment. (n=6-8 segments ± SEM).
—• — no glucose
1 mM  glucose  
^  10 mM glucose
—▼— 50 m M  glucose  
— 100 mM glucose
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Table 6.2: The effect of glucose on the uptake of quercetin-3-glucoside.
Results represent mean values of the key features of quercetin-3-glucoside uptake across rat 
jejunal segments.
Glucose
(mM)
Rate Of Uptake 
(nmotes/10cm/hr)
Cumulative 
uptake 
(nmoles/10cm)
Recovery®
(%)
95% Cl"
No glucose 1.56 + 0.34 0 .8310 .17 8 5 1 2 .0 -
1 1.7310 .29 1.0210 .17 86.1812.31 (-1.23, 1.01)
10 1.37 10.17 0.8510.11 86.11 13.55 (-0.78, 1.19)
50 1.3010 .37 0.7510.21 85 .2711 .30 (-0.67, 1.61)
100 1.21 10.32 0 .6010 .16 85.4512.71 (-0.69, 1.54)
= residuals of quercetin-3-glucoside remaining in the incubation media at the end of the 30 min 
incubation.
 ^ =  95% Cl for significant inhibition of rate of quercetin-3-gIucoside uptake by glucose, 
n = 6 - 8  segments ± SEM
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Figure 6.4; The effect o f phloridzln on the uptake o f '^C-glucose
Uptake of 1 mM ‘“^ C-glucose was investigated in the presence of 1 mM phloridzin in the incubation media. 
Results are exoressed as % of radioactivity absorbed from the incubation media. (n=6-8 segments ± SEM).
without phloridzin 
1 mM phloridzin
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Q i i e r c e t i n - S  - g l u c o s i d e
Figure 6.5 shows the effect of phloridzin (1 mM and 5 mM) on the rate of uptake of 
quercetin-3-glucoside across the intestinal wall. This was compared with the rate of uptake 
of quercetin-3-glucoside in the absence of phloridzin. From the graph, compared with the 
uptake of quercetin-3-glucoside without phloridzin, no inhibition was observed in the 
transport of quercetin-3-glucoside with the presence of 1 mM phloridzin. A higher 
phloridzin concentration (5 mM) was also tested. Again, no difference was observed in the 
rate of uptake of this glucoside. It was evident that phloridzin had no significant effect on 
the rate of uptake of quercetin-3-glucoside (Table 6.3).
Q u e r c e t i n - S ,  4  ' - d i g l u c o s i d e
Figure 6 . 6  illustrates the transport of 10 juM quercetin-3,4'-diglucoside with and 
without the presence of 1 mM phloridzin. Unlike quercetin-3-glucoside, a slight inhibition 
in the transport of this diglucoside was observed when 1 mM phloridzin was added into the 
incubation media. Furthermore, the rate of uptake of quercetin-3,4'-diglucoside with 
phloridzin was approximately half of that of their uptake without phloridzin (Table 6.3). 
However, this inhibition was not statistically significant.
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Figure 6.5; The effect o f  phloridzin on the uptake o f quercetin-3 glucoside
Uptake of 10 pM quercetin-3-glucoside was investigated in the presence of I mM and 5 mM phloridzin in the 
incubation media. Results are expressed as pmoles quercetin-3-glucoside detected in the serosal samples per 
10 cm segment. (n=6-8 segments ± SEM).
—•— widiout phloridzin 
—•— 1 mM phloridzin 
—V 5 mM phloridzin
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Table 6.3: The effect of phloridzin on the uptake of quereetin-3-glucoside and 
quercetin-3,4 -diglucoside.
Results represent mean values of the key features of quercetin-3-glucoside and quercetin- 
3,4'-diglucoside uptake across rat jejunal segments.
Flavonol Phloridrin
(mM)
Rate of uptake 
(nmoles/1 dam/h)
Cumulative
uptake
(nmples/IOcm)
Recovery®
(%)
95% Cl
Quercetin-3- - 1.56 + 0.34 0.83 + 0.17 85 + 2 -
glucoside
1 1.40 + 0.23 0.89 + 0.15 86.34 + 2.24 (-0.67, 1.17)*^
5 1.64 + 0.43 1.00 + 0.26 89.81 + 3.02 (-1.91, 1.43)^
Quercetin-3,4' 2.99 ± 0.62 1.80 + 0.38 92 + 2
-diglucoside
1 1.76 + 0.27 0.99 + 0.16 90.02 + 3.12 (-0.67, 2.91)'=
” -  residuals of quercetin-3-glucoside or quercetin-3,4'-diglucoside remaining in the incubation media 
at the end of the 30 min incubation.
= 95% Cl for significant inhibition of rate of quercetin-3-glucoside uptake by phloridzin.
= 95% Cl for significant inhibition of rate of quercetin-3,4 -diglucoside uptake by phloridzin. 
n = 6 - 8  segments ± SEM
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Figure 6.6: The effect o f phloridzin on the uptake o f quercetin-3,4 '-diglucoside
Uptake of 10 pM quercetin-3,4 -diglucoside was investigated in the presence of I mM phloridzin in the 
incubation media. Results are expressed as pmoles quercetin-3-glucoside detected in the serosal samples per 
10 cm segment. (n=6-8 segments ± SEM).
•  without phloridzin 
—• — 1 mM phloridzin
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6.3.4 The effect of quercetin-3-glucoside on the uptake of 
[^^C]glucose
In this experiment, the possibility of flavonol glucosides acting as inhibitors of 
SGLTl was investigated by examining the uptake of glucose in the presence of varying 
concentrations of quercetin-3-glucoside. The transport of ['^C]glucose into the serosal side 
was expressed as percentage of the initial dose absorbed per 10 cm segment. No difference 
was observed in the uptake of glucose without the presence of quercetin-3-glucoside and 
when 10 pM, 50 pM and 500 pM quercetin-3-glucoside were present in the incubation 
media (Figure 6.7). Statistical comparison of the rate of uptake of glucose with quercetin-3- 
glucoside did not show any difference from with their uptake without quercetin-3-glucoside 
(Table 6.4). Furthermore, similar values for the cumulative uptake were obtained for the 
four conditions used (Table 6.4) suggesting no difference in their uptake.
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Figure 6.7: The effect o f quercetiii-3-glucoside on the uptake o f g l u c o s e
The possibility that quercetin-3-glucoside may inhibit SGLTl was investigated by measuring the rate of uptake 
of ‘'‘C-glucose in the presence of quercetin-3-glucoside at the concentrations stated. Results are expressed as 
% of radioactivity absorbed from the incubation media. (n=6-8 segments ± SEM).
•  control 
—• — 10 uM quercetin-3-glucoside 
V 50 uM quercetin-3-glucoside 
—T— 0.5 mM quercetin-3-glucoside
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Table 6.4: The effect of quercetm-3-glucoside on the uptake of ^ ‘*C-glucose
Results represent mean values of the key features of glucose uptake across rat jejunal 
segments.
Ouercetin-3-
gfucoside
(pM)
Riate Of tiptake 
(®/ocJose/10cm/h)
Cumulative
uptake
(®/odo$e/10om)
Recovery®
m
95% o r
- 4.24 ± 1.25 3.15 ±0.92 82.88 ± 10.91 -
10 4.00 ± 1.06 2.83 ±0.81 91.70 ±4.44 (-4.95, 5.36)
50 5.00 ±0.83 3.71 ± 0.62 93.33 ± 2.42 (-4.96, 5.04)
500 4.61 ±1.39 3.34 ± 1.08 80.26 ± 7.29 (-7.41, 4.80)
 ^= residuals of quercetin-3-glucoside remaining in the incubation media at the end of the 30 min 
incubation.
= 95% Cl for significant inhibition of rate of glucose uptake in the presence of quercetin-3-glucoside. 
n = 6 - 8  segments ± SEM.
1 5 8
6.4 Discussion
In order to establish the mechanism of flavonol transport across the small intestine, 
the first step to evaluate is whether their uptake is carrier-mediated or non-carrier mediated. 
Most polar molecules are transported across the epithelial membrane via a carrier protein as 
they are not able to difiuse across the lipid membrane. To determine if a carrier is involved in 
the transport of flavonols, the uptake of increasing concentrations of quercetin-3-glucoside 
across the intestinal wall was measured. Results revealed that the rate of uptake of quercetin- 
3-glucoside was linear up to 100 pM. A linear plot of 1/rate of uptake against 
1/concentration was also obtained (y=3.899x + 0.199, r^=0.949 and correlation 
coefficient-0.974), suggestive of a hyperbolic relationship between these two parameters and 
for saturation of uptake at higher concentrations. However, the absence of results for 
concentrations between 100 and 500 pM means that the data cannot be assigned with 
certainty to a hyperbolic curve. Nevertheless, the evidence suggests that quercetin-3- 
glucoside is conveyed across the intestinal membrane in association with carrier molecules. 
This is highly likely as the glycosylated forms of the flavonol conjugates will give rise to 
hydrophilic polar molecules which are not able to difiuse passively across the epithelial 
membrane. Evidence of saturation was also reported in the transport of quercetin diglucoside 
across the rat intestine up to a concentration of 1 mM (Gee e t  a l ,  1998), further 
strengthening the possible role of a carrier in mediating flavonol glucoside uptake. However, 
the relevance of the observed saturation at 500 pM and 1 mM concentrations to in vivo 
physiological condition is questionable as such high concentration is not likely to be achieved 
at normal dietary intake.
6.4.1 The Involvement of SGLTl in the transport of flavonol g lu cosid es
It was previously postulated that SGLTl might be involved in the transport of 
flavonol glucosides across the intestinal membrane (Holmann e t  a l ,  1995). This carrier, 
located in the brush border membrane of the small intestine is responsible for the secondary 
active transport of glucose and galactose (Hediger and Rhoads, 1994). However, SGLTl 
has been shown to be able to transport other compounds apart from glucose. SGLTl has 
been shown to mediate uptake of the highly toxic compound cyacasin, a D-glucoside 
derivative of methylazoxymethanol (Kisby e t  a l ,  1992). In addition, this carrier was also
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reported to play a role in the transport of 2-naphthyl glycosides (Mizuma e t  a l . ,  1994). This 
group used similar everted rat gut model and reported a decrease in the transport of 2 - 
naphthyl glycoside in the absence of Na ,^ a co-substrate of SGLTl.
Based on these observations, SGLTl was hypothesised to play a role in mediating the 
uptake of flavonol glucosides from the small intestine. It was postulated that the sugar 
moiety on the flavonol glucosides could bind to the active site on the glucose carrier protein 
in a similar manner to glucose, and so be transported across the intestinal membrane. If this 
was true, the presence of glucose together with flavonol glucosides in the incubation media 
would result in the two compounds competing with each other for binding to the carrier 
protein. However, when everted jejunal segments were incubated with quercetin-3-glucoside 
together with glucose, no significant difference was observed in the amount and rate of 
quercetin-3-glucoside transported across the intestinal membrane (Table 6.2). The presence 
of glucose, even at the highest concentration of 100 mM did not inhibit or reduce the amount 
of flavonol glucoside transported. This suggests that no competition exists between 
quercetin-3-glucoside and glucose for the glucose carrier. As the rate of uptake of quercetin- 
3-glucoside remained the same, it is possible that other carrier proteins may be involved.
To further establish the possible involvement of SGLTl, phloridzin, a known inhibitor 
of this carrier protein was employed to investigate its effects on flavonol glucoside uptake. 
Once more, no inhibition was seen in the amount of quercetin-3-glucoside transported when 
1 mM phloridzin was present together with the flavonol in the incubation media. Even a 
higher concentration of phloridzin (5 mM) did not inhibit the uptake of quercetin-3-glucoside 
implying no interaction between this glucoside and SGLTl. As for quercetin-3,4'- 
diglucoside, there was also no significant inhibition in their uptake across the intestinal 
membrane in the presence of phloridzin. Although the error bars in the graph appeared to 
suggest a significant inhibition { F i g u r e .  6 .6 ), this was not so, possibly due to the small 
number of segments employed in the experiments.
When uptake of [^ "^ Cjglucose was measured in the presence of 1 mM phloridzin, only 
33% inhibition was observed compared to without phloridzin. This implies that complete 
inhibition of SGLTl did not occur in the model used as glucose was still transported across 
the intestinal membrane. Thus, it is possible that this particular method is not suitable to 
assess the role of SGLTl in mediating flavonol uptake. Perhaps a combination of several
techniques can provide a more definite answer.
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A possible explanation for the lack of inhibition of glucose uptake in the presence of 
phloridzin could be that, in addition to the transceliular route of glucose absorption, glucose 
might also pass from the intestinal lumen to the circulation via the paracellular pathway. 
This route involves movement through the tight junction, the site between two adjacent 
enterocytes. The highly dynamic structure of the tight junction is subject to regulation, and 
activation of SGLTl has been shown to cause contraction of the tight junction, leading to 
their increased permeability (Philpott e t  a l . ,  1992). This may allow molecules to cross the 
epithelium via tight junction by solvent drag. Certainly, 30% of glucose has been shown to 
be absorbed this way (Asitook e t  a i ,  1990). The possibility that some flavonol glucosides 
might also be transported through this pathway is, however, unlikely given their polar 
properties. Transport via another carrier system is a more likely explanation.
Our findings contrasted with those of Gee e t  a l  (1998) who demonstrated that several 
quercetin glycosides including quercetin-3-glucoside and quercetin-3,4'-digiucoside 
accelerated the carrier-mediated efflux of pre-loaded galactose. This occurred via a sodium- 
dependent pathway, implying the involvement of SGLTl. The fact that the rate of uptake of 
some of these flavonol glucosides was higher than that of glucose signifies that the quercetin 
conjugates have a higher affinity to the carrier than glucose. In contrast to the findings of 
Gee e i  a l  (1998), our results suggest that the glucose carrier protein has a lower affinity for 
the quercetin conjugates than it does for glucose. It may be of relevance that Gee e t  a l  did 
not actually measure the amounts of flavonol glucosides transported in their incubation 
experiments but estimated uptake based on the efflux of galactose. At the 1 mM 
concentration used, measurable transport of the flavonols should have occurred and it would 
be interesting to see if there was any correlation between the cumulative efflux of both the 
galactose and also the flavonol glucosides tested. It should also be noted that the 1 mM 
concentration was non-physiological and is not representative of a normal dietary intake. 
The validity of this study and its relation to actual in  v i v o  absorption requires careful 
evaluation.
To further investigate the possible interaction between flavonol glucosides and the
glucose transport pathway, a different approach was used. In this instance, the possibility of
flavonol glucosides acting as inhibitors of SGLTl was investigated. The hypothesis was
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based on the structural similarity between phloridzin and quercetin-3-glucoside (Figure 6.8). 
When the glucose moiety on phloridzin binds to the receptor on SGLTl, it inhibits glucose 
transport by acting as a competitive inhibitor (Dorando and Crane, 1984). In view of the 
structural similarity between phloridzin and quercetin-3-glucoside, the latter may possibly 
have the same action as phloridzin. However, this was not evident in our study as we did 
not find any inhibition in glucose transport in the presence of up to
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0uercetin-3-O-(3-glucoside Phloridzin
Figure 6.8: The structures o f  quercetin-3-glucoside and phloridzin
500 juM concentration of quercetin-3-glucoside. This implies that quercetin-3-glucoside did 
not inhibit the glucose carrier protein at the concentrations used.
Publications on the mechanism of flavonol transport across the small intestine are 
sparse as this area of research has received somewhat limited attention. To date, there are 
only three reports on very preliminary studies (Notebom et al., 1997, Gee et al., 1998 and 
Walgren et al., 1998).
Walgren et al (1998) used CaCo-2 cells, which were able to express SGLTl, to
examine the uptake of several quercetin glucosides. They reported no transport of
quercetin-4-glucoside from the apical to basolateral side of the CaCo-2 cells and concluded
that there was no interaction between SGLTl and the flavonol glucoside. In another study,
Notebom et al (1997) studied flavonol uptake using perfusion of surviving rat jejunal
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segments. Their results suggested that some quercetin monoglucosides, e.g. quercetin-4'- 
glucoside might interact with SGLTl based on the flavonols ability to stimulate glucose 
transfer. However, at the same time, they also reported that other quercetin glucosides 
including quercetin-3-glucoside, at concentrations of 10 pM, behaved as inhibitors of this 
glucose carrier. We did not observe this using the same concentration of quercetin-3- 
glucoside. However, Notebom and colleagues measured flavonol absorbed after 2 h 
perfusion of the gut segments. At this point, the reliability of the segments and their ability 
to transport molecule is questionable. Cells in the mucosal side may not be viable and may 
affect transport of molecules across the intestine. Therefore, estimation of true intestinal 
absorption may not be accurate. Certainly further studies are needed to evaluate this matter.
Other techniques exist to further evaluate the possible role of SGLTl in mediating 
the uptake of flavonols. Expression of SGLTl or other specific transporters in a cell system 
for example in oocytes of x a e n o p u s  l a e v i s  (Hediger e t  a l . ,  1987) can provide a more definite 
answer on the ability of this carrier protein to mediate flavonol uptake. Furthermore, other 
transporters exist in epithelial cells with the possibility of mediating flavonol uptake. This 
includes the Na^-dependent amino acids transporters which share 50-60% sequence identity 
as SGLTl (Hediger and Rhoads, 1994). On the other hand, there may exist other, yet to be 
identified, carrier proteins in the small intestine with the ability to mediate flavonol uptake,
6.4.2 Percentage recovery following incubation experiment
After the 30 minute incubation time, recovery of quercetin-3-glucoside and
quercetin-3,4'-diglucoside in the incubation media was more than 80% and 90%
respectively. Overall, when cumulative uptake of both the flavonol glucosides was
expressed as percentage absorbed, less than 0.5% was detected in the serosal side. At the
same time, low absorption of flavonols or other compounds into the serosal side is a typical
characteristic of i n  v i t r o  intestinal transport preparations. This can be partly attributed to the
different hydrodynamic properties to that which would occur in  v i v o ,  for instance the
absence of blood circulation in in  v i t r o  preparations. A few studies have demonstrated
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gîucuronidation of fïavonol glucosides including quercetin-3-glucoside during their 
transport across the epithelial membrane (Shimoi e t  a l . ,  1998, Spencer e t  a t . ,  1999). 
However, we did not detect the presence of HPLC peaks which correspond with putative 
glucuronide conjugates of quercetin-3-glucoside (see Chapter 5).
6.5 Conclusion
This study established that the uptake of flavonol glucosides across the intestinal 
membrane occurred via a carrier-mediated pathway. From the various experiments 
performed, we have established that quercetin-3-glucoside neither interacts with SGLTl for 
their transport nor does it inhibit the glucose transport pathway at the concentrations used. 
Further research are needed to identify the carrier protein responsible for flavonol uptake 
across the intestinal membrane as this will enable investigations on the structural 
requirements for the carrier protein. In this way, flavonols that are highly absorbable can be 
identified and their biological properties determined.
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CHAPTER 7: IN  VITRO METABOLISM OF
FLAVONOLS USING RAT LIVER HOMOGENATES
7.1 Introduction
Available evidence on absorption studies points to extensive metabolism of 
flavonoids following their absorption. We have shown that quercetin glucosides and 
diglucoside were better absorbed from the intestine than the aglycone, quercetin 
(Chapter 5). In studies with ileostomy volunteers, based on the amount excreted in the 
ileal effluent, it was estimated that 52% of quercetin glycosides (Hollman e t  a l . ,  1995) 
and 89% and 5% respectively for isorhamnetin-4'-glucoside and quercetin-4'-glucoside 
(Aziz e t  a l . ,  2000) were absorbed following a fried onion meal. However, when 
percentage absorption was measured in plasma following the same type of diet, only low 
levels of flavonols were detected at peak concentration (<2%) (Hollman e t  a l . ,  1995, 
Aziz e t  a l . ,  1998, McAnlis, 1999). Thus, a large percentage of the absorbed flavonols is 
unaccounted for which raises the possibility that substantial post-absorption metabolism 
of the quercetin glycosides may be occurring.
Not much information is available regarding the pathway of flavonol metabolism
after their absorption. Several studies have reported gîucuronidation as well as
méthylation of quercetin following oral administration of the aglycone to rats (Ueno e t
a l . ,  1983, Manach e t  a l . ,  1997). The liver has been suggested as the major organ
responsible for the metabolism of flavonoids and vaiious reactions can occur including
hydroxylation, méthylation and the formation of sulphate and glucuronide conjugates
(Griffiths, 1982, Hackett, 1986) (See Chapter 1, Section 1.12.2). Although some
research has been performed on the hepatic metabolism of flavonols, they have always
concentrated on aglycones rather than flavonol glycosides. As flavonols in food are
predominantly found conjugated to sugar conjugates (Cook and Samraan, 1996), which
appear to be more absorbable than their aglycones (Chapter 5), investigation of their
post-absorptive metabolism is required. The main objective of this study was to
investigate the metabolism of flavonol conjugates particularly those that were found in
abundance in onions. In addition, the proposal that quercetin-4'-glucoside undergoes
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méthylation to isorhamnetin-4'-glucoside in the liver was also investigated. For this 
purpose, i n  v i t r o  incubations of the test flavonols with rat liver extracts were carried out. 
Similar procedures have been used to study the metabolism of flavonoids such as 
quercetin and fisetin (Zhu e t  a l . ,  1994) and (-)-epicatechin (Piskula and Terao, 1998) by 
hepatic enzymes.
7.2 Materials and Methods
7.2.1 Preparation of flavonol standards and incubation 
buffer
Standards of quercetin-3,4'-diglucoside, quercetin-3-glucoside, quercetin-4'- 
glucoside and isorhamnetin-4'-glucoside (Figure 7.1) were dissolved in methanol. All 
incubation experiments were performed in 50 mM phosphate buffer (pH 7.4) containing 
10 mM MgCL.
7.2.2 Preparation of liver homogenates
Liver samples were obtained from Sprague-Dawley rats (average weight 286.5 g) 
kept on a standard rat and mouse expanded diet (B and K Universal Limited, Hull, UK). 
Rats were stunned with a blow to the head prior to killing by cervical dislocation. An 
incision was made on the abdomen and the liver was removed immediately and placed in 
saline solution on ice. The livers were cleaned and divided into 1 g portions which were 
frozen in liquid nitrogen and stored at -80°C prior to the experiment.
7.2.3 Deglycosylation of flavonol glucosides
A method developed by Shaw and Griffiths (1980) with slight modifications was 
used for the incubation assay. Rat liver extracts were prepared by homogenising 1 g of 
thawed liver in 5 ml of ice-cold phosphate buffer (50 mM, pH 7.4) containing 10 mM 
MgCla. The incubation medium comprised 1 g of homogenated liver and 24 nM of
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flavonol in 10 ml phosphate buffer (50 mM, pH 7.4, containing 10 mM MgCh). The 
reaction was started by the addition of the flavonol substrate and the incubation was 
carried out in a shaking water bath for 2  h at 37°C. Half ml samples were withdrawn at 0  
min and every 10 min for the first half an hour and every 30 min thereafter. Triplicate 
experiments were performed for each flavonol. The flavonols tested were quercetin-3,4'- 
diglucoside, quercetin-4'-glucoside, quercetin-3 -glucoside and isorhamnetin-4
glucoside. Control experiments were conducted in the absence of either the flavonol or 
the liver homogenate.
7.2.4 Méthylation of flavonol g lu cosid es
The same incubation procedures as those outlined in section 7.2.3 were 
performed but with the addition of 24 nM 5'-adenosyl methionine (SAM) as a methyl 
donor (Shaw and Griffiths, 1980). Triplicate incubations were carried out using 
quercetin-3,4'-diglucoside, quercetin-4 -glucoside, quercetin-3-glucoside and
isorhamnetin-4 -glucoside as substrates.
7.2.5 Flavonol extraction from lyophilised tissu es
Samples obtained were immediately frozen with liquid nitrogen prior to 
lyophilisation. The freeze dried incubates were extracted in 0.5 ml of 1 0 0 % methanol 
for 30 min at 4°C and the extracts were centrifuged at 3000 x g for 1 0  min to sediment 
particulate matter. Aliquots of supernatant, 37 pi in volume, were then made up to 250 
pi with distilled water containing 0.5% trifluoroacetic acid prior to the analysis of 200 pi 
volumes by gradient elution reversed phase HPLC (section 3.2.1).
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7.2.6 Identification of isorhamnetin-3-giucoside in the
liver extract^
Standards of isorhamnetin-3-gIucoside and liver extract samples were analysed 
on a Shimadzu lOAvp liquid chromatograph, with an absorbance monitor operating at 
365 nm. A Genesis 4 pm 150 x 3.0 mm C l 8  reversed phase column, maintained at 40°C 
was eluted at 0.8 ml/min with a 45 minute gradient of 10-45% acetonitrile in water 
containing 1% fonnic acid. After passing through the flow cell of the absorbance 
monitor, the column eluate was directed to a Shimadzu LCQ8000 quadropole mass 
spectrometer with an atmospheric pressure chemical ionisation (AfCI) interface in 
positive ion mode operating in full scan mode from 300 to 700 amu.
7.3 Results
7.3.1 Metabolism of quercetin-3,4 -diglucoside
In the presence of liver homogenates, querceti n-3,4'-diglucoside underwent 
deglycosylation as depicted by the gradual decrease in its concentration over the 
incubation period and the concomitant increase in the concentration of quercetin-3- 
glucoside which reached levels of 175 ± 21 ng/g (1.9 ± 0.2 % of the initial substrate 
concentration) after 2 h (Figure 7.2). Essentially the same pattern was observed when 
liver extracts and quercetin-3,4'-diglucoside were incubated in the presence of SAM. 
This suggests that no méthylation of this diglucoside occurred. Quercetin-4'-glucoside 
was not detected in any of the incubation mixtures and no quercetin-3-glucoside was 
detected in the control samples.
A typical HPLC trace obtained from the incubation of quercetin-3,4'-diglucoside
with liver extracts at 0 min and 90 min, detected on the UV monitor at A3 6 5  nm
illustrated in Figure 7.3 (A and B). Co-chromatography established that peaks 1 and 2 
corresponded to querceti n-3,4'-diglucoside and quercetin-3 -glue oside, respectively.
' HPLC and MS identification of isorhamnetin-3-glucoside in liver extract was performed by Mr William 
Mullen, Department of Biochemistry, University of Glasgow.
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Figure 7.2: The profiles of quercetia-3,4^-diglucoside and its metabolites following 
incubation with liver homogenates under the conditions stated.
Incubations were performed for 2 h at 37°C and sampling every 10 min for the first 30 min and every half 
hour thereafter. Following lyophilisation and methanolic extraction, samples were analysed for flavonol 
content on a reversed phase HPLC system. Flavonol content is expressed as ng/g fw ± SEM. Each 
condition is a mean of 3 experiments. Graphs show liver extract profiles of quercetin-3,4'-diglucoside and 
quercetin-3 -glucoside.
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Figure 7.3: Gradient reverse phase HPLC analysis of flavonols in liver extracts
Column: 150 x 3.0 mm i.d. Genesis Cis cartridge column with a 10 x 4.0 mm 4-pm Genesis Cjg 
guard cartridge. Mobile phase: 25 min gradient of 15-40% acetonitrile in water containing 0,5% 
trifluoroacetic acid. Flow rate: 0.5 ml/min. Detector: absorbance monitor operating at 365 nm. Samples: 
(A) aliquot of sample collected immediately after the incubation of quercetin-3,4'-diglucoside with liver 
extracts; (B) as (A) but collected 90 min after the incubation; (C) aliquot of sample collected immediately 
after the incubation of quercetin-4'-gluco si de with liver extracts; (D) as (C) but samples collected 90 min 
after the incubation. Peaks l=quercetin-3,4'-diglucoside; 2=quercetin-3-glucoside; 3=quercetin-4'- 
glucoside; 4=quercetin; 5=isorhamnetin.
1 7 1
Quercetin-3-glucoside accumulated over the 90 min incubation period along with other 
metabolite peaks which did not correspond with any of the available flavonol standards 
(Figure 7.3 B).
7,3.2 Metabolism of quercetin-3-glucosîde
Rapid metabolism of quercetin-3-gIucoside occurred when SAM was added to 
the liver preparations with 4049 ± 55 ng/g f.w at 0 h falling to 354 ± 89 ng/g f.w at the 
last sampling point (Figure 7.4). Three metabolites were detected, isorhamnetin-3- 
glucoside and the aglycones isorhamnetin and quercetin (Figure 7.4). The formation of 
isorhamnetin-3-glucoside was extremely rapid as it was detected at the 0  min time point, 
which was sampled within seconds of the addition of quercetin-3-gluco si de. This 
flavonol glucoside appeared to peak around 20-30 min with a concentration of 914 ± 26 
ng/g f.w (23 ± 0.7 % of the original substrate concentration) before gradually decreasing. 
Free isorhamnetin was also detected in the presence of SAM, with levels peaking at 23.3 
± 3.4 ng/g f.w (0.6 ±0.1 % of the original substrate) after 30 min, after which it declined 
steadily. Trace levels of free quercetin gradually decreased to less than 5 ng/g f  w at the 
end of the 2  h incubation period.
The data demonstrate that in the liver preparations, quercetin-3-glucoside is 
subject primarily to 3'-0-methylation in the presence of SAM. The detection of trace 
levels of quercetin and isorhamnetin indicate that both the substrate quercetin-3- 
glucoside and its major metabolite isorhamnetin-3-glucoside are subject to 
deglycosylation. The levels of quercetin-3-glucoside in the control samples without 
liver homogenate remained high during the 2 h experiment. The three metabolites were 
not detected in the control incubations (Figure 7.4).
Traces obtained in an typical HPLC analysis, with detection at A3 6 5  nm and by
fluorescence detection following on-line post-column derivatization, with a liver
preparation collected after a 20 min incubation are illustrated in Figure 7.5 B and C.
Peak 1 was identified as quercetin-3-glucoside by co-chromatography whereas peaks 2, 4
and 5 corresponded to isorhamnetin-3-glucoside, quercetin and isorhamnetin
respectively. Although traces of isorhamnetin-3-glucoside (peak 2) and the unidentified
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Figure 7.4: The profiles of quercetin-3~glucoside and its metabolites following incubation 
with liver bomogenates under the conditions stated.
Incubations were performed for 2 h at 37°C and sampling every 10 min for the first 30 min and every half 
hour thereafter. Following lyophilisation and methanolic extraction, samples were analysed for fiavonol 
content on a reversed phase HPLC system. Fiavonol content is expressed as ng/g f.w ± SEM. Each 
condition is a mean of 3 experiments. Graphs show liver extract profiles of quercetin-3,-glucoside, 
isorhamnetin-3-glucoside, isorhamnetin and quercetin.
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Figure 7.5: Reverse phase HPLC and mass spectrum analysis o f a liver extract foUmving 
the incubation of quercetin~3-glucoside in the presence o f S-adenosyl methionine.
HPLC analysis. Column: 150 x 3.0 mm i.d. 4 pm genesis Cig cartridge column. Mobile phase: 25 minute 
gradient of 15-40% acetonitrile in water containing 0.5% TFÂ. Flow rate: 0.5 ml/min. Detector: 
absorbance monitor operating at 365 nm and following post-column derivatization, a fluorimeter at 
excitation 425 nm and emission 480 nm HPLC-MS analysis. Shimadzu LCQ8000 quadropole mass 
spectrometer with an Atmospheric Pressure Chemical Ionisation (APCI) interface ;n positive ion mode 
operating in full scan mode from 300 to 700 amu. (A) HPLC trace of flavonols in liver extract collected at 
0 min following incubation with quercetin-3-gIucoside and SAM, detected at A3 6 5 ; (B) as (A) but collected 
20 min after the incubation, detected at (C) same as (B) but with post-column derivatization and 
fluorescence detection; (D) APCI positive ion spectrum of a 50 ng standard of isorhamnetin-3-glucoside, 
M+-m/z 479; aglycone base peak-m/z 317. (E) APCI positive ion spectrum of isorhamnetin-3-glucoside 
obtained from HPLC peak 1 in (B), M+-m/z 479; aglycone base peak-m/z 317.
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HPLC peak 3 were present in the 0 min sample (Figure 7.5A), they were not detected in 
the control sample without the presence of liver extracts. This implies either rapid 
metabolism of quercetin-3-glucoside or the presence of trace impurities from the liver 
preparations.
Isorhamnetin-3-glucoside has the same retention time as quercetin-4'-glucoside 
(see Figure 7.3) but the identity of the isorhamnetin conjugate was continued by LC-MS 
(Figure 7.5 D-E). The isorhamnetin-3-glucoside standard (Figure 7.5 D) and the
metabolite (Figure 7.5 E) both yielded spectra with major ions at m/z 479 (M ' ) and m/z
317. The mass spectrum of quercetin-3-glucoside contains the equivalent fragments ions 
14 amu lower at m/z 465 and m/z 303 (W. Mullen, unpublished).
7,3.3 Metabolism of quercetin-4'-glucoside
Metabolism of quercetin-4'-glucoside by liver homogenates was observed with 
the level of the glucoside decreasing gradually over the 2 h incubation period with 
approximately 175-250 ng/g f.w detected in the last sampling point compared to the 
initial concentration of 5857 ng/g f.w at 0 min (Figure 7.6). Deglycosylation of 
quercetin-4'-glucoside occurred as indicated by the build up of low levels of free 
quercetin, equivalent to ca. 1% of the original substrate concentration after 2 h (Figure 
7.6). Incubation of quercetin-4'-glucoside in the presence of SAM resulted in the 
appearance of isorhamnetin in the liver preparations (Figure 7.6). Isorhamnetin levels 
peaked around 60 min, giving approximately 43.3 ± 3.7 ng/g f.w (0.7 ± 0.1%), after 
which it started to decrease. Trace levels of isorhamnetin also formed in preparations to 
which SAM was not added, possibly as a consequence of endogenous SAM acting as 
methyl donor. Isorhamnetin-4'-glucoside was not detected as a metabolite of quercetin- 
4 '-glucoside. This suggests that the isorhamnetin that accumulated was formed by 3-0- 
methylation of quercetin. Levels of quercetin-4'-glucoside in the control samples were 
generally stable and only fell slightly over the 2 h incubation period (Figure 7.6). 
Neither quercetin nor isorhamnetin were detected when quercetin-4’-glucoside was 
incubated without the liver preparation.
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Figure 7.6; The profiles o f quercetin-4'-glucoside and its metabolites foUo^ving incubation 
with liver homogenates under the conditions stated.
Incubations were performed for 2 h at 37°C and sampling every 10 min for the first 30 min and every half 
hour thereafter. Following lyophilisation and methanolic extraction, samples were analysed for fiavonol 
content on a reversed phase HPLC system. Fiavonol content is expressed as ng/g f.w ± SEM. Each 
condition is a mean of 3 experiments. Graphs show liver extract profiles of quercetin-4'-glucoside; 
quercetin and isorhamnetin.
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Figure 7,3 (C and D) iJlustrate typical HPLC traces of a sample collected at the 0 min 
and 90 min time point, detected by the UV monitor at 365 nm. Peaks 3, 4 and 5 co­
chromatographed with quercetin-4'-glucoside, quercetin and isorhamnetin, respectively. 
Quercetin and isorhamnetin gave higher peaks when detected by fluorimeter after post­
column derivatization (data not shown). Other unknown peaks not present at 0 min 
could also be detected on the UV trace 90 min after the incubation. These peaks did not 
correspond to any of the available standards.
7.3 .4  Metabolism of isorhamnetin-4 -glucoside
Deglycosylation of isorhamnetin-4'-glucoside was obsei*ved when the conjugate 
was incubated with the liver homogenates. There was a ca. 50% decline in the level of 
the glucoside over the 2 h incubation period (Figure 7.7) that was associated with a 
concomitant increase, albeit at a lower level, of isorhamnetin. Free isorhamnetin was not 
detected in the control experiments (Figure 7.7). The rate of decline in the level of 
isorhamnetin-4 '-glucoside was not affected by the presence of SAM in the incubation 
medium (Figure 7.7).
7.3.5 Summary of metabolism of flavonols by rat liver 
hom ogenates
The méthylation and deglycosylation of the fiavonol glucosides by rat liver 
homogenates is summarised in Table 7.1. For comparative purposes, accumulation of 
the metabolites at the end of 2 h was expressed as a percentage of the initial substrate 
concentration. Generally, flavonols in the control samples were stable throughout the 2 h 
incubation period with more than 80% of the parent compounds recovered at the end of 
the experiment.
All four fiavonol glucosides underwent metabolism over the 2 h incubation 
period. Metabolism was highest for quercetin-4'-glucoside (10.9 ± 1.7 % recovered after 
2 h) followed by quercetin-3-glucoside (32.4 ±2.7 %), isorhamnetin-4'-glucoside (36.4 
± 0.4 %) and quercetin-3,4'-diglucoside (68.1+4.1 %) (Table 7.1). Interestingly, when
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Figure 7.7: The profiles o f isorhamnefin-4'-glucoside and its metabolites following 
incubation with liver homogenates under the conditions stated.
Incubations were performed for 2 h at 37°C and sampling every 10 min for the first 30 min and every half
hour thereafter. Following lyophilisation and methanolic extraction, samples were analysed for fiavonol
content on a reversed phase HPLC system, Fiavonol content is expressed as ng/g f.w ± SEM. Each
condition is a mean of 3 experiments. Graphs show liver extract profiles of isorhamnetin-4'-glucoside and
isorhamnetin.
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Table 7.1: The extent of fiavonol metabolism and the accumulation of metabolites 
following incubation with rat liver homogenates.
Fiavonol Recovery of 
substrate after 2 h
Accumulation of metabolites ^
(%), -.
incubation^
(%)
Qiiercetin-3-
glucoside
Isorhamnetin-
3-glucoside
Quercetin Isorhamnetin
Quercetin-3,4'- 
diglucoside
With SAM 46.4 ±6.8 1.2±0.3 - - -
Without SAM 68.1 ±4.1 1.9±0.2 - - -
Control 100 - - - -
Quercetin-3-
giucoside
With SAM 8.6 ±2.2 - 16.7 ±1.5 0.1 ±0.05 0.1 ±0.03
Without SAM 32.4 ±2.7 - 6.5± 1.0 0.2 ±0.15 0.01 ±0.01
Control 100 - - - -
Quercetin-4’-
giucoside
With SAM 14.5 ±2.2 - - 0.8 ±0.3 0.4 ±0.1
Without SAM 10.9±1.7 - - 0.8 ±0.2 0.1 ±0.01
Control 82.9 ±7.9 - - -
lsorhamnetin-4’-
giucoside
With SAM 33.6 ±2.6 - - - 5.7 ±2.6
Without SAM 36.4 ±0.4 - - - 4.6 ±1.4
Control 79.2 ±4.9 - -
Results are expressed as the percentage of fiavonol remaining at the end of the 2 h 
incubation period relative to the amount at the start of the experiments. (n=3 ± SEM).
 ^ Accumulation of the metabolites after 2 h incubation was calculated as a percentage of the 
initial substrate concentration in the incubation media. (n=3 ± SEM).
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accumulation of the metabolites was expressed as percentage of the initial substrate 
concentration, the figures obtained did not directly correspond to the extent of 
metabolism of the substrate at the end of the 2 h period. In most instances, accumulation 
of the metabolites was much lower than we would have expected based on the extent 
ofmetabolism of the parent compound. It would appear that other types of metabolism 
are occurring as well as deglycosylation and méthylation and this will be further 
discussed in the next section.
Quercetin-3-glucoside was methylated extensively when SAM was added to the 
liver homogenates. At the end of a 2 h incubation period, more than 90% of the 
quercetin-3-glucoside added to the liver preparation had been metabolised. At peak 
concentration, the accumulation of methylated products, isorhamnetin-3-glucoside and 
isorhamnetin was 22.6 ± 0.7% and 0.6 ± 0.1%, respectively. In the case where SAM was 
not present, accumulation of isorhamnetin-3-glucoside and isorhamnetin was only 6.5 ± 
1.0% and 0.03 ± 0.02%, respectively, at peak levels. Deglycosylation of quercetin-3- 
glucoside occurred at a much lower extent than 0-methylation with the percentage 
accumulation of quercetin in the range of 0.6-0.8%. The total accumulation of 
metabolites at 2 h only accounted about 20% of the total quercetin-3-glucoside 
metabolised.
Deglycosylation of quercetin-3,4 -diglucoside yielded quercetin-3-gIucoside (1.2- 
1.9%) which accounted for only 6% of the decline in the level of the parent compound 
(32-54%). Quercetin-4'-glucoside was deglycosylated to quercetin (1.0%) and a 
proportion of the free quercetin was methylated to isorhamnetin, as observed in 
incubations with the presence of SAM (0.4%). The extent of metabolism of this 
glucoside was much higher than the metabolites generated implying the involvement of 
other reactions besides deglycosylation. Some deglycosylation of isorhamnetin-4'- 
glucoside also occurred, giving rise to approximately 4.6-5.7% of isorhamnetin, 
representing only about 13% of the metabolised substrate.
1 8 0
7.4 Discussion
Studies on the antioxidant activities of flavonoids suggest higher activities of 
flavonoid aglycones compared to the conjugated forms (Laughton et al., 1991, Rice- 
Evans et al., 1996). However, flavonoids, with the exception of flavan-3-ols, almost 
always occur in the diet as glycosides and only a very small proportion exists as the 
aglycone. Thus, metabolic studies of flavonoids are important to provide information on 
the fate of these compounds following their absorption and the resulting biological 
activities of their metabolites.
7.4.1 Méthylation of flavonols
The ability of the liver catechol-(9-methyl transferase (COMT) to methyl ate 
several flavonoids has been reported (Zhu et a l, 1994). In the present study, méthylation 
of quercetin-3-glucoside occurred when SAM was present in the incubation experiments. 
This was evident from the percentage of the fiavonol substrate recovered at the end of 
the incubation period (8.6%) as well as the amount of metabolites formed. High levels 
of the metabolite isorhamnetin-3-glucoside could be detected. The presence of a 
catechol group (C-3 ,4 -dihydroxylation) on quercetin-3-gIucoside would increase the 
affinity of the COMT for this fiavonol. The additional presence of the aglycone 
isorhamnetin suggests some deglycosylation of quercetin-3-glucoside to liberate 
quercetin which subsequently undergoes 3'-0-methylation to isorhamnetin. 
Alternatively, it could also be a result of deglycosylation of isorhamnetin-3-glucoside. 
Figure 7.8 illustrates a proposed pathway for the hepatic metabolism of quercetin-3- 
glucoside.
Méthylation of quercetin-3-glucoside was rapid and this was evident in the rapid 
increase of the 0-methylated metabolite isorhamnetin-3-glucoside. A higher affinity of 
the COMT for quercetin, ca. 3 orders of magnitude higher than its natural substrates, 
catecholamines, has been reported by Zhu et al. (1994). This may explain the above 
observations. As isorhamnetin-3-glucoside was also detected in incubations without 
SAM, albeit to a lesser extent, some endogenous SAM may already be present in the
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liver homogenates to allow O-methylation to occur. O-methylation was not observed 
with quercetin-3,4'-diglucoside, quercetin-4'-glucoside and isorhamnetin-4 -glucoside, 
possibly due to the absence of the catechol group on the B ring.
Méthylation of flavonols has been demonstrated in rats orally fed quercetin 
(Manach et a l, 1997). In this instance, conjugates of isorhamnetin and tamarixetin (4'- 
O-methyl quercetin) were detected in plasma. Although the 4 -O-methylation of 
quercetin-3-glucoside has not been reported previously, this reaction would appear to be 
feasible because of the presence of the catechol moiety on the B ring of the quercetin 
conjugate. Méthylation of quercetin and fisetin using porcine liver COMT has also been 
reported in vitro (Zhu et al,, 1994). In addition, studies on the tissue distribution of 
COMT showed that liver had the highest activity, supporting the role of liver in this 
reaction (Piskula and Terao, 1998).
Of the four fiavonol conjugates tested in this study, only quercetin-3-glucoside 
underwent méthylation. This is the only fiavonol with a catechol group on the B-ring. 
Quercetin-3,4'-diglucoside, quercetin-4'-glucoside and isorhamnetin-4'-glucoside do not 
have a 3 ',4 '-dihydroxy structure. In addition, the presence of SAM in incubations with 
quercetin-4'-glucoside and isorhamnetin-4 -glucoside did not result in further 
metabolism suggesting that méthylation of these flavonols did not occur.
When quercetin-4'-glucoside was incubated in the liver homogenates, 3 -0- 
methylation of the fiavonol did not occur to yield isorhamnetin-4'-glucoside. This 
implies that the active site on the enzyme COMT is not able to bind quercetin-4'- 
glucoside. Thus, the data obtained with the in vitro rat liver preparations did not support 
the hypothesis that in humans, absorbed quercetin-4'-glucoside undergoes 3 -0- 
methylation to form isorhamnetin-4'-glucoside. It is possible that other tissues may play 
a role in this reaction or that human liver may contain different (9-methyltransferases to 
rat liver. Alternatively, the 24 nM SAM concentration used was too little for 3 -0- 
methylation of quercetin-4'-glucoside to occur.
The enzyme COMT catalyses the inactivation of catecholamines and is also 
responsible for the detoxification of xenobiotic catechols (Creveling et aL, 1970). The 
presence of the catechol structure is a crucial structural moiety for interaction with
183
COMT. In addition, the polarity of the compound to be methylated is probably of 
importance (Piskula and Terao, 1998). Catechols with polar substituents are 
preferentially methylated at C-3' whereas the presence of non-polar substituents, e.g. 
quercetin aglycone leads to random méthylation, giving rise to either 3'- or 4 -0- 
methylated metabolites (Creveling et aL, 1970). In this study, when the fiavonol 
conjugates were deglycosylated to produce quercetin, COMT will O-methylate the 
aglycone, but not the parent compounds, quercetin-3,4’-diglucoside or quercetin-3- 
glucoside, to isorhamnetin.
7.4.2 D eglycosylation of flavonols
Deglycosylation was observed with all four flavonols, albeit at seemingly 
different rates as evident from the concomitant rise in levels of the aglycones (Table 7.1), 
Variation in the percentage accumulation of deglycosylated products of fiavonol 
glucoside metabolism suggests structural specificity of the liver p-glucosidase. The 
enzyme appears to have a higher affinity for fiavonol glucosides with glucose 
substitutions at C-4' than at the C-3 position. This was evident in the conversion of 
quercetin-3,4 -diglucoside to quercetin-3-glucoside and metabolism of quercetin-4'- 
glucoside to quercetin compared to the low level of quercetin accumulation in 
incubations with quercetin-3-glucoside. The apparent lack of conversion of quercetin- 
3,4'-diglucoside to quercetin-4'-glucoside is in keeping with this proposal.
Day et al. (1998) described in vitro deglycosylation of several flavonoids by 
glycosidases of liver cell-free extracts. In particular, they observed 69% deglycosylation 
of quercetin-4'-glucoside. Interestingly, this group reported that quercetin-3-glucoside 
and quercetin-3,4 -diglucoside were not hydrolysed by the enzymes from the liver 
extract. Nevertheless, we detected some metabolism of quercetin-3,4 -diglucoside and 
possibly quercetin-3-glucoside, with recoveries of ca. 32% and 68% respectively, of the 
original substrate. However, as mentioned above, the 68% metabolism of quercetin-3- 
glucoside could be primarily the result of méthylation rather than deglycosylation.
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7.4.3 Other metabolic reactions
One interesting observation from this study is the possible involvement of other 
metabolic reactions in addition to méthylation and deglycosylation. Based on our 
results, the accumulation of metabolic products did not correspond to the extent of 
metabolism of the corresponding fiavonol glucoside (see Table 7.1). In most instances, 
the level of metabolites recovered at the end of the 2 h incubation was equivalent to <6% 
of the initial substrate concentration. In contrast, there was a >30% fall in the level of 
substrate, leaving ca. 24% of metabolites unaccounted for. As the fiavonol glucosides 
were relatively stable in the control samples, it would imply that other metabolic 
reactions are occurring in addition to deglycosylation and méthylation. As an example, 
extensive metabolism of quercetin-3-glucoside was observed from the appearance of 
methylated metabolites. However, based on the decline in the levels of the glucoside and 
accumulation of the metabolites, it would appear that a large percentage of the 
metabolites were not accounted for. As we only detected 0.2% of deglycosylated 
products, other reactions may have occurred in addition to deglycosylation and 
méthylation. The possibility that other methylated metabolites were produced as well as 
isorhamnetin-3-glucoside and isorhamnetin should be taken into consideration. In 
addition to 3 '-O-methylation of quercetin-3-glucoside, 4 '-O-methylation of this 
glucoside could also have taken place to yield tamarixetin-3-glucoside. Indeed, we 
detected an unknown HPLC peak, which when analysed by the LC-MS showed similar 
mass spectrum to isorhamnetin-3-glucoside (peak 3, Figure 7.5 B). However, due to the 
lack of this standard and limited time, this was not further investigated.
The liver has been reported to be able to glucuronidate, sulphate and hydroxylate 
flavonoids as well as carry out deglycosylations and méthylations (Griffiths, 1982, 
Hackett, 1986). A study by Day et al (1999) demonstrated glucuronidation of free 
quercetin and isorhamnetin following incubations with liver cell-free extracts. 
Glucuroni dation of these aglycones was extensive and three to four glucuronidation 
metabolites were detected. Glucuronic acids were added to the fiavonol molecule at 
various sites, mainly C-4', C-7 and C-3. In addition to in vitro experiment, in vivo studies 
with animals also demonstrated glucuronidation and/or sulphation of flavonols following 
oral administration of the parent compound. Glucuronides of quercetin, isorhamnetin
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and tamarixetin as well as sulphates of quercetin were detected in the bile and urine of 
rats fed quercetin (Ueno et al., 1983). Sulphation of quercetin was also reported in 
an isolated perfusion experiment with rat liver (Shali et a i, 1991). Zhu et al (1994) 
described extensive metabolism of quercetin following its intraperitoneal administration 
to hamsters. In addition to extensive O-methylation of the parent compound to form 
isorhamnetin, a portion of the resulting metabolites was also conjugated by 
glucuronidation or sulphation. In another study where rats were supplemented with 
0.2% quercetin, the major circulating metabolites were glucurono-sulpho conjugates of 
isorhamnetin and quercetin (92%) (Morand et ai, 1998). This group also demonstrated 
in vitro sulphation and glucuronidation of quercetin by liver extracts. Although in vitro 
glucuronidation of fiavonol glucosides by the liver has not been reported, the likelihood 
of this happening is high given that the liver is likely to conjugate flavonols rather than 
deglycosylate.
7.5 Conclusion
This study confirms that the liver is capable of O-methylation and 
deglycosylation of several naturally occurring fiavonol glucosides, particularly those that 
are found in abundance in onions. Quercetin-3-glucoside underwent extensive 
méthylation to yield methylated metabolites of this fiavonol. This stresses the 
importance of the catechol group for méthylation of flavonols, catalysed by the enzyme 
COMT. Deglycosylation of quercetin-4'-glucoside, isorhamnetin-4'-glucoside, and to a 
less degree quercetin-3,4 '-diglucoside, implies structural specificity of the enzyme 
glycosidases towards the flavonols. Results from this study also suggest that méthylation 
and deglycosylation are not the only metabolic reactions involved in the liver 
metabolism of fiavonol glucosides. The possibility of other metabolic events occurring 
merits further research, especially the possible formation of glucuronide and sulphate 
conjugates. Furthermore, the rate and extent of fiavonol metabolism appear to be 
dependent on their structure as well as the position of their sugar moiety. Such study is 
highly relevant in determining the metabolites formed by flavonols following their 
absorption. In this way, the potency of the original flavonols ingested can be determined 
and the benefits of their consumption evaluated. The information will also be useful for 
any in vivo metabolic studies of fiavonol glucosides.
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CHAPTER 8: GENERAL DISCUSSION
Recent interest in the absorption and metabolism of flavonoids in humans was 
sparked by reports of their potent antioxidant activities and possible protection against 
diseases associated with oxidative damage. Evidence from epidemiology studies, 
although still limited, points to a possible protection of dietary flavonoids against 
coronary heart disease and possibly cancer (Hertog et a i, 1993, Keli et al., 1996, Knekt 
et a i, 1997). This area of research requires further investigation as the information 
available is limited and several questions remain unanswered.
The main objective of this thesis was to carry out research on the absorption and 
metabolism of flavonoids particularly from the sub-class flavonols. Attempts were made 
to identify absorption of individual flavonols prior to acid hydrolyses treatment which 
breaks the glycoside as well as any glucuronide or sulphate linkages. Most studies have 
analysed fiavonol content after the hydrolyses of conjugates. This gives only a 
combined estimate of the free flavonols and the aglycones liberated from the conjugates. 
Specific fiavonol glycosides cannot be identified this way. At the same time, the mode 
and extent of fiavonol absorption from the small intestine was also evaluated. The 
process that occurs in the gut or during transepithelial transport is the first step that 
determines the bioavailability of fiavonol. In addition, we investigated the hepatic 
metabolism of several flavonols.
To achieve this, first, we performed a feeding study with healthy human 
volunteers. They consumed a single dose of flavonol-rich fried onions after which the 
presence of flavonols in the plasma and urine was analysed (Chapter 4). A modified in 
vitro everted rat gut model developed by Wilson and Wiseman (1954) was applied for 
the investigations of fiavonol absorption from the small intestine. This common and 
widely used method is useful in evaluating intestinal uptake of flavonols as it allows easy 
sampling from the serosal side as well as maintaining cell viability. In the case of 
fiavonol metabolism, the liver was chosen as it has been widely reported to play a major 
role in fiavonol metabolism. In vitro incubations of flavonols commonly found in onions 
was carried out in the presence of rat liver homogenates. In this way, the route of their
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metabolism can be evaluated and will give an indication as to the extent of their 
metabolism and susceptibility towards biotransformation.
8.1 Discussion of the techniques used in this study
This thesis involved extensive use of HPLC as a means of fiavonol identification 
and quantification. Development of a post-column derivatization procedure involving 
formation of a fiavonol-A1(N0 3 ) 3  fluorescent complex has allowed increased sensitivity 
and selectivity for fiavonol analysis (Holiman et al., 1996). Such method provided ease 
in analysing fiavonol normally present in biological fluids in minute levels. Flavonols 
with a free hydroxyl group at C3 and a keto group at C4 can form fluorescent complexes 
with aluminium ion, hence increasing their sensitivity for the purpose of identification 
(Hollman et al., 1996). The procedures of Ho liman et al (1996) were made more reliable 
and suitable for automated HPLC by using 0.1 M rather than the much more viscous 1.0 
M methanolic A1(N0 3 )3 . This resulted in only a 2-3-fold drop in sensitivity and a ten­
fold saving in the cost of A1(N0 3 )3 .
The everted rat gut model adapted for studying intestinal transport of flavonols 
provided reliable results. It is a convenient way of studying intestinal transport due to its 
simplicity as well as sensitivity. The large standard error in certain incubations is 
indicative of the different characteristics (e.g thickness of intestine) and transport 
behaviour between different segments and also between different animals. The age of 
the rats used is important as intestine from young rats remain viable for longer periods 
than those taken from adult animals. However, newborn intestine is not suitable due to 
their fragility.
The liver is the main organ responsible for the metabolism of absorbed 
compounds. Development of in vitro methods to study hepatic metabolism has enabled 
the identification of metabolites produced following the metabolism of specific 
flavonols. This has allowed investigation of the relationship between fiavonol structure 
and the extent of their metabolism. Such study is more complicated in in vivo systems
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due to interference from other substances and other physiological processes as well as 
the difficulty of sampling.
8 .2  Absorption o f flavonols
The quercetin glucosides from onions were well absorbed into the plasma of 
human volunteers and excreted into urine. This was the first study which described the 
absorption of individual onion flavonols, mainly quercetin-4'-glucoside and 
isorhamnetin-4'-glucoside. So far, feeding studies with onions reported absorption of 
only quercetin glycosides, determined after acid or enzymic hydrolyses (Hollman et al., 
1995, 1996, McAnlis et ai, 1999). Such studies allow estimation of quercetin glycosides 
only after liberation of the aglycone from the sugar bonds. As they did not analyse the 
samples before acid/enzyme hydrolysis, it was not clear if the quercetin detected was 
actually that liberated from sugar bonds or the free quercetin already present before 
hydrolysis. With this method, the absorption and identification of specific fiavonol 
glucosides is not known. However, the availability of standards as well as sensitive 
HPLC and post-column derivatization procedure has enabled the identification of the 
fiavonol glucosides. The data obtained in the present study demonstrated absorption of 
fiavonol conjugates, hence contrast and so refutes the hypothesis of Kuhnau (1976) that 
only fiavonol aglycones are absorbed.
In our study, we found high plasma levels of isorhamnetin-4'-glucoside, a minor 
fiavonol in onions whereas quercetin-4'-glucoside, which was present in high 
concentrations in onions, was present in low levels in plasma. Interestingly, quercetin- 
3,4'-diglucoside, which was the major onion fiavonol was not detected in plasma of the 5 
subjects despite being highly absorbed in the everted rat gut model. Our study 
demonstrated selective absorption of flavonols from the small intestine. On the other 
hand, their differential metabolism or sequestration into tissues following absorption may 
explain the results obtained. Several hypotheses are proposed to explain the results 
obtained based on our work and the existing literature.
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The higher accumulation of isorhamnetin-4'-glucoside compared to quercetin-4'- 
glucoside is in agreement with another recent study where ileostomy volunteers ingested 
200 g of fried yellow onions (Aziz et al., 2000). This study reported approximately 40 
times greater accumulation of isorhamnetin-4'-glucoside compared to quercetin-4'- 
glucoside in plasma of the volunteers following a meal of lightly fried onions. An 80 
fold difference was obtained in our study (chapter 4). Interestingly, when the content of 
the ileostomy effluent was analysed for unabsorbed flavonols, more than 80% of the 
ingested isorhamnetin-4'-glucoside was recovered whereas only about 5% of the 
quercetin-4'-glucoside remained in the ileostomy effluent. Our in vitro incubations of 
onions with digestive juices to mimic the small intestinal digestion process demonstrated 
the stability of the fiavonol glucosides. Less than 20% degradation was observed despite 
the presence of O.IM HCl in the lumen of the small intestine (Chapter 4). Indeed, 
Hollman et al (1995) also reported the relative stability of flavonols to gastric juices in 
vitro. This implies that metabolism of flavonols did not occur in the lumen of the small 
intestine, leaving the flavonols unchanged for absorption. Thus, the flavonols recovered 
in the ileostomy effluent were the unabsorbed flavonols remaining after passing through 
the small intestine. The high recovery of isorhamnetin-4'-glucoside in the ileostomy 
fluid implies that intestinal absorption of this fiavonol glucoside was not very efficient 
despite its presence in high levels in plasma. Certainly our in vitro everted rat gut model 
showed less efficient uptake of isorhamnetin-4'-glucoside compared to the other fiavonol 
glucosides (Chapter 5). One explanation for the high levels of isorhamnetin-4'-glucoside 
in plasma is its poor metabolism and/or less efficient removal from the bloodstream. 
Longer retention of isorhamnetin in plasma compared to quercetin has been reported, 
possibly as a result of more effective release of isorhamnetin into the hepatic venous 
blood (Manach et ai, 1997). An alternative explanation is that a proportion of the 
absorbed isorhamnetin-4'-glucoside is excreted into bile and is reabsorbed via the 
enterohepatic circulation, thus maintaining its presence in plasma. Biliary excretion of 
conjugated isorhamnetin (Manach et ai, 1996) as well as conjugated forms of quercetin 
and tamarixetin (Crespy et al., 1999) has been described in rats orally fed quercetin. It 
has also been proposed that some of the isorhamnetin-4'-glucoside present in plasma 
may have been fonned by 3 '-O-methylation of the absorbed quercetin-4'-glucoside 
(Aziz et al., 1998), hence explaining higher levels of the former and lower levels of the 
latter. However, our in vitro experiments with liver homogenates did not show this. The
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absence of the catechol structure on ring B, required for O-methylation by COMT 
(Creveling et al., 1970) could have prevented this reaction. The possibility that tissues 
other than the liver playing a role in this reaction should also be considered. The kidney 
has been reported to have the ability to methylate the anthocyanin cyanidin-3-glucoside 
(Tsuda et al., 1999). Alternatively, rat liver and human liver may have different 
metabolic properties.
Unlike isorhamnetin-4'-glucoside, the low recovery of quercetin-4'-glucoside in 
the ileostomy effluent implies their efficient absorption from the small intestine. Thus 
the low levels of this glucoside in plasma is likely due to their effective metabolism 
and/or removal from the bloodstream. One possible pathway for their metabolism is by 
deglycosylation of the sugar bonds, catalysed by the liver (3-glycosidase. Our incubation 
study with liver extracts demonstrated almost 90% metabolism of quercetin-4'-glucoside 
(Chapter 7). Another study reported 69% deglycosylation of quercetin-4'-glucoside 
following incubations with cell-free preparations from human liver (Day et al., 1998). 
This group also found extensive deglycosylation of quercetin-4'-glucoside following 
incubations with cell-free preparations from small intestine which may further explain 
their low levels in plasma. They proposed that deglycosylation occurs during the 
transport of quercetin-4'-glucoside across the intestinal membrane, releasing free 
quercetin. If this was the case, large amounts of free quercetin should be present in 
plasma and urine of the volunteers following the fried onion meal. However, we did not 
detect the presence of high levels of this aglycone in plasma and urine. This implies that 
if deglycosylation of quercetin-4'-glucoside occurred during their passage across the 
small intestine and in the liver, there is another pathway which metabolises or effectively 
removes the free quercetin from the bloodstream.
Our feeding study did not detect the presence of quercetin-3,4'-diglucoside in 
plasma or urine despite their efficient absorption in the everted rat gut model (chapter 5) 
and also in the study of Gee et al (1998). The ileostomy fluid of volunteers fed the fried 
onion meal was also devoid of this diglucoside (Aziz et al., 2000). This suggests the 
efficient absorption of quercetin-3,4'-diglucoside from the small intestine. The 
diglucoside did not accumulate in plasma in detectable amounts despite its absence in the 
ileostomy fluid (Aziz et al., 2000). This indicates that if quercetin-3,4'-diglucoside is
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absorbed from the small intestine, there exists an efficient pathway that metabolises this 
compound or effectively removes it from the bloodstream. The liver has been proposed 
as the organ responsible for metabolism of quercetin-3,4'-diglucoside. Our in vitro 
hepatic metabolism of quercetin-3,4'-diglucoside showed approximately 50% 
metabolism (chapter 7). However, we only detected 2% of deglycosylation products, 
indicating the possible involvement of other reactions, possibly glucuronidation and/or 
sulphation. From our feeding study with the volunteers, estimation of levels of 
conjugated quercetin after the fried onion meal in the acid hydrolysed samples gave a 
percentage of intake of 0.97% at peak plasma concentration (chapter 4). Compared to 
the 0.13% accumulation of quercetin-4'-glucoside in the non-hydrolysed plasma, a 
percentage of the conjugated quercetin could be contributed by metabolites of this 
aglycone as well as its glucosides and diglucosides, possibly glucuronide or sulpho- 
conjugates. Certainly, more in vitro experiments are needed to confinn the metabolic 
pathway for fiavonol glucosides as well as the metabolites formed as this is the most 
common ingested form of flavonols. Glucuronidation and sulphation of quercetin by 
enzymes of the liver is widely reported (Ueno et al., 1983, Shali et al., 1991).
In recent studies, the ability of several flavonoid glycosides as well as free 
quercetin and isorhamnetin to undergo glucuronidation during their passage across the 
small intestine has been described (Day et al., 1999, Spencer et al., 1999). This raises 
the possibility that the liver is not the only organ capable of this reaction. Although the 
authors did not investigate the glucuronidation of quercetin-3,4'-diglucoside and 
quercetin-4'-glucoside, the possibility of these two flavonols following this reaction 
should be considered. Spencer et al (1999) suggested that glucuronidation favours the 
presence of the catechol structure (3 ',4'-(9-dihydroxylation) on ring B. However, 
neither quercetin-3-glucoside nor rutin have this structure and both were absorbed 
mainly as glycosides. It should be noted that a higher concentration of the perfused 
compound was employed by Spencer et al. (> 50 pM) than was used in our study (10 
pM). It is unlikely that such a high concentration of flavonols will be present in the 
small intestine at one time given that the average daily intake of flavonols is only 23 
mg/d (Hertog et al., 1993) spread throughout the day. Based on these results, it is highly 
unlikely that a large proportion of the quercetin-3,4'-diglucoside and quercetin-4'- 
glucoside pools are subjected to intestinal glucuronidation. Furthermore, these two
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fiavonol glucosides did not possess the catechol structure on ring B which have been 
proposed as a structural requirement for intestinal glucuronidation (Spencer et al., 1999). 
Perhaps the liver plays a more prominent role in glucuronidation of flavonols. The 
characteristic of the liver glucuronyltransferase and sulphotransferase is not known and 
the requirements for binding to the flavonols are not known. It is possible that a different 
glucuronyltransferase and sulphotransferase from that found in the intestinal membrane 
is reacting in the liver.
8.3 Accumulation of flavonols in plasma
We estimated the relative area under the curve (AUC) of plasma fiavonol 
glucosides and the aglycone in the onion study. In keeping with their presence in 
plasma, the bioavailability o f quercetin-4'-glucoside was one eighth that of 
isorhamnetin-4'-glucoside. When AUC was estimated for conjugated quercetin after 
acid hydrolysis, a much higher value was obtained, approximately 2- fold and 16-fold 
higher than isorhamnetin-4'-glucoside and quercetin-4 -glucoside, respectively. 
Conjugated quercetin in the hydrolysed plasma may contain other glycosides, 
glucuronides or sulphates in addition to quercetin-4'-glucoside. Their bioavailability 
may be different from quercetin glucoside, depending on the rate and extent of their 
absorption from the intestine, hence the high AUC observed (Chapter 5).
Bioavailability most likely differs with different flavonols. Tomatoes for 
example are rich in quercetin rutinoside (Stewart, personal communication), apples 
contain high levels o f quercetin galactoside (Lister, 1994) whereas tea contains mainly 
conjugated forms o f quercetin and kaempferol as well as low levels o f myricetin (Hertog, 
1994). The bioavailability of dietary rutin in humans is not widely studied. A pilot 
study investigating the absorption of flavonols in human volunteers who ingested cherry 
tomatoes only detected very low levels of conjugated quercetin in plasma (<2%) (Crozier 
et al., 2000). Unchanged rutin was not detected in samples of unhydrolysed plasma, 
probably because it was present at levels below the limits of detection. Bioavailability of 
pure rutin was one third (Hollman, 1997) that of quercetin glycosides from onions 
(Chapter 4). In addition, the bioavailability o f quercetin glycosides from apples was also
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lower than onions (Hollman, 1997). The fact that apples contain different sugar 
substitution attached to quercetin compared to onions may explain the difference in 
bioavailability (Lister, 1994). On the other hand, the bioavailability of tea flavonols has 
not been described, possibly because fiavonol concentration in tea is lower than other 
dietary source and coupled with extensive metabolism will preclude their identification 
in plasma. A pilot study detected less than 2% accumulation of conjugated quercetin at 
peak plasma level following ingestion of 400 ml of black tea (Crozier et al., 2000). The 
clear difference in bioavailability of quercetin glycosides described above suggests that 
eating tomatoes and apples or drinking tea may not increase plasma fiavonol levels as 
much as onions.
Determination of the bioavailability of flavonols from various dietary sources can 
provide useful data on foods containing highly bioavailable flavonoids. The information 
is highly useful in epidemiology studies whereby the major source of dietary flavonols 
can be compared with their bioavailability. In this way, a more precise association 
between fiavonol intake and disease occurrence can be made. Several epidemiology 
studies reported tea as the main source of flavonols, but tea flavonols did not appear to 
be highly absorbable (Crozier et al., 2000). This may indicate that the inverse 
association may have been contributed by other compounds in tea such as catechins 
instead of flavonols.
8.4 Mechanisms of absorption of flavonols
The mode and extent of fiavonol absorption from the small intestine is one of the 
determinants of their bioavailability. Results from both the onions feeding study and 
uptake of individual flavonols from the everted rat gut model suggest differences in the 
extent of their absorption. A carrier protein is the most likely vehicle for the transfer of 
fiavonol glycosides across the intestinal membrane due to the polar properties of 
fiavonol conjugates. Existing literature also seems to point to the involvement of a 
carrier protein for the transport of flavonols across the small intestine (Gee et al., 1998). 
Attempts to identify the carrier involved have provided conflicting results. Our study
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indicated that SGLTl was unlikely to play a major role in mediating fiavonol glucoside 
uptake across the small intestine (Chapter 6).
Clearly, more studies are required to determine the exact mechanism. Other 
transport pathways and carrier protein exist in the membrane of the small intestine 
responsible for the uptake of a variety of compounds. The prospect of these carriers 
being involved in mediating fiavonol uptake should not be ruled out. We proposed 
several possible mechanisms for intestinal transport of flavonols (Figure 8.1). GLUTS, a 
fructose transporter is a potential carrier. It has a 39-65% sequence identity with other 
glucose transporters (Mueckler, 1994), suggesting a possible involvement in mediating 
the uptake of flavonols. In addition to SGLTl, the presence of a second Na^-dependent 
glucose transporter in the brush border membrane has been suggested based on kinetic 
studies (Ferraris and Diamond, 1986). The ability of phloridzin to inhibit this transporter 
has not been determined and its involvement in fiavonol uptake is possible. In addition 
to the known transporters, there maybe other carrier proteins with the ability to transport 
flavonols which to-date have not been identified. As mentioned previously (Chapter 6), 
several compounds including glucose are capable of being transported via the tight 
junction which can be regulated by SGLTl. However, the likelihood of flavonols 
following this pathway is dependent on their structure particularly their polarity.
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Figure 8.1: Possible m echanism s o f  intestinal fiavonol transport.
Four possible routes are hypothesised for the transport of flavonols on the apical 
membrane and one possible route for transport across the basolateral membrane: (I) 
sodium-independent fructose transporter (GLUTS); (II) the sodium-dependent glucose 
transporter; (III) an unidentified transporter; (IV) the paracellular pathway and (V) the 
sodium-independent glucose transporter.
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8.5 Metabolism of flavonols
8.5.1 Liver metabolism
Differences in the degree of metabolism of various flavonols by liver extracts 
imply structural-dependence on their metabolism. This was observed in the feeding 
study with onions (chapter 4). Excretion of onion flavonols in urine following ingestion 
of the fried onions ranged from as low as 0.2 % (quercetin-4'-glucoside) to 17.4 % 
(isorhamnetin-4'-gIucoside), expressed as a percentage of the total intake (Chapter 4). 
Their accumulation in plasma showed a similar trend. Differences in excretion of the 
onion flavonols imply differences in the extent of their metabolism. Holiman e t  a !  
(1995) reported 52% absorption of quercetin glucosides from onions whereas we 
detected less than 1% at peak levels in plasma and 0.8% in urine. This suggests 
extensive metabolism of quercetin glucosides following their absorption. Indeed, 
substantial metabolism of flavonoi glucosides was seen with experiments using rat liver 
homogenates with percentage metabolism ranging from 32-91% (Chapter 7). Although 
we could detect only méthylation and degiycosylation of flavonoi glucosides, the 
possible involvement of other reactions should not be discounted.
In addition to méthylation, liver is also capable of forming flavonoi conjugates 
with glucuronic acid and sulphate. The enzyme glucuronosyltransferase and 
phenolsulfotransferase are responsible for glucuronidation and sulphation, respectively. 
Formation of glucuronides and sulphates of quercetin has been demonstrated using an 
isolated perfused rat liver system (Shah e t  a i ,  1991). The types of metabolites formed 
appear to be dependent on the parent compound. In rats fed a quercetin diet, 92% of the 
circulating metabolites were glucurono-sulfo derivatives of isorhamnetin and quercetin 
(Morand e t  a l . ,  1998). The remaining 8% was contributed by the glucuronides of 
methoxylated forms of quercetin (e.g isorhamnetin or tamarixetin). The glucurono- 
sulpho derivative of isorhamnetin is 6 times higher than the glucurono-sulpho derivatives 
of quercetin. This implies extensive méthylation of the parent compound. The extent of 
the same reaction occurring following ingestion of quercetin glucosides is not known. I n  
v i v o  glucuronidation of quercetin glucosides following their ingestion has not been
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reported. This is because analysis of quercetin conjugates from biological samples has 
always been done based on the free quercetin liberated after acid or enzymic treatment. 
Nevertheless, the prospect of this happening is likely and merits further investigation.
Our i n  v i t r o  incubation of quercetin-3,4'-diglucoside with liver extracts showed 
about 32-54% metabolism of this diglucoside with 2% accumulation of quercetin-3- 
glucoside. If the same occurred i n  v i v o ,  we should have detected some quercetin-3- 
glucoside in plasma or urine after the onion supplement. However, there was no 
evidence of this. This is probably a result of the extensive méthylation of the liberated 
quercetin-3-glucoside to isorhamnetin-3-glucoside or possibly tamarixetin-3-glucoside. 
As these two methylated metabolites do not form fluorescent complexes with A1(N0 3 )3, 
which facilitates detection with enhanced sensitivity, their possible presence in plasma or 
urine could not be confirmed using an absorbance monitor operating at 365 nm. 
Conjugation is possibly the most common final step in the metabolic pathway of 
flavonoids to generate hydrophilic molecules to assist in their excretion.
8.5.2 Small intestinal metabolism
In addition to liver, recent findings suggest that the small intestine may play a 
substantial role in the initial metabolism of flavonoids. I n  v i t r o  incubations of fried 
onions with digestive juices demonstrated the stability: of onion flavonols towards 
enzymes in the juices as well as the acidic environment. However, degiycosylation and 
glucuronidation of flavonols has been reported in the small intestine (Notebom e t  a l . ,  
1997, Day e t  a l . ,  1998, Shi moi e t  a l . ,  1998, Spencer e t  a i ,  1999). It was proposed that 
these reactions occur in the brush border membrane during flavonoi transport across the 
intestinal membrane rather than in the lumen of the intestine (Day e i  a i ,  1998). 
Quercetin was mainly glucuronidated whereas quercetin-3-glucoside was deglycosylated 
more extensively than being subjected to glucuronidation during their movement across 
the intestinal wall (Spencer e t  a i ,  1999). If degiycosylation of quercetin-3-glucoside 
occurred during their uptake, we should have detected quercetin aglycone in our everted 
segment incubations. However, this was not apparent and several reasons could have 
caused this. The 10 pM concentration of quercetin-3-glucoside was probably too low to
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see any measurable amount of free quercetin in the serosal side, given that the percentage 
absorption of the parent compound was low in the first place. Furthermore, Spencer e f  
a l . ,  1999, in their study used a higher concentration of quercetin-3-glucoside and longer 
incubation periods and such high concentration may not be achieved at normal dietary 
intake.
8.5.3 Colonic metabolism of flavonols
An i n  v i t r o  fermentation of digested and undigested fried onions was carried out 
to investigate colonic bacterial metabolism of flavonols which escaped absorption. 
Extensive degiudation of flavonols occurred with neither flavonoi glycosides nor their 
aglycones being present in significant amounts at the end of a 24 h incubation period. 
The liberated through hydrolysis were not detected. Thus, absorption of unchanged 
flavonols in the large intestine is improbable, leaving the small intestine responsible for 
flavonoi absorption. Ring fission of flavonols appears to be the main step in colonic 
bacterial metabolism of flavonoids. This reaction yields metabolites such as phenolic 
acids which possess considerable antioxidant activities and can be absorbed (Kim e t  a l . ,  
1998). Hence, a small part of the ingested onion flavonols which escaped absorption in 
the small intestine could still provide beneficial health properties through their action 
with colonic microorganisms. Studies investigating the extent of phenolic acid 
absorption following ingestion of flavonol-rich food and their antioxidant activities can 
provide more information on the potential of these metabolites.
8.6 Proposed pathway for the metaboHsm of 
flavonols
Based on the results obtained in this study as well as published reports, we 
proposed a hypothetical pathway for the metabolism of flavonols. Absorption of 
flavonols occurred in the small intestine, most likely in the jejunal segments. Following 
absorption, flavonols enter the portal veifi primarily as the unchanged compound. 
Glucuronidation and degiycosylation may occur in the liver as well as sulphation and
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méthylation before appearing in the general circulation (see Figure 7.8, chapter 7). 
Again, the extent of these reactions occurring on the flavonoi molecule is highly 
dependent on their structure. The kidney may be involved in méthylation of flavonols 
(Piskula and Terao, 1998, Tsuda e t  a i ,  1999) although the extent of their contribution is 
not known. Degiycosylation by the liver may only be a minor pathway as the 
metabolism of flavonols tend to go in the direction of producing more polar molecules 
for the purpose of excretion. This was observed in rats fed a diet of quercetin whereby 
conjugated forms of quercetin including glucuronides and sulphates were detected in 
plasma instead of aglycone (Ueno e t  a i ,  1983; Manach e t  a l . ,  1997). The order in which 
these reactions occurred and the metabolites that accumulate will be dependent on the 
flavonols present, their structure and sugar substitution. In a study where rats were fed a 
quercetin diet, conjugated forms of isorhamnetin accumulated in levels ca. 4.5 fold 
higher than quercetin conjugates (Manach e t  a i ,  1995). This implies méthylation as a 
more prominent reaction in the metabolism of quercetin than conjugation.
Following the above reactions, the metabolites generated can be sequestered in 
various tissues or excreted either via urine or bile. Metabolites excreted in bile are 
capable of further metabolism and absorption through the enterohepatic circulation.
8.7 Absorption of flavonols and the impact of their 
biological properties.
Based on the onion feeding study, flavonols particularly quercetin conjugates 
persist in the blood for a number of hours following consumption and had a long 
elimination period. Levels above baseline could be detected in samples of several 
volunteers collected 24 h after they first ate the onions. Subjects on a normal diet had 
quercetin levels of 25 ng/ml. This implies that continuous consumption of high flavonoi 
food can lead to an elevated steady state level of flavonols in plasma. Owing to the low 
bioavailability and extensive metabolism of flavonoids, consumption and identification 
of highly bioavailable flavonoids is crucial.
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Results from this present study, together with published reports show very low 
levels of the unchanged administered flavonoi excreted in urine (< 20%). The relevance 
of the absorption and metabolism of flavonols in the human body is ultimately related to 
their biological properties particularly as antioxidants. Flavonoi aglycones are more 
potent antioxidants than their glycosides owing to the higher numbers of free OH groups 
for hydrogen donation (Rice-Evans e t  a i ,  1996). However, flavonols in the diet exist 
almost exclusively in the glycoside form. Although some flavonoi glycosides may 
undergo degiycosylation during their absorption, the likelihood that the resulting 
aglycone will circulate in the blood circulation is minimal. Most likely, the flavonoi 
aglycone will be further metabolised by the liver or kidney to conjugated flavonoi to give 
a more polar molecule.
Thus, epidemiological studies describing association between flavonoi intake and 
reduced risk of heart disease is probably not caused by the unchanged flavonols due to 
their extensive metabolism. Rather, the protective effect is probably a result of the 
biological properties of the metabolites of flavonoids or the involvement of other 
compounds with antioxidant properties. Several phenolic acids, arising from ring fission 
of quercetin glycosides showed considerable antioxidant activities (Merfort e t  a l . ,  1996). 
Phenolic acids for instance 3,4-dihydroxyphenylacetic acid and 4-hydroxyphenylacetic 
acid were more effective in anti-platelet aggregation activity than quercetin (Kim e t  a i ,  
1998). Thus, the potential of the metabolites of flavonoids acting as antioxidants cannot 
be discounted. Alternatively, the association observed with increased flavonoid intake 
may only mean that high flavonoid intake can be associated with a healthier lifestyle, 
consumption of high amounts of fruit and vegetable which are rich in other antioxidants 
and regular exercise.
8.8 I n  v i v o  antioxidant activity of flavonoids
Several flavonols showed higher antioxidant activity than vitamins C and E. 
Quercetin, for instance, is more potent than the 2 vitamins when their antioxidant activity 
was measured as the Trolox equivalent antioxidant activity (TEAC) (Rice-Evans e t  a i ,  
1997). The TEAC technique measures the relative ability of flavonoids to scavenge the
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ABTS radical cation (2,2’-azinobis (3-ethylbenzothiazoline-6-sulphonic acid) generated 
in the aqueous phase, compared with standard amounts of Trolox, a synthetic water- 
soluble vitamin E analogue. Using a different antioxidant assay, flavonoids were again 
shown to have higher antioxidant activities than vitamin C, E and p-carotene. In this 
instance, antioxidant activity was measured as the concentration of flavonoids needed for 
50% inhibition of LDL oxidation (Vinson e t  a i ,  1995).
In i n  v i t r o  experiments, metabolites of quercetin including quercetin glucuronides 
were shown to significantly delay copper-induced lipoprotein oxidation at concentrations 
of 0.5 pM (Morand e t  a l . ,  1998). Furthermore, in another recently published article, 
several quercetin glucosides found in onions, mainly quercetin-3-glucoside and 
quercetin-4'-glucoside were capable of inhibiting lipoxygenase-induced LDL oxidation 
i n  v i t r o  (Da Silva e t  a i ,  1998). Quercetin and quercetin-3-glucoside exhibited a higher 
inhibitory effect than quercetin-4'-glucoside with IC50 values of 0.4, 0.5 and 1.2 pM 
respectively. Glucose substitution at C-4' significantly reduced antioxidant activity, due 
to absence of C-3',4' G-dihydroxylation, which is one of the requirements for strong 
anti oxidant activities (van Acker e t  a l . ,  1996). It is highly likely that isorhamnetin-4'- 
giucoside will exhibit similar antioxidant properties as quercetin-4'-glucoside due to 
sugar binding at C-4'.
One way to determine the effectiveness of flavonoi consumption is to evaluate 
their i n  v i v o  antioxidant activity. This can be done by measuring the antioxidant activity 
of a sample of plasma following ingestion of a high-flavonoid food. One recent study 
measured plasma antioxidant activity of human volunteers following ingestion of 225g 
fried onions (McAnlis e t  a l ,  1999). Although the antioxidant activities of plasma 
increased after the onion meal, it was not enough to cause a significant change in the 
susceptibility of plasma to LDL oxidation. This study gave a peak plasma concentration 
of 284.4 ng/ml (0.82 pM) for quercetin. Comparing this value with the IC50 values of 
quercetin metabolites obtained by Da Silva e t  a l  (1998) (0.4 -  1.2 pM) and the 
concentration for inhibiting copper-induced lipoprotein oxidation (Morand e t  a l . ,  1998) 
(0.5 pM), some inhibition should have been observed in LDL oxidation. However, the 
possibility of quercetin binding to protein in plasma may explain the lack of inhibition of 
LDL. Binding of quercetin to plasma albumin following their oral administration to rats
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has been described (Manach e t  a h ,  1995). Furthermore, an i n  v i t r o  study also 
demonstrated extensive binding of quercetin to plasma proteins with more than 90% 
attached to serum albumin (Boulton e t  a h ,  1998). The extent to which plasma binding 
inhibits the cellular association of quercetin is of utmost importance as this may affect 
their antioxidative capability.
In our study, we obtained a peak plasma concentration of 45 ng/ml (0.1 pM) for 
quercetin-4 -glucoside after the fried onion meal. This concentration was much lower 
than the reported IC50 of 1.2 pM for quercetin-4'-glucoside (Da Silva e t  a h ,  1998). This 
implies that the presence of quercetin-4'-glucoside at this concentration was probably 
insufficient to inhibit LDL oxidation. In contrast to this, the 452 ng/ml (1.5 pM) peak 
plasma concentration of conjugated quercetin was significantly higher than the i n  v i t r o  
quercetin conjugates concentration of 0.5 pM required to delay copper-induced 
lipoprotein oxidation (Morand e t  a h ,  1998). This is assuming that a large proportion of 
the quercetin conjugates is present as glucuronides. Thus, there is a high possibility of 
plasma inhibiting lipoprotein oxidation at this concentration and this clearly merits 
further investigation. In theory, we probably do not consume 300 g of fried onions in a 
single meal. However, consumption of flavonol-rich foods spread throughout the day 
may lead to build-up of flavonols in the circulation. Although the onions used in our 
feeding studies did not contain quercetin-3-glucoside, which showed substantial 
antioxidant activity (Da Silva e t  a h ,  1998), other varieties of onions contain substantial 
levels of this monoglucoside (Tsushida and Suzuki, 1996, Price and Rhodes, 1997). 
Since their i n  v i t r o  antioxidant activity is higher than that of quercetin-4'-glucoside (Da 
Silva e t  a h ,  1998), fiirther investigation on the absorption of quercetin-3-glucoside is 
interesting in view of its potential role as an i n  v i v o  antioxidant.
Based on the IC50 values for quercetin and the concentration of quercetin 
glucuronides required to inhibit lipoprotein oxidation, «the reported daily quercetin intake 
of 16 mg (Hertog e t  a h ,  1994) will be insufficient to cause any beneficial antioxidant 
activities. Assuming 1% of the total intake was present at peak plasma concentration and 
approximately 3 L volume of plasma, a circulating quercetin concentration of 0.17 |iM is 
obtained at peak levels. Thus, the presence of quercetin at this concentration is likely 
insufficient to prevent LDL oxidation. Nevertheless, the bioavailability of quercetin
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from different dietary sources may vary, hence influencing antioxidant capacity of 
plasma. Therefore, studies evaluating the absorption of flavonols following ingestion of 
different flavonol-rich foods can provide more information on their bioavailability. At 
the same time, encouraging the public to increase intakes of high-flavonoi foods above 
the present reported levels may lead to increase in plasma flavonoi concentration.
8-9 Prospects for future research
8.9.1 Bioavailability of flavonoids
Clearly, there is still limited information on the bioavailability of flavonoids. Our 
main interest is of the bioavailability of flavonoids from dietary sources. Although 
extensive studies have been performed on the absorption of flavonols from onions, not 
much is known regarding the bioavailability of flavonols from other main sources such 
as tea, tomatoes, apples, red wine and fruit juices. In addition, estimation of the 
absorption of specific flavonoi glycosides will provide us with information regarding the 
bioavailability of these flavonols. Identification of the absorption of specific flavonoi 
glycosides is desirable rather than their estimation based on the aglycone liberated 
following acidic or enzymic hydrolyses. This is because similar flavonoi conjugates, but 
with variations in the nature/position of the sugar moiety, may be absorbed at different 
rates. Therefore, hydrolysis of the sugar bonds or any glucuronide'or sulphate bonds will 
only , give estimates of the overall bioavailability of the flavonoid conjugates and not the 
individual compounds. Ultimately, such studies are useful in determining the 
relationship between the structure of flavonoids including sugar substitution and the 
extent of their absorption.
8.9.2 Metabolism of flavonoids
In addition to bioavailability, knowledge on the metabolism of flavonoids is also 
vital to determine the end products and the route of their metabolism. In view of the 
extensive metabolism of flavonols particularly quercetin glucosides, perhaps research 
should focus instead on identifying the metabolites produced. The prospect of tissues
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other than the liver playing a role in flavonoi metabolism should also be investigated. 
Metabolic studies with radiolabelled flavonols are the best approach as metabolites 
produced can be easily tracked and identified. The availability of complex 
instrumentation, for instance mass spectrometry analysis has opened up a wider area of 
research and enabled the identification and confirmation of various structures of 
flavonols which could not be done on a normal HPLC system. Identification of 
metabolites is important towards evaluating the biological properties of dietary 
flavonoids. It is not sufficient from epidemiology evidence to conclude that high intakes 
of flavonoids are protective against diseases if in truth, they are metabolised to a non­
reactive form.
8.9.3 The m ode and extent of flavonoid absorption
The mechanisms of flavonoid absorption from the intestine warrants further 
research. I n  v i t r o  methods are ideal as they allow easy access to the serosal side of the 
intestine. Thus, flavonols absorbed can be immediately sampled prior to metabolism as 
would have probably occurred with i n  v i v o  system. Determination of the carrier protein 
requires a more specific method. Experiments involving isolation of brush border 
vesicles for instance can be used to investigate the involvement of SGLTl in flavonoid 
uptake. In addition, the expression of specific transporters for instance SGLTl or 
GLUTS in the oocytes o f  X a e n o p u s  l a e v i s  offers a powerful tool for identification of the 
carrier involved for intestinal transport of specific compounds (Hediger and Rhoads, 
1994). Such method can be adapted for investigating the transport system of flavonols. 
Furthermore, this technique can also be used to identify the actual flavonoi glucoside 
transporter if any of the transporters mentioned before did not play a role in their uptake. 
As current data are limited and showed contrasting results, clearly more studies are 
needed, comparing various techniques for intestinal absorption, before any conclusion 
can be drawn.
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CHAPTER 9: CONCLUSION AND 
RECOMMENDATIONS
9.1 Conclusion
9.1.1 Absorption of flavonoids
Absorption of quercetin occurred in the small intestine. Following a single dose 
of fried onions, there was higher accumulation of isorhamnetin-4'-glucoside than 
quercetin conjugates, including quercetin-3,4'-diglucoside and quercetin-4'-glucoside in 
plasma and urine of humans. Glycosylation of flavonoids enhanced their absorption. A 
carrier protein is most likely involved in the uptake of flavonoid glycoside across the 
intestinal membrane. The study described in this thesis provided no evidence that the 
sodium-glucose co-transport protein (SGLTl) mediates the uptake of flavonoi 
glucosides. In addition, quercetin-3-glucoside did not inhibit the glucose transport 
pathway. Structural modification in the flavonoid molecule, particularly the
nature/position of sugar substitution determines the extent of their absorption.
9.1.2 Metabolism of flavonoids
Based on the low levels of flavonols appearing in plasma and excreted in urine 
after the onions feeding study, flavonols especially quercetin glycoside are extensively 
metabolised. Méthylation is one route for metabolism of flavonols with a catechol 
moiety, for example quercetin and quercetin-3-glucoside. Degiycosylation of flavonoi 
glycosides may occur to a certain extent although reactions favouring the formation of 
more polar molecules appear to predominate. The extent of flavonoi metabolism by the 
liver is dependent on their structure as well as sugar substitution. Changes in 
stereospecificity will affect binding to the active site of the relevant metabolic enzymes. 
It remains to be detennined whether metabolites arising from flavonoi metabolism have 
the potential to act as anti oxidants and provide protection against oxidative damage.
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9.1.3 Flavonols in plasma and antioxidant activity
The reported average quercetin intake of 16 mg/d is probably insufficient to 
provide significant quercetin concentration in the circulating blood to prevent LDL 
oxidation. Consumption of foods containing highly bioavailable flavonoids, spread 
throughout the day can potentially lead to build up of flavonols in plasma. 
Determination of the concentration of quercetin metabolites in plasma and their 
anti oxidant ability is required to fully evaluate the beneficial effects of flavonoids.
9.2 Application of findings
Knowledge on the absorption and metabolism of flavonoids can be used to 
evaluate their biological role, particularly as antioxidants, and their ability to prevent 
LDL oxidation. Determination of the structural modification of the ingested flavonols is 
essential to obtain further understanding of their beneficial health properties i n  v i v o .  
Identification of flavonoids that are highly bioavailable can be used as a public health 
message to encourage increased consumption of foods containing high concentration of 
these flavonols, which will accumulate in high levels in the blood stream.
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